Discuss the applications of nuclear chemistry in medicine,
industry, and energy production
Introduction
Nuclear chemistry is the study of how nuclei react and change. It involves
changes in the composition and structure of atomic nuclei. Many important
practical applications of nuclear chemistry have emerged that have
massively impacted medicine, industry, and energy production. This paper
will explore the diverse applications of nuclear chemistry across these three
domains and discuss both their benefits as well as some criticisms and
concerns about their use.
Part 1: Applications in Medicine
Medical imaging
One of the most widespread medical applications of nuclear chemistry is in
medical imaging techniques such as positron emission tomography (PET)
scans, single photon emission computed tomography (SPECT) scans, and
nuclear magnetic resonance (NMR) imaging. These techniques utilize
radioactive tracers, which are molecules that have been labeled with
radioactive isotopes. When these tracers are introduced into the body, they
can be detected by specialized cameras and used to form detailed 3D
images of tissues and organs.
PET scans use radioactive tracers that emit positrons. Common PET
radiotracers include fluorine-18, carbon-11, nitrogen-13, and oxygen-15.
These radioactive atoms are attached to molecules that are involved in
normal body processes like glucose metabolism, blood flow, and protein
synthesis. As the radiotracer accumulates in tissues, the positions of emitting
positrons can be detected and used to construct tomographic images of
metabolic activity in the body. PET scans provide extremely sensitive and
quantitative measurements and have revolutionized the detection, diagnosis,
and monitoring of many cancers as well as brain disorders like Alzheimer's
disease.
SPECT scans similarly use gamma-ray emitting radioactive tracers but form
lower resolution images than PET. Common SPECT radiotracers include
technetium-99m, thallium-201, gallium-67, and iodine-123. Like PET tracers,
these label molecules involved in key physiological processes. By monitoring
the distribution and movement of radiotracers in the body, SPECT scans can
identify abnormalities and lesions. For example, SPECT scans with thallium-
201 or technetium-99m can detect blood flow issues in the heart muscle to
diagnose heart disease. Iodine-123 scans are also useful for diagnosing
thyroid disease and cancers.
NMR imaging, more commonly known as magnetic resonance imaging (MRI),
uses the magnetic properties of atomic nuclei instead of radioactivity. Many
MRI scans utilize the hydrogen nuclei naturally present in water molecules in
the body. Powerful magnets and radiofrequency pulses are used to excite the
magnetic dipoles of these nuclei, causing them to emit radio signals that can
be used to construct diagnostic images. MRI provides excellent soft tissue
contrast and has become an invaluable tool for examining the brain, spine,
joints, and many other internal structures without exposure to radiation.
Contrast agents containing gadolinium can also be intravenously
administered to enhance MRI images.
Radioisotope therapy
In addition to diagnostics, some radionuclides have therapeutic applications
for treating various medical conditions. One of the most well established is
the use of iodine-131 to treat hyperthyroidism and thyroid cancer. Iodine-131
has similar chemical properties to stable iodine and readily accumulates in
the thyroid gland where it destroys remaining thyroid tissue through beta
radiation exposure. This reduces overproduction of hormones in
hyperthyroidism while also destroying any cancerous thyroid cells. Treatment
is usually very effective with few side effects.
Strontium-89 and samarium-153 are also effective medical radioisotopes for
treating bone metastases from cancers like prostate and breast cancer.
These beta emitters selectively concentrate in areas of increased bone
turnover like cancerous bone lesions. Their radiation can help strengthen
bones weakened by metastases and relieve pain by ablating the cancer cells
within bone tissue. Radioimmunotherapy uses antibodies tagged with short-
range alpha or beta-emitting radioisotopes to bind to and destroy cancer
cells at a molecular level. Targeted isotopes include yttrium-90, iodine-131,
lutetium-177 and bismuth-213.
Other promising therapeutic radionuclides in development include actinium-
225 and lead-212. Actinium-225 generates four alpha particle emissions in
its decay chain and shows potential for treating acute myeloid leukemia and
other cancers if attached to monoclonal antibodies. Lead-212 can also
generate alpha decays and has a very short half-life of only 10.6 hours,
allowing it to deliver highly localized radiation doses without traveling far
from tumors. As radiotherapeutics continue to be researched and refined,
selective internal radiation exposures may become viable alternatives or
supplements to external beam radiation treatments for various cancers and
other conditions.
Radiopharmaceutical production
The production of radiotracers and radiopharmaceuticals for medical
applications is a major industry that generates billions in revenue annually.
Common medical radioisotopes like technetium-99m, iodine-123 and -131,
gallium-67, thallium-201, fluorine-18 and others are produced globally in
specialized nuclear reactors, particle accelerators, or generators. Radioactive
milling and processing facilities purify and formulate radionuclides into stable
chemical compounds suitable for intravenous injection or ingestion by
patients before scanning or therapy. Stringent regulations and quality
controls ensure the radioactive drugs are manufactured under high purity,
sterility, and maximum specific radioactivity standards. Continuous fission
reactors like those in Canada routinely supply over 80% of the U.S. demand
for the workhorse technetium-99m isotope needed for tens of thousands of
SPECT scans every day. The global medical radioisotope market, dominated
by the top three firms, is projected to grow annually by over 5% through
2027 due to expanding clinical applications and replacements for aging
reactor infrastructure. Overall, nuclear medicine has revolutionized diagnosis
and treatment, helping improve millions of lives.
Part 2: Applications in Industry
Isotope production
In addition to medical uses, nuclear processes are employed industrially to
produce important stable and radioactive isotopes. Light water reactors
generate sizeable quantities of plutonium-239 as a byproduct of uranium-238
absorbing neutrons. Plutonium-239 has a half-life of 24,100 years and its
decay produces mostly alpha particles, making it well suited for
thermoelectric applications in radioisotope thermoelectric generators (RTGs).
RTGs powered U.S. space missions for over 50 years including Voyager,
Galileo, and Curiosity by using the heat from plutonium-238's radioactive
decay.
Tritium, a radioactive isotope of hydrogen, is primarily used in self-luminous
sights for firearms, emergency exit signs, and other low light applications. It
is commercially produced by irradiating a lithium target with neutrons in a
nuclear reactor, followed by chemical separation. Large quantities of
naturally occurring krypton-81 are also collected from gaseous fission
products extracted from reactor off-gases. This stable noble gas isotope finds
use as an inert filler for energy efficient light bulbs and flat panel displays.
Neutron activation analysis
Another nuclear technique employed in industry is neutron activation
analysis (NAA), which involves irradiating samples with neutrons in a nuclear
reactor. This process causes certain elements in the sample to become
radioactive via neutron capture. By precisely measuring the gamma radiation
signatures emitted as these artificially produced radioisotopes decay, it is
possible to quantitatively determine the elemental composition of even
complex industrial materials down to trace quantities. NAA is useful for
quality control in sectors like mining, metallurgy, electronics manufacturing
and more. It can rapidly screen bulk samples for contaminants or verify
purity in a non-destructive manner.
Industrial radiography
Industrial radiography utilizes penetrating gamma and X-rays from
radioactive isotopes to examine the internal structures and defects in large
industrial components without having to dismantle or destroy them.
Common radiographic sources include cobalt-60, iridium-192, selenium-75
and caesium-137. The images reveal flaws invisible from the surface like
cracks, voids, corrosion or faulty welds in critical infrastructure parts like
pipelines, pressure vessels, bridges and machinery. This allows issues to be
addressed before catastrophic failures occur. While X-ray machines can also
perform industrial radiography, radioactive sources provide more penetrating
power for larger and higher density objects. However, their encapsulated
sources must be carefully shielded and handled to prevent exposure when
not in use.
Sterilization
Today, over half of all medical devices and many food products worldwide are
sterilized using gamma or electron beam radiation from radioactive isotopes.
Cobalt-60 is a popular gamma source that can penetrate packaging and
thoroughly sterilize items. The high-energy photons destroy microbes like
bacteria and viruses without leaving chemical residues. As no thermal or
pressure factors are involved, radiation sterilization maintains product
integrity and is suitable for heat- and moisture-sensitive items. In addition to
consumables, radiation has widespread uses decontaminating medical
equipment and sterilizing surgical gowns, drapes and implants before they
reach hospitals and patients. When combined with strict quality controls,
radiation-based sterilization provides a safe, effective and environmentally-
friendly alternative to steam, EtO gas or other chemical sterilants.
Part 3: Applications in Energy Production
Nuclear fission power
Nuclear fission reactors harness the energy released during nuclear fission
chain reactions to generate electricity on a commercial scale. Fissile
uranium-235 or plutonium-239 atoms are bombarded with neutrons and then
split apart, releasing additional neutrons, heat in the form of kinetic energy,
and gamma radiation. In a nuclear power plant, the heat generated is used
to produce steam that drives turbines connected to electricity generators.
Over 450 nuclear reactors worldwide currently supply about 10% of the
global electricity demand and one-third of low-carbon power. Generation II
light water reactors dominate the global fleet while Generation III+ and IV
designs incorporate passive safety and materials innovations.
Proponents argue nuclear energy is a stable, reliable, low-carbon baseload
power source able to meet rising energy needs. Unlike intermittent
renewables, fission continuously operates 24/7 and maintains the grid
reliability required by modern societies and industries. The energy density
per unit fuel mass from fission vastly exceeds fossil or renewable
alternatives. However, nuclear faces challenges from high capital costs and
construction timescales, nuclear waste management and proliferation
concerns as well as safety risks if accidents occur. Nevertheless, many
experts see it as indispensable for climate goals given its clean attributes,
and over 50 new reactors are under construction worldwide. Ongoing
research aims to sustain a nuclear renaissance through new small modular,
advanced, and fast neutron reactors.
Nuclear fusion power
Nuclear fusion harnesses the energy from fusing atomic nuclei lighter than
iron, the opposite reaction to fission. The most promising approach is using
strong magnetic fields in doughnut-shaped tokamak reactors to heat and
compress hydrogen isotopes deuterium and tritium under extreme
conditions, where their nuclei fuse and release helium atoms along with
energetic neutrons. This fusion process occurs naturally in the cores of stars
and greatly outstrips any chemical energy source on an energy per unit mass
basis. Researchers envision inertial confinement fusion using lasers and
hypersonic z-pinches as alternatives to the magnetic confinement approach.
The International Thermonuclear Experimental Reactor (ITER) tokamak
project currently underway in France aims to demonstrate the scientific and
technical feasibility of fusion power by generating net energy from fusion for
periods of several minutes by 2035. Beyond ITER, commercial fusion reactors
would not emit greenhouse gases, deplete resources or create long-lived
nuclear waste. With hydrogen as fuel, worldwide reserves could last for
millions of years. However, achieving economically viable and self-sustaining
fusion remains an immense technical challenge still far in the future given
difficulty in maintaining plasma stability, tailoring magnetic fields or focusing
laser energy precisely enough for efficient fusion conditions. Yet many think
mastering fusion could revolutionize future energy production sustainably if
the scientific obstacles are overcome.
Nuclear batteries
Radioisotope thermoelectric generators (RTGs) that operate on the heat from
radioactive decay have powered interplanetary spacecraft explorations since
the 1960s. Efforts are underway by companies to design small modular
nuclear batteries optimized to decentralize electricity access for off-grid
communities, charging electric vehicles, powering remote infrastructure
stations and more on Earth. Proposed designs use uranium or plutonium-
based heat sources coupled to micro-CHP engines that convert heat to
electricity via thermoelectrics or Stirling engines. The multi-decade long
operating lifetimes from self-contained and sealed devices could enable
independent power for areas without transmission grids. However nuclear
batteries face commercialization barriers from public acceptance issues,
developing long-term waste storage and obtaining regulatory approvals for
small-scale reactors despite inherent safety advantages versus larger plants.
Their potential role in energy access remains an open question.
Nuclear waste management
Effectively managing nuclear waste produced from both power generation
and medical/research applications remains an outstanding technical
challenge requiring long-term geological isolation. Most waste solutions
center around deep geologic repositories that exploit low water flow and
geochemically stable formations to contain radionuclides for thousands of
years. Engineered thick concrete barriers and steel casks provide multiple
redundant levels of containment and isolation deep underground where the
heat from radioactive decay can dissipate harmlessly. Waste matrices like
glass or ceramics immobilize radionuclides, while advanced monitoring
systems track any subsurface fluid movement. Some countries like Finland
have made significant progress developing permanent nuclear waste
repositories with regulatory approval and community consent. However
political opposition and siting difficulties have stalled other repository
programs worldwide. Advanced reprocessing to reduce long-term
radionuclide inventories and transmute select actinides into shorter-lived
isotopes represent alternatives still under research. Considering the
enormous quantities of long-lived nuclear waste that must be properly
entombed, developing safe geological storage solutions on the timescales of
human civilization remains an unfinished story of high importance.
Conclusion
In conclusion, nuclear chemistry technologies applied across medicine,
industry and energy have greatly benefited humanity but also present
unique challenges that must be soundly addressed. Medical applications of
radioactive tracers and radiotherapeutics have revolutionized diagnosis and
treatment by non-invasively imaging physiological processes in vivo and
selectively targeting diseased tissue. Industrial processes make use of
radioisotopes for isotope production, materials analysis, non-destructive
testing and sterilization under strictly controlled conditions. Nuclear power
already supplies massive amounts of reliable low-carbon energy worldwide,
with the possibility of fusion and modular fission batteries decentralizing
access if technical obstacles are one day overcome.
However, issues from waste management, safety risks, weapons proliferation
linkage and cost overruns associated with nuclear technologies demand
prudent regulation and innovation. Long-term isolation of highly radioactive
byproducts in geological repositories poses scientific and institutional
challenges on tens of thousands of year timescales. Incidents like Chernobyl
and Fukushima also remind of nuclear’s unforgiving realities if accidents
breach multiple safety barriers. Advancing novel reactor concepts and fuel
cycles to proliferate-resistant, walk-away safe and more resource efficient
designs therefore retains importance alongside non-nuclear climate
solutions. Public trust and transparent risk communication likewise matter
greatly for continued development. Overall, a balanced, evidence-based
approach is needed to maximize nuclear’s benefits judiciously, while
prioritizing safety, oversight, waste confinement and nonproliferation into the
deep future. With comprehensive management, nuclear science's peaceful
applications will likely expand to a technology for humanity as keen
understanding of the atom's power increases.
Nuclear chemistry is the study of how nuclei react and change. It involves
changes in the composition and structure of atomic nuclei. Many important
practical applications of nuclear chemistry have emerged that have
massively impacted medicine, industry, and energy production. This paper
will explore the diverse applications of nuclear chemistry across these three
domains and discuss both their benefits as well as some criticisms and
concerns about their use.
Part 1: Applications in Medicine
Medical imaging
One of the most widespread medical applications of nuclear chemistry is in
medical imaging techniques such as positron emission tomography (PET)
scans, single photon emission computed tomography (SPECT) scans, and
nuclear magnetic resonance (NMR) imaging. These techniques utilize
radioactive tracers, which are molecules that have been labeled with
radioactive isotopes. When these tracers are introduced into the body, they
can be detected by specialized cameras and used to form detailed 3D
images of tissues and organs.
PET scans use radioactive tracers that emit positrons. Common PET
radiotracers include fluorine-18, carbon-11, nitrogen-13, and oxygen-15.
These radioactive atoms are attached to molecules that are involved in
normal body processes like glucose metabolism, blood flow, and protein
synthesis. As the radiotracer accumulates in tissues, the positions of emitting
positrons can be detected and used to construct tomographic images of
metabolic activity in the body. PET scans provide extremely sensitive and
quantitative measurements and have revolutionized the detection, diagnosis,
and monitoring of many cancers as well as brain disorders like Alzheimer's
disease.
SPECT scans similarly use gamma-ray emitting radioactive tracers but form
lower resolution images than PET. Common SPECT radiotracers include
technetium-99m, thallium-201, gallium-67, and iodine-123. Like PET tracers,
these label molecules involved in key physiological processes. By monitoring
the distribution and movement of radiotracers in the body, SPECT scans can
identify abnormalities and lesions. For example, SPECT scans with thallium-
201 or technetium-99m can detect blood flow issues in the heart muscle to
diagnose heart disease. Iodine-123 scans are also useful for diagnosing
thyroid disease and cancers.
NMR imaging, more commonly known as magnetic resonance imaging (MRI),
uses the magnetic properties of atomic nuclei instead of radioactivity. Many
MRI scans utilize the hydrogen nuclei naturally present in water molecules in
the body. Powerful magnets and radiofrequency pulses are used to excite the
magnetic dipoles of these nuclei, causing them to emit radio signals that can
be used to construct diagnostic images. MRI provides excellent soft tissue
contrast and has become an invaluable tool for examining the brain, spine,
joints, and many other internal structures without exposure to radiation.
Contrast agents containing gadolinium can also be intravenously
administered to enhance MRI images.
Radioisotope therapy
In addition to diagnostics, some radionuclides have therapeutic applications
for treating various medical conditions. One of the most well established is
the use of iodine-131 to treat hyperthyroidism and thyroid cancer. Iodine-131
has similar chemical properties to stable iodine and readily accumulates in
the thyroid gland where it destroys remaining thyroid tissue through beta
radiation exposure. This reduces overproduction of hormones in
hyperthyroidism while also destroying any cancerous thyroid cells. Treatment
is usually very effective with few side effects.
Strontium-89 and samarium-153 are also effective medical radioisotopes for
treating bone metastases from cancers like prostate and breast cancer.
These beta emitters selectively concentrate in areas of increased bone
turnover like cancerous bone lesions. Their radiation can help strengthen
bones weakened by metastases and relieve pain by ablating the cancer cells
within bone tissue. Radioimmunotherapy uses antibodies tagged with short-
range alpha or beta-emitting radioisotopes to bind to and destroy cancer
cells at a molecular level. Targeted isotopes include yttrium-90, iodine-131,
lutetium-177 and bismuth-213.
Other promising therapeutic radionuclides in development include actinium-
225 and lead-212. Actinium-225 generates four alpha particle emissions in
its decay chain and shows potential for treating acute myeloid leukemia and
other cancers if attached to monoclonal antibodies. Lead-212 can also
generate alpha decays and has a very short half-life of only 10.6 hours,
allowing it to deliver highly localized radiation doses without traveling far
from tumors. As radiotherapeutics continue to be researched and refined,
selective internal radiation exposures may become viable alternatives or
supplements to external beam radiation treatments for various cancers and
other conditions.
Radiopharmaceutical production
The production of radiotracers and radiopharmaceuticals for medical
applications is a major industry that generates billions in revenue annually.
Common medical radioisotopes like technetium-99m, iodine-123 and -131,
gallium-67, thallium-201, fluorine-18 and others are produced globally in
specialized nuclear reactors, particle accelerators, or generators. Radioactive
milling and processing facilities purify and formulate radionuclides into stable
chemical compounds suitable for intravenous injection or ingestion by
patients before scanning or therapy. Stringent regulations and quality
controls ensure the radioactive drugs are manufactured under high purity,
sterility, and maximum specific radioactivity standards. Continuous fission
reactors like those in Canada routinely supply over 80% of the U.S. demand
for the workhorse technetium-99m isotope needed for tens of thousands of
SPECT scans every day. The global medical radioisotope market, dominated
by the top three firms, is projected to grow annually by over 5% through
2027 due to expanding clinical applications and replacements for aging
reactor infrastructure. Overall, nuclear medicine has revolutionized diagnosis
and treatment, helping improve millions of lives.
Part 2: Applications in Industry
Isotope production
In addition to medical uses, nuclear processes are employed industrially to
produce important stable and radioactive isotopes. Light water reactors
generate sizeable quantities of plutonium-239 as a byproduct of uranium-238
absorbing neutrons. Plutonium-239 has a half-life of 24,100 years and its
decay produces mostly alpha particles, making it well suited for
thermoelectric applications in radioisotope thermoelectric generators (RTGs).
RTGs powered U.S. space missions for over 50 years including Voyager,
Galileo, and Curiosity by using the heat from plutonium-238's radioactive
decay.
Tritium, a radioactive isotope of hydrogen, is primarily used in self-luminous
sights for firearms, emergency exit signs, and other low light applications. It
is commercially produced by irradiating a lithium target with neutrons in a
nuclear reactor, followed by chemical separation. Large quantities of
naturally occurring krypton-81 are also collected from gaseous fission
products extracted from reactor off-gases. This stable noble gas isotope finds
use as an inert filler for energy efficient light bulbs and flat panel displays.
Neutron activation analysis
Another nuclear technique employed in industry is neutron activation
analysis (NAA), which involves irradiating samples with neutrons in a nuclear
reactor. This process causes certain elements in the sample to become
radioactive via neutron capture. By precisely measuring the gamma radiation
signatures emitted as these artificially produced radioisotopes decay, it is
possible to quantitatively determine the elemental composition of even
complex industrial materials down to trace quantities. NAA is useful for
quality control in sectors like mining, metallurgy, electronics manufacturing
and more. It can rapidly screen bulk samples for contaminants or verify
purity in a non-destructive manner.
Industrial radiography
Industrial radiography utilizes penetrating gamma and X-rays from
radioactive isotopes to examine the internal structures and defects in large
industrial components without having to dismantle or destroy them.
Common radiographic sources include cobalt-60, iridium-192, selenium-75
and caesium-137. The images reveal flaws invisible from the surface like
cracks, voids, corrosion or faulty welds in critical infrastructure parts like
pipelines, pressure vessels, bridges and machinery. This allows issues to be
addressed before catastrophic failures occur. While X-ray machines can also
perform industrial radiography, radioactive sources provide more penetrating
power for larger and higher density objects. However, their encapsulated
sources must be carefully shielded and handled to prevent exposure when
not in use.
Sterilization
Today, over half of all medical devices and many food products worldwide are
sterilized using gamma or electron beam radiation from radioactive isotopes.
Cobalt-60 is a popular gamma source that can penetrate packaging and
thoroughly sterilize items. The high-energy photons destroy microbes like
bacteria and viruses without leaving chemical residues. As no thermal or
pressure factors are involved, radiation sterilization maintains product
integrity and is suitable for heat- and moisture-sensitive items. In addition to
consumables, radiation has widespread uses decontaminating medical
equipment and sterilizing surgical gowns, drapes and implants before they
reach hospitals and patients. When combined with strict quality controls,
radiation-based sterilization provides a safe, effective and environmentally-
friendly alternative to steam, EtO gas or other chemical sterilants.
Part 3: Applications in Energy Production
Nuclear fission power
Nuclear fission reactors harness the energy released during nuclear fission
chain reactions to generate electricity on a commercial scale. Fissile
uranium-235 or plutonium-239 atoms are bombarded with neutrons and then
split apart, releasing additional neutrons, heat in the form of kinetic energy,
and gamma radiation. In a nuclear power plant, the heat generated is used
to produce steam that drives turbines connected to electricity generators.
Over 450 nuclear reactors worldwide currently supply about 10% of the
global electricity demand and one-third of low-carbon power. Generation II
light water reactors dominate the global fleet while Generation III+ and IV
designs incorporate passive safety and materials innovations.
Proponents argue nuclear energy is a stable, reliable, low-carbon baseload
power source able to meet rising energy needs. Unlike intermittent
renewables, fission continuously operates 24/7 and maintains the grid
reliability required by modern societies and industries. The energy density
per unit fuel mass from fission vastly exceeds fossil or renewable
alternatives. However, nuclear faces challenges from high capital costs and
construction timescales, nuclear waste management and proliferation
concerns as well as safety risks if accidents occur. Nevertheless, many
experts see it as indispensable for climate goals given its clean attributes,
and over 50 new reactors are under construction worldwide. Ongoing
research aims to sustain a nuclear renaissance through new small modular,
advanced, and fast neutron reactors.
Nuclear fusion power
Nuclear fusion harnesses the energy from fusing atomic nuclei lighter than
iron, the opposite reaction to fission. The most promising approach is using
strong magnetic fields in doughnut-shaped tokamak reactors to heat and
compress hydrogen isotopes deuterium and tritium under extreme
conditions, where their nuclei fuse and release helium atoms along with
energetic neutrons. This fusion process occurs naturally in the cores of stars
and greatly outstrips any chemical energy source on an energy per unit mass
basis. Researchers envision inertial confinement fusion using lasers and
hypersonic z-pinches as alternatives to the magnetic confinement approach.
The International Thermonuclear Experimental Reactor (ITER) tokamak
project currently underway in France aims to demonstrate the scientific and
technical feasibility of fusion power by generating net energy from fusion for
periods of several minutes by 2035. Beyond ITER, commercial fusion reactors
would not emit greenhouse gases, deplete resources or create long-lived
nuclear waste. With hydrogen as fuel, worldwide reserves could last for
millions of years. However, achieving economically viable and self-sustaining
fusion remains an immense technical challenge still far in the future given
difficulty in maintaining plasma stability, tailoring magnetic fields or focusing
laser energy precisely enough for efficient fusion conditions. Yet many think
mastering fusion could revolutionize future energy production sustainably if
the scientific obstacles are overcome.
Nuclear batteries
Radioisotope thermoelectric generators (RTGs) that operate on the heat from
radioactive decay have powered interplanetary spacecraft explorations since
the 1960s. Efforts are underway by companies to design small modular
nuclear batteries optimized to decentralize electricity access for off-grid
communities, charging electric vehicles, powering remote infrastructure
stations and more on Earth. Proposed designs use uranium or plutonium-
based heat sources coupled to micro-CHP engines that convert heat to
electricity via thermoelectrics or Stirling engines. The multi-decade long
operating lifetimes from self-contained and sealed devices could enable
independent power for areas without transmission grids. However nuclear
batteries face commercialization barriers from public acceptance issues,
developing long-term waste storage and obtaining regulatory approvals for
small-scale reactors despite inherent safety advantages versus larger plants.
Their potential role in energy access remains an open question.
Nuclear waste management
Effectively managing nuclear waste produced from both power generation
and medical/research applications remains an outstanding technical
challenge requiring long-term geological isolation. Most waste solutions
center around deep geologic repositories that exploit low water flow and
geochemically stable formations to contain radionuclides for thousands of
years. Engineered thick concrete barriers and steel casks provide multiple
redundant levels of containment and isolation deep underground where the
heat from radioactive decay can dissipate harmlessly. Waste matrices like
glass or ceramics immobilize radionuclides, while advanced monitoring
systems track any subsurface fluid movement. Some countries like Finland
have made significant progress developing permanent nuclear waste
repositories with regulatory approval and community consent. However
political opposition and siting difficulties have stalled other repository
programs worldwide. Advanced reprocessing to reduce long-term
radionuclide inventories and transmute select actinides into shorter-lived
isotopes represent alternatives still under research. Considering the
enormous quantities of long-lived nuclear waste that must be properly
entombed, developing safe geological storage solutions on the timescales of
human civilization remains an unfinished story of high importance.
Conclusion
In conclusion, nuclear chemistry technologies applied across medicine,
industry and energy have greatly benefited humanity but also present
unique challenges that must be soundly addressed. Medical applications of
radioactive tracers and radiotherapeutics have revolutionized diagnosis and
treatment by non-invasively imaging physiological processes in vivo and
selectively targeting diseased tissue. Industrial processes make use of
radioisotopes for isotope production, materials analysis, non-destructive
testing and sterilization under strictly controlled conditions. Nuclear power
already supplies massive amounts of reliable low-carbon energy worldwide,
with the possibility of fusion and modular fission batteries decentralizing
access if technical obstacles are one day overcome.
However, issues from waste management, safety risks, weapons proliferation
linkage and cost overruns associated with nuclear technologies demand
prudent regulation and innovation. Long-term isolation of highly radioactive
byproducts in geological repositories poses scientific and institutional
challenges on tens of thousands of year timescales. Incidents like Chernobyl
and Fukushima also remind of nuclear’s unforgiving realities if accidents
breach multiple safety barriers. Advancing novel reactor concepts and fuel
cycles to proliferate-resistant, walk-away safe and more resource efficient
designs therefore retains importance alongside non-nuclear climate
solutions. Public trust and transparent risk communication likewise matter
greatly for continued development. Overall, a balanced, evidence-based
approach is needed to maximize nuclear’s benefits judiciously, while
prioritizing safety, oversight, waste confinement and nonproliferation into the
deep future. With comprehensive management, nuclear science's peaceful
applications will likely expand to a technology for humanity as keen
understanding of the atom's power increases.
Nuclear chemistry is the study of how nuclei react and change. It involves
changes in the composition and structure of atomic nuclei. Many important
practical applications of nuclear chemistry have emerged that have
massively impacted medicine, industry, and energy production. This paper
will explore the diverse applications of nuclear chemistry across these three
domains and discuss both their benefits as well as some criticisms and
concerns about their use.
Part 1: Applications in Medicine
Medical imaging
One of the most widespread medical applications of nuclear chemistry is in
medical imaging techniques such as positron emission tomography (PET)
scans, single photon emission computed tomography (SPECT) scans, and
nuclear magnetic resonance (NMR) imaging. These techniques utilize
radioactive tracers, which are molecules that have been labeled with
radioactive isotopes. When these tracers are introduced into the body, they
can be detected by specialized cameras and used to form detailed 3D
images of tissues and organs.
PET scans use radioactive tracers that emit positrons. Common PET
radiotracers include fluorine-18, carbon-11, nitrogen-13, and oxygen-15.
These radioactive atoms are attached to molecules that are involved in
normal body processes like glucose metabolism, blood flow, and protein
synthesis. As the radiotracer accumulates in tissues, the positions of emitting
positrons can be detected and used to construct tomographic images of
metabolic activity in the body. PET scans provide extremely sensitive and
quantitative measurements and have revolutionized the detection, diagnosis,
and monitoring of many cancers as well as brain disorders like Alzheimer's
disease.
SPECT scans similarly use gamma-ray emitting radioactive tracers but form
lower resolution images than PET. Common SPECT radiotracers include
technetium-99m, thallium-201, gallium-67, and iodine-123. Like PET tracers,
these label molecules involved in key physiological processes. By monitoring
the distribution and movement of radiotracers in the body, SPECT scans can
identify abnormalities and lesions. For example, SPECT scans with thallium-
201 or technetium-99m can detect blood flow issues in the heart muscle to
diagnose heart disease. Iodine-123 scans are also useful for diagnosing
thyroid disease and cancers.
NMR imaging, more commonly known as magnetic resonance imaging (MRI),
uses the magnetic properties of atomic nuclei instead of radioactivity. Many
MRI scans utilize the hydrogen nuclei naturally present in water molecules in
the body. Powerful magnets and radiofrequency pulses are used to excite the
magnetic dipoles of these nuclei, causing them to emit radio signals that can
be used to construct diagnostic images. MRI provides excellent soft tissue
contrast and has become an invaluable tool for examining the brain, spine,
joints, and many other internal structures without exposure to radiation.
Contrast agents containing gadolinium can also be intravenously
administered to enhance MRI images.
Radioisotope therapy
In addition to diagnostics, some radionuclides have therapeutic applications
for treating various medical conditions. One of the most well established is
the use of iodine-131 to treat hyperthyroidism and thyroid cancer. Iodine-131
has similar chemical properties to stable iodine and readily accumulates in
the thyroid gland where it destroys remaining thyroid tissue through beta
radiation exposure. This reduces overproduction of hormones in
hyperthyroidism while also destroying any cancerous thyroid cells. Treatment
is usually very effective with few side effects.
Strontium-89 and samarium-153 are also effective medical radioisotopes for
treating bone metastases from cancers like prostate and breast cancer.
These beta emitters selectively concentrate in areas of increased bone
turnover like cancerous bone lesions. Their radiation can help strengthen
bones weakened by metastases and relieve pain by ablating the cancer cells
within bone tissue. Radioimmunotherapy uses antibodies tagged with short-
range alpha or beta-emitting radioisotopes to bind to and destroy cancer
cells at a molecular level. Targeted isotopes include yttrium-90, iodine-131,
lutetium-177 and bismuth-213.
Other promising therapeutic radionuclides in development include actinium-
225 and lead-212. Actinium-225 generates four alpha particle emissions in
its decay chain and shows potential for treating acute myeloid leukemia and
other cancers if attached to monoclonal antibodies. Lead-212 can also
generate alpha decays and has a very short half-life of only 10.6 hours,
allowing it to deliver highly localized radiation doses without traveling far
from tumors. As radiotherapeutics continue to be researched and refined,
selective internal radiation exposures may become viable alternatives or
supplements to external beam radiation treatments for various cancers and
other conditions.
Radiopharmaceutical production
The production of radiotracers and radiopharmaceuticals for medical
applications is a major industry that generates billions in revenue annually.
Common medical radioisotopes like technetium-99m, iodine-123 and -131,
gallium-67, thallium-201, fluorine-18 and others are produced globally in
specialized nuclear reactors, particle accelerators, or generators. Radioactive
milling and processing facilities purify and formulate radionuclides into stable
chemical compounds suitable for intravenous injection or ingestion by
patients before scanning or therapy. Stringent regulations and quality
controls ensure the radioactive drugs are manufactured under high purity,
sterility, and maximum specific radioactivity standards. Continuous fission
reactors like those in Canada routinely supply over 80% of the U.S. demand
for the workhorse technetium-99m isotope needed for tens of thousands of
SPECT scans every day. The global medical radioisotope market, dominated
by the top three firms, is projected to grow annually by over 5% through
2027 due to expanding clinical applications and replacements for aging
reactor infrastructure. Overall, nuclear medicine has revolutionized diagnosis
and treatment, helping improve millions of lives.
Part 2: Applications in Industry
Isotope production
In addition to medical uses, nuclear processes are employed industrially to
produce important stable and radioactive isotopes. Light water reactors
generate sizeable quantities of plutonium-239 as a byproduct of uranium-238
absorbing neutrons. Plutonium-239 has a half-life of 24,100 years and its
decay produces mostly alpha particles, making it well suited for
thermoelectric applications in radioisotope thermoelectric generators (RTGs).
RTGs powered U.S. space missions for over 50 years including Voyager,
Galileo, and Curiosity by using the heat from plutonium-238's radioactive
decay.
Tritium, a radioactive isotope of hydrogen, is primarily used in self-luminous
sights for firearms, emergency exit signs, and other low light applications. It
is commercially produced by irradiating a lithium target with neutrons in a
nuclear reactor, followed by chemical separation. Large quantities of
naturally occurring krypton-81 are also collected from gaseous fission
products extracted from reactor off-gases. This stable noble gas isotope finds
use as an inert filler for energy efficient light bulbs and flat panel displays.
Neutron activation analysis
Another nuclear technique employed in industry is neutron activation
analysis (NAA), which involves irradiating samples with neutrons in a nuclear
reactor. This process causes certain elements in the sample to become
radioactive via neutron capture. By precisely measuring the gamma radiation
signatures emitted as these artificially produced radioisotopes decay, it is
possible to quantitatively determine the elemental composition of even
complex industrial materials down to trace quantities. NAA is useful for
quality control in sectors like mining, metallurgy, electronics manufacturing
and more. It can rapidly screen bulk samples for contaminants or verify
purity in a non-destructive manner.
Industrial radiography
Industrial radiography utilizes penetrating gamma and X-rays from
radioactive isotopes to examine the internal structures and defects in large
industrial components without having to dismantle or destroy them.
Common radiographic sources include cobalt-60, iridium-192, selenium-75
and caesium-137. The images reveal flaws invisible from the surface like
cracks, voids, corrosion or faulty welds in critical infrastructure parts like
pipelines, pressure vessels, bridges and machinery. This allows issues to be
addressed before catastrophic failures occur. While X-ray machines can also
perform industrial radiography, radioactive sources provide more penetrating
power for larger and higher density objects. However, their encapsulated
sources must be carefully shielded and handled to prevent exposure when
not in use.
Sterilization
Today, over half of all medical devices and many food products worldwide are
sterilized using gamma or electron beam radiation from radioactive isotopes.
Cobalt-60 is a popular gamma source that can penetrate packaging and
thoroughly sterilize items. The high-energy photons destroy microbes like
bacteria and viruses without leaving chemical residues. As no thermal or
pressure factors are involved, radiation sterilization maintains product
integrity and is suitable for heat- and moisture-sensitive items. In addition to
consumables, radiation has widespread uses decontaminating medical
equipment and sterilizing surgical gowns, drapes and implants before they
reach hospitals and patients. When combined with strict quality controls,
radiation-based sterilization provides a safe, effective and environmentally-
friendly alternative to steam, EtO gas or other chemical sterilants.
Part 3: Applications in Energy Production
Nuclear fission power
Nuclear fission reactors harness the energy released during nuclear fission
chain reactions to generate electricity on a commercial scale. Fissile
uranium-235 or plutonium-239 atoms are bombarded with neutrons and then
split apart, releasing additional neutrons, heat in the form of kinetic energy,
and gamma radiation. In a nuclear power plant, the heat generated is used
to produce steam that drives turbines connected to electricity generators.
Over 450 nuclear reactors worldwide currently supply about 10% of the
global electricity demand and one-third of low-carbon power. Generation II
light water reactors dominate the global fleet while Generation III+ and IV
designs incorporate passive safety and materials innovations.
Proponents argue nuclear energy is a stable, reliable, low-carbon baseload
power source able to meet rising energy needs. Unlike intermittent
renewables, fission continuously operates 24/7 and maintains the grid
reliability required by modern societies and industries. The energy density
per unit fuel mass from fission vastly exceeds fossil or renewable
alternatives. However, nuclear faces challenges from high capital costs and
construction timescales, nuclear waste management and proliferation
concerns as well as safety risks if accidents occur. Nevertheless, many
experts see it as indispensable for climate goals given its clean attributes,
and over 50 new reactors are under construction worldwide. Ongoing
research aims to sustain a nuclear renaissance through new small modular,
advanced, and fast neutron reactors.
Nuclear fusion power
Nuclear fusion harnesses the energy from fusing atomic nuclei lighter than
iron, the opposite reaction to fission. The most promising approach is using
strong magnetic fields in doughnut-shaped tokamak reactors to heat and
compress hydrogen isotopes deuterium and tritium under extreme
conditions, where their nuclei fuse and release helium atoms along with
energetic neutrons. This fusion process occurs naturally in the cores of stars
and greatly outstrips any chemical energy source on an energy per unit mass
basis. Researchers envision inertial confinement fusion using lasers and
hypersonic z-pinches as alternatives to the magnetic confinement approach.
The International Thermonuclear Experimental Reactor (ITER) tokamak
project currently underway in France aims to demonstrate the scientific and
technical feasibility of fusion power by generating net energy from fusion for
periods of several minutes by 2035. Beyond ITER, commercial fusion reactors
would not emit greenhouse gases, deplete resources or create long-lived
nuclear waste. With hydrogen as fuel, worldwide reserves could last for
millions of years. However, achieving economically viable and self-sustaining
fusion remains an immense technical challenge still far in the future given
difficulty in maintaining plasma stability, tailoring magnetic fields or focusing
laser energy precisely enough for efficient fusion conditions. Yet many think
mastering fusion could revolutionize future energy production sustainably if
the scientific obstacles are overcome.
Nuclear batteries
Radioisotope thermoelectric generators (RTGs) that operate on the heat from
radioactive decay have powered interplanetary spacecraft explorations since
the 1960s. Efforts are underway by companies to design small modular
nuclear batteries optimized to decentralize electricity access for off-grid
communities, charging electric vehicles, powering remote infrastructure
stations and more on Earth. Proposed designs use uranium or plutonium-
based heat sources coupled to micro-CHP engines that convert heat to
electricity via thermoelectrics or Stirling engines. The multi-decade long
operating lifetimes from self-contained and sealed devices could enable
independent power for areas without transmission grids. However nuclear
batteries face commercialization barriers from public acceptance issues,
developing long-term waste storage and obtaining regulatory approvals for
small-scale reactors despite inherent safety advantages versus larger plants.
Their potential role in energy access remains an open question.
Nuclear waste management
Effectively managing nuclear waste produced from both power generation
and medical/research applications remains an outstanding technical
challenge requiring long-term geological isolation. Most waste solutions
center around deep geologic repositories that exploit low water flow and
geochemically stable formations to contain radionuclides for thousands of
years. Engineered thick concrete barriers and steel casks provide multiple
redundant levels of containment and isolation deep underground where the
heat from radioactive decay can dissipate harmlessly. Waste matrices like
glass or ceramics immobilize radionuclides, while advanced monitoring
systems track any subsurface fluid movement. Some countries like Finland
have made significant progress developing permanent nuclear waste
repositories with regulatory approval and community consent. However
political opposition and siting difficulties have stalled other repository
programs worldwide. Advanced reprocessing to reduce long-term
radionuclide inventories and transmute select actinides into shorter-lived
isotopes represent alternatives still under research. Considering the
enormous quantities of long-lived nuclear waste that must be properly
entombed, developing safe geological storage solutions on the timescales of
human civilization remains an unfinished story of high importance.
Conclusion
In conclusion, nuclear chemistry technologies applied across medicine,
industry and energy have greatly benefited humanity but also present
unique challenges that must be soundly addressed. Medical applications of
radioactive tracers and radiotherapeutics have revolutionized diagnosis and
treatment by non-invasively imaging physiological processes in vivo and
selectively targeting diseased tissue. Industrial processes make use of
radioisotopes for isotope production, materials analysis, non-destructive
testing and sterilization under strictly controlled conditions. Nuclear power
already supplies massive amounts of reliable low-carbon energy worldwide,
with the possibility of fusion and modular fission batteries decentralizing
access if technical obstacles are one day overcome.
However, issues from waste management, safety risks, weapons proliferation
linkage and cost overruns associated with nuclear technologies demand
prudent regulation and innovation. Long-term isolation of highly radioactive
byproducts in geological repositories poses scientific and institutional
challenges on tens of thousands of year timescales. Incidents like Chernobyl
and Fukushima also remind of nuclear’s unforgiving realities if accidents
breach multiple safety barriers. Advancing novel reactor concepts and fuel
cycles to proliferate-resistant, walk-away safe and more resource efficient
designs therefore retains importance alongside non-nuclear climate
solutions. Public trust and transparent risk communication likewise matter
greatly for continued development. Overall, a balanced, evidence-based
approach is needed to maximize nuclear’s benefits judiciously, while
prioritizing safety, oversight, waste confinement and nonproliferation into the
deep future. With comprehensive management, nuclear science's peaceful
applications will likely expand to a technology for humanity as keen
understanding of the atom's power increases.
Nuclear chemistry is the study of how nuclei react and change. It involves
changes in the composition and structure of atomic nuclei. Many important
practical applications of nuclear chemistry have emerged that have
massively impacted medicine, industry, and energy production. This paper
will explore the diverse applications of nuclear chemistry across these three
domains and discuss both their benefits as well as some criticisms and
concerns about their use.
Part 1: Applications in Medicine
Medical imaging
One of the most widespread medical applications of nuclear chemistry is in
medical imaging techniques such as positron emission tomography (PET)
scans, single photon emission computed tomography (SPECT) scans, and
nuclear magnetic resonance (NMR) imaging. These techniques utilize
radioactive tracers, which are molecules that have been labeled with
radioactive isotopes. When these tracers are introduced into the body, they
can be detected by specialized cameras and used to form detailed 3D
images of tissues and organs.
PET scans use radioactive tracers that emit positrons. Common PET
radiotracers include fluorine-18, carbon-11, nitrogen-13, and oxygen-15.
These radioactive atoms are attached to molecules that are involved in
normal body processes like glucose metabolism, blood flow, and protein
synthesis. As the radiotracer accumulates in tissues, the positions of emitting
positrons can be detected and used to construct tomographic images of
metabolic activity in the body. PET scans provide extremely sensitive and
quantitative measurements and have revolutionized the detection, diagnosis,
and monitoring of many cancers as well as brain disorders like Alzheimer's
disease.
SPECT scans similarly use gamma-ray emitting radioactive tracers but form
lower resolution images than PET. Common SPECT radiotracers include
technetium-99m, thallium-201, gallium-67, and iodine-123. Like PET tracers,
these label molecules involved in key physiological processes. By monitoring
the distribution and movement of radiotracers in the body, SPECT scans can
identify abnormalities and lesions. For example, SPECT scans with thallium-
201 or technetium-99m can detect blood flow issues in the heart muscle to
diagnose heart disease. Iodine-123 scans are also useful for diagnosing
thyroid disease and cancers.
NMR imaging, more commonly known as magnetic resonance imaging (MRI),
uses the magnetic properties of atomic nuclei instead of radioactivity. Many
MRI scans utilize the hydrogen nuclei naturally present in water molecules in
the body. Powerful magnets and radiofrequency pulses are used to excite the
magnetic dipoles of these nuclei, causing them to emit radio signals that can
be used to construct diagnostic images. MRI provides excellent soft tissue
contrast and has become an invaluable tool for examining the brain, spine,
joints, and many other internal structures without exposure to radiation.
Contrast agents containing gadolinium can also be intravenously
administered to enhance MRI images.
Radioisotope therapy
In addition to diagnostics, some radionuclides have therapeutic applications
for treating various medical conditions. One of the most well established is
the use of iodine-131 to treat hyperthyroidism and thyroid cancer. Iodine-131
has similar chemical properties to stable iodine and readily accumulates in
the thyroid gland where it destroys remaining thyroid tissue through beta
radiation exposure. This reduces overproduction of hormones in
hyperthyroidism while also destroying any cancerous thyroid cells. Treatment
is usually very effective with few side effects.
Strontium-89 and samarium-153 are also effective medical radioisotopes for
treating bone metastases from cancers like prostate and breast cancer.
These beta emitters selectively concentrate in areas of increased bone
turnover like cancerous bone lesions. Their radiation can help strengthen
bones weakened by metastases and relieve pain by ablating the cancer cells
within bone tissue. Radioimmunotherapy uses antibodies tagged with short-
range alpha or beta-emitting radioisotopes to bind to and destroy cancer
cells at a molecular level. Targeted isotopes include yttrium-90, iodine-131,
lutetium-177 and bismuth-213.
Other promising therapeutic radionuclides in development include actinium-
225 and lead-212. Actinium-225 generates four alpha particle emissions in
its decay chain and shows potential for treating acute myeloid leukemia and
other cancers if attached to monoclonal antibodies. Lead-212 can also
generate alpha decays and has a very short half-life of only 10.6 hours,
allowing it to deliver highly localized radiation doses without traveling far
from tumors. As radiotherapeutics continue to be researched and refined,
selective internal radiation exposures may become viable alternatives or
supplements to external beam radiation treatments for various cancers and
other conditions.
Radiopharmaceutical production
The production of radiotracers and radiopharmaceuticals for medical
applications is a major industry that generates billions in revenue annually.
Common medical radioisotopes like technetium-99m, iodine-123 and -131,
gallium-67, thallium-201, fluorine-18 and others are produced globally in
specialized nuclear reactors, particle accelerators, or generators. Radioactive
milling and processing facilities purify and formulate radionuclides into stable
chemical compounds suitable for intravenous injection or ingestion by
patients before scanning or therapy. Stringent regulations and quality
controls ensure the radioactive drugs are manufactured under high purity,
sterility, and maximum specific radioactivity standards. Continuous fission
reactors like those in Canada routinely supply over 80% of the U.S. demand
for the workhorse technetium-99m isotope needed for tens of thousands of
SPECT scans every day. The global medical radioisotope market, dominated
by the top three firms, is projected to grow annually by over 5% through
2027 due to expanding clinical applications and replacements for aging
reactor infrastructure. Overall, nuclear medicine has revolutionized diagnosis
and treatment, helping improve millions of lives.
Part 2: Applications in Industry
Isotope production
In addition to medical uses, nuclear processes are employed industrially to
produce important stable and radioactive isotopes. Light water reactors
generate sizeable quantities of plutonium-239 as a byproduct of uranium-238
absorbing neutrons. Plutonium-239 has a half-life of 24,100 years and its
decay produces mostly alpha particles, making it well suited for
thermoelectric applications in radioisotope thermoelectric generators (RTGs).
RTGs powered U.S. space missions for over 50 years including Voyager,
Galileo, and Curiosity by using the heat from plutonium-238's radioactive
decay.
Tritium, a radioactive isotope of hydrogen, is primarily used in self-luminous
sights for firearms, emergency exit signs, and other low light applications. It
is commercially produced by irradiating a lithium target with neutrons in a
nuclear reactor, followed by chemical separation. Large quantities of
naturally occurring krypton-81 are also collected from gaseous fission
products extracted from reactor off-gases. This stable noble gas isotope finds
use as an inert filler for energy efficient light bulbs and flat panel displays.
Neutron activation analysis
Another nuclear technique employed in industry is neutron activation
analysis (NAA), which involves irradiating samples with neutrons in a nuclear
reactor. This process causes certain elements in the sample to become
radioactive via neutron capture. By precisely measuring the gamma radiation
signatures emitted as these artificially produced radioisotopes decay, it is
possible to quantitatively determine the elemental composition of even
complex industrial materials down to trace quantities. NAA is useful for
quality control in sectors like mining, metallurgy, electronics manufacturing
and more. It can rapidly screen bulk samples for contaminants or verify
purity in a non-destructive manner.
Industrial radiography
Industrial radiography utilizes penetrating gamma and X-rays from
radioactive isotopes to examine the internal structures and defects in large
industrial components without having to dismantle or destroy them.
Common radiographic sources include cobalt-60, iridium-192, selenium-75
and caesium-137. The images reveal flaws invisible from the surface like
cracks, voids, corrosion or faulty welds in critical infrastructure parts like
pipelines, pressure vessels, bridges and machinery. This allows issues to be
addressed before catastrophic failures occur. While X-ray machines can also
perform industrial radiography, radioactive sources provide more penetrating
power for larger and higher density objects. However, their encapsulated
sources must be carefully shielded and handled to prevent exposure when
not in use.
Sterilization
Today, over half of all medical devices and many food products worldwide are
sterilized using gamma or electron beam radiation from radioactive isotopes.
Cobalt-60 is a popular gamma source that can penetrate packaging and
thoroughly sterilize items. The high-energy photons destroy microbes like
bacteria and viruses without leaving chemical residues. As no thermal or
pressure factors are involved, radiation sterilization maintains product
integrity and is suitable for heat- and moisture-sensitive items. In addition to
consumables, radiation has widespread uses decontaminating medical
equipment and sterilizing surgical gowns, drapes and implants before they
reach hospitals and patients. When combined with strict quality controls,
radiation-based sterilization provides a safe, effective and environmentally-
friendly alternative to steam, EtO gas or other chemical sterilants.
Part 3: Applications in Energy Production
Nuclear fission power
Nuclear fission reactors harness the energy released during nuclear fission
chain reactions to generate electricity on a commercial scale. Fissile
uranium-235 or plutonium-239 atoms are bombarded with neutrons and then
split apart, releasing additional neutrons, heat in the form of kinetic energy,
and gamma radiation. In a nuclear power plant, the heat generated is used
to produce steam that drives turbines connected to electricity generators.
Over 450 nuclear reactors worldwide currently supply about 10% of the
global electricity demand and one-third of low-carbon power. Generation II
light water reactors dominate the global fleet while Generation III+ and IV
designs incorporate passive safety and materials innovations.
Proponents argue nuclear energy is a stable, reliable, low-carbon baseload
power source able to meet rising energy needs. Unlike intermittent
renewables, fission continuously operates 24/7 and maintains the grid
reliability required by modern societies and industries. The energy density
per unit fuel mass from fission vastly exceeds fossil or renewable
alternatives. However, nuclear faces challenges from high capital costs and
construction timescales, nuclear waste management and proliferation
concerns as well as safety risks if accidents occur. Nevertheless, many
experts see it as indispensable for climate goals given its clean attributes,
and over 50 new reactors are under construction worldwide. Ongoing
research aims to sustain a nuclear renaissance through new small modular,
advanced, and fast neutron reactors.
Nuclear fusion power
Nuclear fusion harnesses the energy from fusing atomic nuclei lighter than
iron, the opposite reaction to fission. The most promising approach is using
strong magnetic fields in doughnut-shaped tokamak reactors to heat and
compress hydrogen isotopes deuterium and tritium under extreme
conditions, where their nuclei fuse and release helium atoms along with
energetic neutrons. This fusion process occurs naturally in the cores of stars
and greatly outstrips any chemical energy source on an energy per unit mass
basis. Researchers envision inertial confinement fusion using lasers and
hypersonic z-pinches as alternatives to the magnetic confinement approach.
The International Thermonuclear Experimental Reactor (ITER) tokamak
project currently underway in France aims to demonstrate the scientific and
technical feasibility of fusion power by generating net energy from fusion for
periods of several minutes by 2035. Beyond ITER, commercial fusion reactors
would not emit greenhouse gases, deplete resources or create long-lived
nuclear waste. With hydrogen as fuel, worldwide reserves could last for
millions of years. However, achieving economically viable and self-sustaining
fusion remains an immense technical challenge still far in the future given
difficulty in maintaining plasma stability, tailoring magnetic fields or focusing
laser energy precisely enough for efficient fusion conditions. Yet many think
mastering fusion could revolutionize future energy production sustainably if
the scientific obstacles are overcome.
Nuclear batteries
Radioisotope thermoelectric generators (RTGs) that operate on the heat from
radioactive decay have powered interplanetary spacecraft explorations since
the 1960s. Efforts are underway by companies to design small modular
nuclear batteries optimized to decentralize electricity access for off-grid
communities, charging electric vehicles, powering remote infrastructure
stations and more on Earth. Proposed designs use uranium or plutonium-
based heat sources coupled to micro-CHP engines that convert heat to
electricity via thermoelectrics or Stirling engines. The multi-decade long
operating lifetimes from self-contained and sealed devices could enable
independent power for areas without transmission grids. However nuclear
batteries face commercialization barriers from public acceptance issues,
developing long-term waste storage and obtaining regulatory approvals for
small-scale reactors despite inherent safety advantages versus larger plants.
Their potential role in energy access remains an open question.
Nuclear waste management
Effectively managing nuclear waste produced from both power generation
and medical/research applications remains an outstanding technical
challenge requiring long-term geological isolation. Most waste solutions
center around deep geologic repositories that exploit low water flow and
geochemically stable formations to contain radionuclides for thousands of
years. Engineered thick concrete barriers and steel casks provide multiple
redundant levels of containment and isolation deep underground where the
heat from radioactive decay can dissipate harmlessly. Waste matrices like
glass or ceramics immobilize radionuclides, while advanced monitoring
systems track any subsurface fluid movement. Some countries like Finland
have made significant progress developing permanent nuclear waste
repositories with regulatory approval and community consent. However
political opposition and siting difficulties have stalled other repository
programs worldwide. Advanced reprocessing to reduce long-term
radionuclide inventories and transmute select actinides into shorter-lived
isotopes represent alternatives still under research. Considering the
enormous quantities of long-lived nuclear waste that must be properly
entombed, developing safe geological storage solutions on the timescales of
human civilization remains an unfinished story of high importance.
Conclusion
In conclusion, nuclear chemistry technologies applied across medicine,
industry and energy have greatly benefited humanity but also present
unique challenges that must be soundly addressed. Medical applications of
radioactive tracers and radiotherapeutics have revolutionized diagnosis and
treatment by non-invasively imaging physiological processes in vivo and
selectively targeting diseased tissue. Industrial processes make use of
radioisotopes for isotope production, materials analysis, non-destructive
testing and sterilization under strictly controlled conditions. Nuclear power
already supplies massive amounts of reliable low-carbon energy worldwide,
with the possibility of fusion and modular fission batteries decentralizing
access if technical obstacles are one day overcome.
However, issues from waste management, safety risks, weapons proliferation
linkage and cost overruns associated with nuclear technologies demand
prudent regulation and innovation. Long-term isolation of highly radioactive
byproducts in geological repositories poses scientific and institutional
challenges on tens of thousands of year timescales. Incidents like Chernobyl
and Fukushima also remind of nuclear’s unforgiving realities if accidents
breach multiple safety barriers. Advancing novel reactor concepts and fuel
cycles to proliferate-resistant, walk-away safe and more resource efficient
designs therefore retains importance alongside non-nuclear climate
solutions. Public trust and transparent risk communication likewise matter
greatly for continued development. Overall, a balanced, evidence-based
approach is needed to maximize nuclear’s benefits judiciously, while
prioritizing safety, oversight, waste confinement and nonproliferation into the
deep future. With comprehensive management, nuclear science's peaceful
applications will likely expand to a technology for humanity as keen
understanding of the atom's power increases.
Nuclear chemistry is the study of how nuclei react and change. It involves
changes in the composition and structure of atomic nuclei. Many important
practical applications of nuclear chemistry have emerged that have
massively impacted medicine, industry, and energy production. This paper
will explore the diverse applications of nuclear chemistry across these three
domains and discuss both their benefits as well as some criticisms and
concerns about their use.
Part 1: Applications in Medicine
Medical imaging
One of the most widespread medical applications of nuclear chemistry is in
medical imaging techniques such as positron emission tomography (PET)
scans, single photon emission computed tomography (SPECT) scans, and
nuclear magnetic resonance (NMR) imaging. These techniques utilize
radioactive tracers, which are molecules that have been labeled with
radioactive isotopes. When these tracers are introduced into the body, they
can be detected by specialized cameras and used to form detailed 3D
images of tissues and organs.
PET scans use radioactive tracers that emit positrons. Common PET
radiotracers include fluorine-18, carbon-11, nitrogen-13, and oxygen-15.
These radioactive atoms are attached to molecules that are involved in
normal body processes like glucose metabolism, blood flow, and protein
synthesis. As the radiotracer accumulates in tissues, the positions of emitting
positrons can be detected and used to construct tomographic images of
metabolic activity in the body. PET scans provide extremely sensitive and
quantitative measurements and have revolutionized the detection, diagnosis,
and monitoring of many cancers as well as brain disorders like Alzheimer's
disease.
SPECT scans similarly use gamma-ray emitting radioactive tracers but form
lower resolution images than PET. Common SPECT radiotracers include
technetium-99m, thallium-201, gallium-67, and iodine-123. Like PET tracers,
these label molecules involved in key physiological processes. By monitoring
the distribution and movement of radiotracers in the body, SPECT scans can
identify abnormalities and lesions. For example, SPECT scans with thallium-
201 or technetium-99m can detect blood flow issues in the heart muscle to
diagnose heart disease. Iodine-123 scans are also useful for diagnosing
thyroid disease and cancers.
NMR imaging, more commonly known as magnetic resonance imaging (MRI),
uses the magnetic properties of atomic nuclei instead of radioactivity. Many
MRI scans utilize the hydrogen nuclei naturally present in water molecules in
the body. Powerful magnets and radiofrequency pulses are used to excite the
magnetic dipoles of these nuclei, causing them to emit radio signals that can
be used to construct diagnostic images. MRI provides excellent soft tissue
contrast and has become an invaluable tool for examining the brain, spine,
joints, and many other internal structures without exposure to radiation.
Contrast agents containing gadolinium can also be intravenously
administered to enhance MRI images.
Radioisotope therapy
In addition to diagnostics, some radionuclides have therapeutic applications
for treating various medical conditions. One of the most well established is
the use of iodine-131 to treat hyperthyroidism and thyroid cancer. Iodine-131
has similar chemical properties to stable iodine and readily accumulates in
the thyroid gland where it destroys remaining thyroid tissue through beta
radiation exposure. This reduces overproduction of hormones in
hyperthyroidism while also destroying any cancerous thyroid cells. Treatment
is usually very effective with few side effects.
Strontium-89 and samarium-153 are also effective medical radioisotopes for
treating bone metastases from cancers like prostate and breast cancer.
These beta emitters selectively concentrate in areas of increased bone
turnover like cancerous bone lesions. Their radiation can help strengthen
bones weakened by metastases and relieve pain by ablating the cancer cells
within bone tissue. Radioimmunotherapy uses antibodies tagged with short-
range alpha or beta-emitting radioisotopes to bind to and destroy cancer
cells at a molecular level. Targeted isotopes include yttrium-90, iodine-131,
lutetium-177 and bismuth-213.
Other promising therapeutic radionuclides in development include actinium-
225 and lead-212. Actinium-225 generates four alpha particle emissions in
its decay chain and shows potential for treating acute myeloid leukemia and
other cancers if attached to monoclonal antibodies. Lead-212 can also
generate alpha decays and has a very short half-life of only 10.6 hours,
allowing it to deliver highly localized radiation doses without traveling far
from tumors. As radiotherapeutics continue to be researched and refined,
selective internal radiation exposures may become viable alternatives or
supplements to external beam radiation treatments for various cancers and
other conditions.
Radiopharmaceutical production
The production of radiotracers and radiopharmaceuticals for medical
applications is a major industry that generates billions in revenue annually.
Common medical radioisotopes like technetium-99m, iodine-123 and -131,
gallium-67, thallium-201, fluorine-18 and others are produced globally in
specialized nuclear reactors, particle accelerators, or generators. Radioactive
milling and processing facilities purify and formulate radionuclides into stable
chemical compounds suitable for intravenous injection or ingestion by
patients before scanning or therapy. Stringent regulations and quality
controls ensure the radioactive drugs are manufactured under high purity,
sterility, and maximum specific radioactivity standards. Continuous fission
reactors like those in Canada routinely supply over 80% of the U.S. demand
for the workhorse technetium-99m isotope needed for tens of thousands of
SPECT scans every day. The global medical radioisotope market, dominated
by the top three firms, is projected to grow annually by over 5% through
2027 due to expanding clinical applications and replacements for aging
reactor infrastructure. Overall, nuclear medicine has revolutionized diagnosis
and treatment, helping improve millions of lives.
Part 2: Applications in Industry
Isotope production
In addition to medical uses, nuclear processes are employed industrially to
produce important stable and radioactive isotopes. Light water reactors
generate sizeable quantities of plutonium-239 as a byproduct of uranium-238
absorbing neutrons. Plutonium-239 has a half-life of 24,100 years and its
decay produces mostly alpha particles, making it well suited for
thermoelectric applications in radioisotope thermoelectric generators (RTGs).
RTGs powered U.S. space missions for over 50 years including Voyager,
Galileo, and Curiosity by using the heat from plutonium-238's radioactive
decay.
Tritium, a radioactive isotope of hydrogen, is primarily used in self-luminous
sights for firearms, emergency exit signs, and other low light applications. It
is commercially produced by irradiating a lithium target with neutrons in a
nuclear reactor, followed by chemical separation. Large quantities of
naturally occurring krypton-81 are also collected from gaseous fission
products extracted from reactor off-gases. This stable noble gas isotope finds
use as an inert filler for energy efficient light bulbs and flat panel displays.
Neutron activation analysis
Another nuclear technique employed in industry is neutron activation
analysis (NAA), which involves irradiating samples with neutrons in a nuclear
reactor. This process causes certain elements in the sample to become
radioactive via neutron capture. By precisely measuring the gamma radiation
signatures emitted as these artificially produced radioisotopes decay, it is
possible to quantitatively determine the elemental composition of even
complex industrial materials down to trace quantities. NAA is useful for
quality control in sectors like mining, metallurgy, electronics manufacturing
and more. It can rapidly screen bulk samples for contaminants or verify
purity in a non-destructive manner.
Industrial radiography
Industrial radiography utilizes penetrating gamma and X-rays from
radioactive isotopes to examine the internal structures and defects in large
industrial components without having to dismantle or destroy them.
Common radiographic sources include cobalt-60, iridium-192, selenium-75
and caesium-137. The images reveal flaws invisible from the surface like
cracks, voids, corrosion or faulty welds in critical infrastructure parts like
pipelines, pressure vessels, bridges and machinery. This allows issues to be
addressed before catastrophic failures occur. While X-ray machines can also
perform industrial radiography, radioactive sources provide more penetrating
power for larger and higher density objects. However, their encapsulated
sources must be carefully shielded and handled to prevent exposure when
not in use.
Sterilization
Today, over half of all medical devices and many food products worldwide are
sterilized using gamma or electron beam radiation from radioactive isotopes.
Cobalt-60 is a popular gamma source that can penetrate packaging and
thoroughly sterilize items. The high-energy photons destroy microbes like
bacteria and viruses without leaving chemical residues. As no thermal or
pressure factors are involved, radiation sterilization maintains product
integrity and is suitable for heat- and moisture-sensitive items. In addition to
consumables, radiation has widespread uses decontaminating medical
equipment and sterilizing surgical gowns, drapes and implants before they
reach hospitals and patients. When combined with strict quality controls,
radiation-based sterilization provides a safe, effective and environmentally-
friendly alternative to steam, EtO gas or other chemical sterilants.
Part 3: Applications in Energy Production
Nuclear fission power
Nuclear fission reactors harness the energy released during nuclear fission
chain reactions to generate electricity on a commercial scale. Fissile
uranium-235 or plutonium-239 atoms are bombarded with neutrons and then
split apart, releasing additional neutrons, heat in the form of kinetic energy,
and gamma radiation. In a nuclear power plant, the heat generated is used
to produce steam that drives turbines connected to electricity generators.
Over 450 nuclear reactors worldwide currently supply about 10% of the
global electricity demand and one-third of low-carbon power. Generation II
light water reactors dominate the global fleet while Generation III+ and IV
designs incorporate passive safety and materials innovations.
Proponents argue nuclear energy is a stable, reliable, low-carbon baseload
power source able to meet rising energy needs. Unlike intermittent
renewables, fission continuously operates 24/7 and maintains the grid
reliability required by modern societies and industries. The energy density
per unit fuel mass from fission vastly exceeds fossil or renewable
alternatives. However, nuclear faces challenges from high capital costs and
construction timescales, nuclear waste management and proliferation
concerns as well as safety risks if accidents occur. Nevertheless, many
experts see it as indispensable for climate goals given its clean attributes,
and over 50 new reactors are under construction worldwide. Ongoing
research aims to sustain a nuclear renaissance through new small modular,
advanced, and fast neutron reactors.
Nuclear fusion power
Nuclear fusion harnesses the energy from fusing atomic nuclei lighter than
iron, the opposite reaction to fission. The most promising approach is using
strong magnetic fields in doughnut-shaped tokamak reactors to heat and
compress hydrogen isotopes deuterium and tritium under extreme
conditions, where their nuclei fuse and release helium atoms along with
energetic neutrons. This fusion process occurs naturally in the cores of stars
and greatly outstrips any chemical energy source on an energy per unit mass
basis. Researchers envision inertial confinement fusion using lasers and
hypersonic z-pinches as alternatives to the magnetic confinement approach.
The International Thermonuclear Experimental Reactor (ITER) tokamak
project currently underway in France aims to demonstrate the scientific and
technical feasibility of fusion power by generating net energy from fusion for
periods of several minutes by 2035. Beyond ITER, commercial fusion reactors
would not emit greenhouse gases, deplete resources or create long-lived
nuclear waste. With hydrogen as fuel, worldwide reserves could last for
millions of years. However, achieving economically viable and self-sustaining
fusion remains an immense technical challenge still far in the future given
difficulty in maintaining plasma stability, tailoring magnetic fields or focusing
laser energy precisely enough for efficient fusion conditions. Yet many think
mastering fusion could revolutionize future energy production sustainably if
the scientific obstacles are overcome.
Nuclear batteries
Radioisotope thermoelectric generators (RTGs) that operate on the heat from
radioactive decay have powered interplanetary spacecraft explorations since
the 1960s. Efforts are underway by companies to design small modular
nuclear batteries optimized to decentralize electricity access for off-grid
communities, charging electric vehicles, powering remote infrastructure
stations and more on Earth. Proposed designs use uranium or plutonium-
based heat sources coupled to micro-CHP engines that convert heat to
electricity via thermoelectrics or Stirling engines. The multi-decade long
operating lifetimes from self-contained and sealed devices could enable
independent power for areas without transmission grids. However nuclear
batteries face commercialization barriers from public acceptance issues,
developing long-term waste storage and obtaining regulatory approvals for
small-scale reactors despite inherent safety advantages versus larger plants.
Their potential role in energy access remains an open question.
Nuclear waste management
Effectively managing nuclear waste produced from both power generation
and medical/research applications remains an outstanding technical
challenge requiring long-term geological isolation. Most waste solutions
center around deep geologic repositories that exploit low water flow and
geochemically stable formations to contain radionuclides for thousands of
years. Engineered thick concrete barriers and steel casks provide multiple
redundant levels of containment and isolation deep underground where the
heat from radioactive decay can dissipate harmlessly. Waste matrices like
glass or ceramics immobilize radionuclides, while advanced monitoring
systems track any subsurface fluid movement. Some countries like Finland
have made significant progress developing permanent nuclear waste
repositories with regulatory approval and community consent. However
political opposition and siting difficulties have stalled other repository
programs worldwide. Advanced reprocessing to reduce long-term
radionuclide inventories and transmute select actinides into shorter-lived
isotopes represent alternatives still under research. Considering the
enormous quantities of long-lived nuclear waste that must be properly
entombed, developing safe geological storage solutions on the timescales of
human civilization remains an unfinished story of high importance.
Conclusion
In conclusion, nuclear chemistry technologies applied across medicine,
industry and energy have greatly benefited humanity but also present
unique challenges that must be soundly addressed. Medical applications of
radioactive tracers and radiotherapeutics have revolutionized diagnosis and
treatment by non-invasively imaging physiological processes in vivo and
selectively targeting diseased tissue. Industrial processes make use of
radioisotopes for isotope production, materials analysis, non-destructive
testing and sterilization under strictly controlled conditions. Nuclear power
already supplies massive amounts of reliable low-carbon energy worldwide,
with the possibility of fusion and modular fission batteries decentralizing
access if technical obstacles are one day overcome.
However, issues from waste management, safety risks, weapons proliferation
linkage and cost overruns associated with nuclear technologies demand
prudent regulation and innovation. Long-term isolation of highly radioactive
byproducts in geological repositories poses scientific and institutional
challenges on tens of thousands of year timescales. Incidents like Chernobyl
and Fukushima also remind of nuclear’s unforgiving realities if accidents
breach multiple safety barriers. Advancing novel reactor concepts and fuel
cycles to proliferate-resistant, walk-away safe and more resource efficient
designs therefore retains importance alongside non-nuclear climate
solutions. Public trust and transparent risk communication likewise matter
greatly for continued development. Overall, a balanced, evidence-based
approach is needed to maximize nuclear’s benefits judiciously, while
prioritizing safety, oversight, waste confinement and nonproliferation into the
deep future. With comprehensive management, nuclear science's peaceful
applications will likely expand to a technology for humanity as keen
understanding of the atom's power increases.
Nuclear chemistry is the study of how nuclei react and change. It involves
changes in the composition and structure of atomic nuclei. Many important
practical applications of nuclear chemistry have emerged that have
massively impacted medicine, industry, and energy production. This paper
will explore the diverse applications of nuclear chemistry across these three
domains and discuss both their benefits as well as some criticisms and
concerns about their use.
Part 1: Applications in Medicine
Medical imaging
One of the most widespread medical applications of nuclear chemistry is in
medical imaging techniques such as positron emission tomography (PET)
scans, single photon emission computed tomography (SPECT) scans, and
nuclear magnetic resonance (NMR) imaging. These techniques utilize
radioactive tracers, which are molecules that have been labeled with
radioactive isotopes. When these tracers are introduced into the body, they
can be detected by specialized cameras and used to form detailed 3D
images of tissues and organs.
PET scans use radioactive tracers that emit positrons. Common PET
radiotracers include fluorine-18, carbon-11, nitrogen-13, and oxygen-15.
These radioactive atoms are attached to molecules that are involved in
normal body processes like glucose metabolism, blood flow, and protein
synthesis. As the radiotracer accumulates in tissues, the positions of emitting
positrons can be detected and used to construct tomographic images of
metabolic activity in the body. PET scans provide extremely sensitive and
quantitative measurements and have revolutionized the detection, diagnosis,
and monitoring of many cancers as well as brain disorders like Alzheimer's
disease.
SPECT scans similarly use gamma-ray emitting radioactive tracers but form
lower resolution images than PET. Common SPECT radiotracers include
technetium-99m, thallium-201, gallium-67, and iodine-123. Like PET tracers,
these label molecules involved in key physiological processes. By monitoring
the distribution and movement of radiotracers in the body, SPECT scans can
identify abnormalities and lesions. For example, SPECT scans with thallium-
201 or technetium-99m can detect blood flow issues in the heart muscle to
diagnose heart disease. Iodine-123 scans are also useful for diagnosing
thyroid disease and cancers.
NMR imaging, more commonly known as magnetic resonance imaging (MRI),
uses the magnetic properties of atomic nuclei instead of radioactivity. Many
MRI scans utilize the hydrogen nuclei naturally present in water molecules in
the body. Powerful magnets and radiofrequency pulses are used to excite the
magnetic dipoles of these nuclei, causing them to emit radio signals that can
be used to construct diagnostic images. MRI provides excellent soft tissue
contrast and has become an invaluable tool for examining the brain, spine,
joints, and many other internal structures without exposure to radiation.
Contrast agents containing gadolinium can also be intravenously
administered to enhance MRI images.
Radioisotope therapy
In addition to diagnostics, some radionuclides have therapeutic applications
for treating various medical conditions. One of the most well established is
the use of iodine-131 to treat hyperthyroidism and thyroid cancer. Iodine-131
has similar chemical properties to stable iodine and readily accumulates in
the thyroid gland where it destroys remaining thyroid tissue through beta
radiation exposure. This reduces overproduction of hormones in
hyperthyroidism while also destroying any cancerous thyroid cells. Treatment
is usually very effective with few side effects.
Strontium-89 and samarium-153 are also effective medical radioisotopes for
treating bone metastases from cancers like prostate and breast cancer.
These beta emitters selectively concentrate in areas of increased bone
turnover like cancerous bone lesions. Their radiation can help strengthen
bones weakened by metastases and relieve pain by ablating the cancer cells
within bone tissue. Radioimmunotherapy uses antibodies tagged with short-
range alpha or beta-emitting radioisotopes to bind to and destroy cancer
cells at a molecular level. Targeted isotopes include yttrium-90, iodine-131,
lutetium-177 and bismuth-213.
Other promising therapeutic radionuclides in development include actinium-
225 and lead-212. Actinium-225 generates four alpha particle emissions in
its decay chain and shows potential for treating acute myeloid leukemia and
other cancers if attached to monoclonal antibodies. Lead-212 can also
generate alpha decays and has a very short half-life of only 10.6 hours,
allowing it to deliver highly localized radiation doses without traveling far
from tumors. As radiotherapeutics continue to be researched and refined,
selective internal radiation exposures may become viable alternatives or
supplements to external beam radiation treatments for various cancers and
other conditions.
Radiopharmaceutical production
The production of radiotracers and radiopharmaceuticals for medical
applications is a major industry that generates billions in revenue annually.
Common medical radioisotopes like technetium-99m, iodine-123 and -131,
gallium-67, thallium-201, fluorine-18 and others are produced globally in
specialized nuclear reactors, particle accelerators, or generators. Radioactive
milling and processing facilities purify and formulate radionuclides into stable
chemical compounds suitable for intravenous injection or ingestion by
patients before scanning or therapy. Stringent regulations and quality
controls ensure the radioactive drugs are manufactured under high purity,
sterility, and maximum specific radioactivity standards. Continuous fission
reactors like those in Canada routinely supply over 80% of the U.S. demand
for the workhorse technetium-99m isotope needed for tens of thousands of
SPECT scans every day. The global medical radioisotope market, dominated
by the top three firms, is projected to grow annually by over 5% through
2027 due to expanding clinical applications and replacements for aging
reactor infrastructure. Overall, nuclear medicine has revolutionized diagnosis
and treatment, helping improve millions of lives.
Part 2: Applications in Industry
Isotope production
In addition to medical uses, nuclear processes are employed industrially to
produce important stable and radioactive isotopes. Light water reactors
generate sizeable quantities of plutonium-239 as a byproduct of uranium-238
absorbing neutrons. Plutonium-239 has a half-life of 24,100 years and its
decay produces mostly alpha particles, making it well suited for
thermoelectric applications in radioisotope thermoelectric generators (RTGs).
RTGs powered U.S. space missions for over 50 years including Voyager,
Galileo, and Curiosity by using the heat from plutonium-238's radioactive
decay.
Tritium, a radioactive isotope of hydrogen, is primarily used in self-luminous
sights for firearms, emergency exit signs, and other low light applications. It
is commercially produced by irradiating a lithium target with neutrons in a
nuclear reactor, followed by chemical separation. Large quantities of
naturally occurring krypton-81 are also collected from gaseous fission
products extracted from reactor off-gases. This stable noble gas isotope finds
use as an inert filler for energy efficient light bulbs and flat panel displays.
Neutron activation analysis
Another nuclear technique employed in industry is neutron activation
analysis (NAA), which involves irradiating samples with neutrons in a nuclear
reactor. This process causes certain elements in the sample to become
radioactive via neutron capture. By precisely measuring the gamma radiation
signatures emitted as these artificially produced radioisotopes decay, it is
possible to quantitatively determine the elemental composition of even
complex industrial materials down to trace quantities. NAA is useful for
quality control in sectors like mining, metallurgy, electronics manufacturing
and more. It can rapidly screen bulk samples for contaminants or verify
purity in a non-destructive manner.
Industrial radiography
Industrial radiography utilizes penetrating gamma and X-rays from
radioactive isotopes to examine the internal structures and defects in large
industrial components without having to dismantle or destroy them.
Common radiographic sources include cobalt-60, iridium-192, selenium-75
and caesium-137. The images reveal flaws invisible from the surface like
cracks, voids, corrosion or faulty welds in critical infrastructure parts like
pipelines, pressure vessels, bridges and machinery. This allows issues to be
addressed before catastrophic failures occur. While X-ray machines can also
perform industrial radiography, radioactive sources provide more penetrating
power for larger and higher density objects. However, their encapsulated
sources must be carefully shielded and handled to prevent exposure when
not in use.
Sterilization
Today, over half of all medical devices and many food products worldwide are
sterilized using gamma or electron beam radiation from radioactive isotopes.
Cobalt-60 is a popular gamma source that can penetrate packaging and
thoroughly sterilize items. The high-energy photons destroy microbes like
bacteria and viruses without leaving chemical residues. As no thermal or
pressure factors are involved, radiation sterilization maintains product
integrity and is suitable for heat- and moisture-sensitive items. In addition to
consumables, radiation has widespread uses decontaminating medical
equipment and sterilizing surgical gowns, drapes and implants before they
reach hospitals and patients. When combined with strict quality controls,
radiation-based sterilization provides a safe, effective and environmentally-
friendly alternative to steam, EtO gas or other chemical sterilants.
Part 3: Applications in Energy Production
Nuclear fission power
Nuclear fission reactors harness the energy released during nuclear fission
chain reactions to generate electricity on a commercial scale. Fissile
uranium-235 or plutonium-239 atoms are bombarded with neutrons and then
split apart, releasing additional neutrons, heat in the form of kinetic energy,
and gamma radiation. In a nuclear power plant, the heat generated is used
to produce steam that drives turbines connected to electricity generators.
Over 450 nuclear reactors worldwide currently supply about 10% of the
global electricity demand and one-third of low-carbon power. Generation II
light water reactors dominate the global fleet while Generation III+ and IV
designs incorporate passive safety and materials innovations.
Proponents argue nuclear energy is a stable, reliable, low-carbon baseload
power source able to meet rising energy needs. Unlike intermittent
renewables, fission continuously operates 24/7 and maintains the grid
reliability required by modern societies and industries. The energy density
per unit fuel mass from fission vastly exceeds fossil or renewable
alternatives. However, nuclear faces challenges from high capital costs and
construction timescales, nuclear waste management and proliferation
concerns as well as safety risks if accidents occur. Nevertheless, many
experts see it as indispensable for climate goals given its clean attributes,
and over 50 new reactors are under construction worldwide. Ongoing
research aims to sustain a nuclear renaissance through new small modular,
advanced, and fast neutron reactors.
Nuclear fusion power
Nuclear fusion harnesses the energy from fusing atomic nuclei lighter than
iron, the opposite reaction to fission. The most promising approach is using
strong magnetic fields in doughnut-shaped tokamak reactors to heat and
compress hydrogen isotopes deuterium and tritium under extreme
conditions, where their nuclei fuse and release helium atoms along with
energetic neutrons. This fusion process occurs naturally in the cores of stars
and greatly outstrips any chemical energy source on an energy per unit mass
basis. Researchers envision inertial confinement fusion using lasers and
hypersonic z-pinches as alternatives to the magnetic confinement approach.
The International Thermonuclear Experimental Reactor (ITER) tokamak
project currently underway in France aims to demonstrate the scientific and
technical feasibility of fusion power by generating net energy from fusion for
periods of several minutes by 2035. Beyond ITER, commercial fusion reactors
would not emit greenhouse gases, deplete resources or create long-lived
nuclear waste. With hydrogen as fuel, worldwide reserves could last for
millions of years. However, achieving economically viable and self-sustaining
fusion remains an immense technical challenge still far in the future given
difficulty in maintaining plasma stability, tailoring magnetic fields or focusing
laser energy precisely enough for efficient fusion conditions. Yet many think
mastering fusion could revolutionize future energy production sustainably if
the scientific obstacles are overcome.
Nuclear batteries
Radioisotope thermoelectric generators (RTGs) that operate on the heat from
radioactive decay have powered interplanetary spacecraft explorations since
the 1960s. Efforts are underway by companies to design small modular
nuclear batteries optimized to decentralize electricity access for off-grid
communities, charging electric vehicles, powering remote infrastructure
stations and more on Earth. Proposed designs use uranium or plutonium-
based heat sources coupled to micro-CHP engines that convert heat to
electricity via thermoelectrics or Stirling engines. The multi-decade long
operating lifetimes from self-contained and sealed devices could enable
independent power for areas without transmission grids. However nuclear
batteries face commercialization barriers from public acceptance issues,
developing long-term waste storage and obtaining regulatory approvals for
small-scale reactors despite inherent safety advantages versus larger plants.
Their potential role in energy access remains an open question.
Nuclear waste management
Effectively managing nuclear waste produced from both power generation
and medical/research applications remains an outstanding technical
challenge requiring long-term geological isolation. Most waste solutions
center around deep geologic repositories that exploit low water flow and
geochemically stable formations to contain radionuclides for thousands of
years. Engineered thick concrete barriers and steel casks provide multiple
redundant levels of containment and isolation deep underground where the
heat from radioactive decay can dissipate harmlessly. Waste matrices like
glass or ceramics immobilize radionuclides, while advanced monitoring
systems track any subsurface fluid movement. Some countries like Finland
have made significant progress developing permanent nuclear waste
repositories with regulatory approval and community consent. However
political opposition and siting difficulties have stalled other repository
programs worldwide. Advanced reprocessing to reduce long-term
radionuclide inventories and transmute select actinides into shorter-lived
isotopes represent alternatives still under research. Considering the
enormous quantities of long-lived nuclear waste that must be properly
entombed, developing safe geological storage solutions on the timescales of
human civilization remains an unfinished story of high importance.
Conclusion
In conclusion, nuclear chemistry technologies applied across medicine,
industry and energy have greatly benefited humanity but also present
unique challenges that must be soundly addressed. Medical applications of
radioactive tracers and radiotherapeutics have revolutionized diagnosis and
treatment by non-invasively imaging physiological processes in vivo and
selectively targeting diseased tissue. Industrial processes make use of
radioisotopes for isotope production, materials analysis, non-destructive
testing and sterilization under strictly controlled conditions. Nuclear power
already supplies massive amounts of reliable low-carbon energy worldwide,
with the possibility of fusion and modular fission batteries decentralizing
access if technical obstacles are one day overcome.
However, issues from waste management, safety risks, weapons proliferation
linkage and cost overruns associated with nuclear technologies demand
prudent regulation and innovation. Long-term isolation of highly radioactive
byproducts in geological repositories poses scientific and institutional
challenges on tens of thousands of year timescales. Incidents like Chernobyl
and Fukushima also remind of nuclear’s unforgiving realities if accidents
breach multiple safety barriers. Advancing novel reactor concepts and fuel
cycles to proliferate-resistant, walk-away safe and more resource efficient
designs therefore retains importance alongside non-nuclear climate
solutions. Public trust and transparent risk communication likewise matter
greatly for continued development. Overall, a balanced, evidence-based
approach is needed to maximize nuclear’s benefits judiciously, while
prioritizing safety, oversight, waste confinement and nonproliferation into the
deep future. With comprehensive management, nuclear science's peaceful
applications will likely expand to a technology for humanity as keen
understanding of the atom's power increases.
Nuclear chemistry is the study of how nuclei react and change. It involves
changes in the composition and structure of atomic nuclei. Many important
practical applications of nuclear chemistry have emerged that have
massively impacted medicine, industry, and energy production. This paper
will explore the diverse applications of nuclear chemistry across these three
domains and discuss both their benefits as well as some criticisms and
concerns about their use.
Part 1: Applications in Medicine
Medical imaging
One of the most widespread medical applications of nuclear chemistry is in
medical imaging techniques such as positron emission tomography (PET)
scans, single photon emission computed tomography (SPECT) scans, and
nuclear magnetic resonance (NMR) imaging. These techniques utilize
radioactive tracers, which are molecules that have been labeled with
radioactive isotopes. When these tracers are introduced into the body, they
can be detected by specialized cameras and used to form detailed 3D
images of tissues and organs.
PET scans use radioactive tracers that emit positrons. Common PET
radiotracers include fluorine-18, carbon-11, nitrogen-13, and oxygen-15.
These radioactive atoms are attached to molecules that are involved in
normal body processes like glucose metabolism, blood flow, and protein
synthesis. As the radiotracer accumulates in tissues, the positions of emitting
positrons can be detected and used to construct tomographic images of
metabolic activity in the body. PET scans provide extremely sensitive and
quantitative measurements and have revolutionized the detection, diagnosis,
and monitoring of many cancers as well as brain disorders like Alzheimer's
disease.
SPECT scans similarly use gamma-ray emitting radioactive tracers but form
lower resolution images than PET. Common SPECT radiotracers include
technetium-99m, thallium-201, gallium-67, and iodine-123. Like PET tracers,
these label molecules involved in key physiological processes. By monitoring
the distribution and movement of radiotracers in the body, SPECT scans can
identify abnormalities and lesions. For example, SPECT scans with thallium-
201 or technetium-99m can detect blood flow issues in the heart muscle to
diagnose heart disease. Iodine-123 scans are also useful for diagnosing
thyroid disease and cancers.
NMR imaging, more commonly known as magnetic resonance imaging (MRI),
uses the magnetic properties of atomic nuclei instead of radioactivity. Many
MRI scans utilize the hydrogen nuclei naturally present in water molecules in
the body. Powerful magnets and radiofrequency pulses are used to excite the
magnetic dipoles of these nuclei, causing them to emit radio signals that can
be used to construct diagnostic images. MRI provides excellent soft tissue
contrast and has become an invaluable tool for examining the brain, spine,
joints, and many other internal structures without exposure to radiation.
Contrast agents containing gadolinium can also be intravenously
administered to enhance MRI images.
Radioisotope therapy
In addition to diagnostics, some radionuclides have therapeutic applications
for treating various medical conditions. One of the most well established is
the use of iodine-131 to treat hyperthyroidism and thyroid cancer. Iodine-131
has similar chemical properties to stable iodine and readily accumulates in
the thyroid gland where it destroys remaining thyroid tissue through beta
radiation exposure. This reduces overproduction of hormones in
hyperthyroidism while also destroying any cancerous thyroid cells. Treatment
is usually very effective with few side effects.
Strontium-89 and samarium-153 are also effective medical radioisotopes for
treating bone metastases from cancers like prostate and breast cancer.
These beta emitters selectively concentrate in areas of increased bone
turnover like cancerous bone lesions. Their radiation can help strengthen
bones weakened by metastases and relieve pain by ablating the cancer cells
within bone tissue. Radioimmunotherapy uses antibodies tagged with short-
range alpha or beta-emitting radioisotopes to bind to and destroy cancer
cells at a molecular level. Targeted isotopes include yttrium-90, iodine-131,
lutetium-177 and bismuth-213.
Other promising therapeutic radionuclides in development include actinium-
225 and lead-212. Actinium-225 generates four alpha particle emissions in
its decay chain and shows potential for treating acute myeloid leukemia and
other cancers if attached to monoclonal antibodies. Lead-212 can also
generate alpha decays and has a very short half-life of only 10.6 hours,
allowing it to deliver highly localized radiation doses without traveling far
from tumors. As radiotherapeutics continue to be researched and refined,
selective internal radiation exposures may become viable alternatives or
supplements to external beam radiation treatments for various cancers and
other conditions.
Radiopharmaceutical production
The production of radiotracers and radiopharmaceuticals for medical
applications is a major industry that generates billions in revenue annually.
Common medical radioisotopes like technetium-99m, iodine-123 and -131,
gallium-67, thallium-201, fluorine-18 and others are produced globally in
specialized nuclear reactors, particle accelerators, or generators. Radioactive
milling and processing facilities purify and formulate radionuclides into stable
chemical compounds suitable for intravenous injection or ingestion by
patients before scanning or therapy. Stringent regulations and quality
controls ensure the radioactive drugs are manufactured under high purity,
sterility, and maximum specific radioactivity standards. Continuous fission
reactors like those in Canada routinely supply over 80% of the U.S. demand
for the workhorse technetium-99m isotope needed for tens of thousands of
SPECT scans every day. The global medical radioisotope market, dominated
by the top three firms, is projected to grow annually by over 5% through
2027 due to expanding clinical applications and replacements for aging
reactor infrastructure. Overall, nuclear medicine has revolutionized diagnosis
and treatment, helping improve millions of lives.
Part 2: Applications in Industry
Isotope production
In addition to medical uses, nuclear processes are employed industrially to
produce important stable and radioactive isotopes. Light water reactors
generate sizeable quantities of plutonium-239 as a byproduct of uranium-238
absorbing neutrons. Plutonium-239 has a half-life of 24,100 years and its
decay produces mostly alpha particles, making it well suited for
thermoelectric applications in radioisotope thermoelectric generators (RTGs).
RTGs powered U.S. space missions for over 50 years including Voyager,
Galileo, and Curiosity by using the heat from plutonium-238's radioactive
decay.
Tritium, a radioactive isotope of hydrogen, is primarily used in self-luminous
sights for firearms, emergency exit signs, and other low light applications. It
is commercially produced by irradiating a lithium target with neutrons in a
nuclear reactor, followed by chemical separation. Large quantities of
naturally occurring krypton-81 are also collected from gaseous fission
products extracted from reactor off-gases. This stable noble gas isotope finds
use as an inert filler for energy efficient light bulbs and flat panel displays.
Neutron activation analysis
Another nuclear technique employed in industry is neutron activation
analysis (NAA), which involves irradiating samples with neutrons in a nuclear
reactor. This process causes certain elements in the sample to become
radioactive via neutron capture. By precisely measuring the gamma radiation
signatures emitted as these artificially produced radioisotopes decay, it is
possible to quantitatively determine the elemental composition of even
complex industrial materials down to trace quantities. NAA is useful for
quality control in sectors like mining, metallurgy, electronics manufacturing
and more. It can rapidly screen bulk samples for contaminants or verify
purity in a non-destructive manner.
Industrial radiography
Industrial radiography utilizes penetrating gamma and X-rays from
radioactive isotopes to examine the internal structures and defects in large
industrial components without having to dismantle or destroy them.
Common radiographic sources include cobalt-60, iridium-192, selenium-75
and caesium-137. The images reveal flaws invisible from the surface like
cracks, voids, corrosion or faulty welds in critical infrastructure parts like
pipelines, pressure vessels, bridges and machinery. This allows issues to be
addressed before catastrophic failures occur. While X-ray machines can also
perform industrial radiography, radioactive sources provide more penetrating
power for larger and higher density objects. However, their encapsulated
sources must be carefully shielded and handled to prevent exposure when
not in use.
Sterilization
Today, over half of all medical devices and many food products worldwide are
sterilized using gamma or electron beam radiation from radioactive isotopes.
Cobalt-60 is a popular gamma source that can penetrate packaging and
thoroughly sterilize items. The high-energy photons destroy microbes like
bacteria and viruses without leaving chemical residues. As no thermal or
pressure factors are involved, radiation sterilization maintains product
integrity and is suitable for heat- and moisture-sensitive items. In addition to
consumables, radiation has widespread uses decontaminating medical
equipment and sterilizing surgical gowns, drapes and implants before they
reach hospitals and patients. When combined with strict quality controls,
radiation-based sterilization provides a safe, effective and environmentally-
friendly alternative to steam, EtO gas or other chemical sterilants.
Part 3: Applications in Energy Production
Nuclear fission power
Nuclear fission reactors harness the energy released during nuclear fission
chain reactions to generate electricity on a commercial scale. Fissile
uranium-235 or plutonium-239 atoms are bombarded with neutrons and then
split apart, releasing additional neutrons, heat in the form of kinetic energy,
and gamma radiation. In a nuclear power plant, the heat generated is used
to produce steam that drives turbines connected to electricity generators.
Over 450 nuclear reactors worldwide currently supply about 10% of the
global electricity demand and one-third of low-carbon power. Generation II
light water reactors dominate the global fleet while Generation III+ and IV
designs incorporate passive safety and materials innovations.
Proponents argue nuclear energy is a stable, reliable, low-carbon baseload
power source able to meet rising energy needs. Unlike intermittent
renewables, fission continuously operates 24/7 and maintains the grid
reliability required by modern societies and industries. The energy density
per unit fuel mass from fission vastly exceeds fossil or renewable
alternatives. However, nuclear faces challenges from high capital costs and
construction timescales, nuclear waste management and proliferation
concerns as well as safety risks if accidents occur. Nevertheless, many
experts see it as indispensable for climate goals given its clean attributes,
and over 50 new reactors are under construction worldwide. Ongoing
research aims to sustain a nuclear renaissance through new small modular,
advanced, and fast neutron reactors.
Nuclear fusion power
Nuclear fusion harnesses the energy from fusing atomic nuclei lighter than
iron, the opposite reaction to fission. The most promising approach is using
strong magnetic fields in doughnut-shaped tokamak reactors to heat and
compress hydrogen isotopes deuterium and tritium under extreme
conditions, where their nuclei fuse and release helium atoms along with
energetic neutrons. This fusion process occurs naturally in the cores of stars
and greatly outstrips any chemical energy source on an energy per unit mass
basis. Researchers envision inertial confinement fusion using lasers and
hypersonic z-pinches as alternatives to the magnetic confinement approach.
The International Thermonuclear Experimental Reactor (ITER) tokamak
project currently underway in France aims to demonstrate the scientific and
technical feasibility of fusion power by generating net energy from fusion for
periods of several minutes by 2035. Beyond ITER, commercial fusion reactors
would not emit greenhouse gases, deplete resources or create long-lived
nuclear waste. With hydrogen as fuel, worldwide reserves could last for
millions of years. However, achieving economically viable and self-sustaining
fusion remains an immense technical challenge still far in the future given
difficulty in maintaining plasma stability, tailoring magnetic fields or focusing
laser energy precisely enough for efficient fusion conditions. Yet many think
mastering fusion could revolutionize future energy production sustainably if
the scientific obstacles are overcome.
Nuclear batteries
Radioisotope thermoelectric generators (RTGs) that operate on the heat from
radioactive decay have powered interplanetary spacecraft explorations since
the 1960s. Efforts are underway by companies to design small modular
nuclear batteries optimized to decentralize electricity access for off-grid
communities, charging electric vehicles, powering remote infrastructure
stations and more on Earth. Proposed designs use uranium or plutonium-
based heat sources coupled to micro-CHP engines that convert heat to
electricity via thermoelectrics or Stirling engines. The multi-decade long
operating lifetimes from self-contained and sealed devices could enable
independent power for areas without transmission grids. However nuclear
batteries face commercialization barriers from public acceptance issues,
developing long-term waste storage and obtaining regulatory approvals for
small-scale reactors despite inherent safety advantages versus larger plants.
Their potential role in energy access remains an open question.
Nuclear waste management
Effectively managing nuclear waste produced from both power generation
and medical/research applications remains an outstanding technical
challenge requiring long-term geological isolation. Most waste solutions
center around deep geologic repositories that exploit low water flow and
geochemically stable formations to contain radionuclides for thousands of
years. Engineered thick concrete barriers and steel casks provide multiple
redundant levels of containment and isolation deep underground where the
heat from radioactive decay can dissipate harmlessly. Waste matrices like
glass or ceramics immobilize radionuclides, while advanced monitoring
systems track any subsurface fluid movement. Some countries like Finland
have made significant progress developing permanent nuclear waste
repositories with regulatory approval and community consent. However
political opposition and siting difficulties have stalled other repository
programs worldwide. Advanced reprocessing to reduce long-term
radionuclide inventories and transmute select actinides into shorter-lived
isotopes represent alternatives still under research. Considering the
enormous quantities of long-lived nuclear waste that must be properly
entombed, developing safe geological storage solutions on the timescales of
human civilization remains an unfinished story of high importance.
Conclusion
In conclusion, nuclear chemistry technologies applied across medicine,
industry and energy have greatly benefited humanity but also present
unique challenges that must be soundly addressed. Medical applications of
radioactive tracers and radiotherapeutics have revolutionized diagnosis and
treatment by non-invasively imaging physiological processes in vivo and
selectively targeting diseased tissue. Industrial processes make use of
radioisotopes for isotope production, materials analysis, non-destructive
testing and sterilization under strictly controlled conditions. Nuclear power
already supplies massive amounts of reliable low-carbon energy worldwide,
with the possibility of fusion and modular fission batteries decentralizing
access if technical obstacles are one day overcome.
However, issues from waste management, safety risks, weapons proliferation
linkage and cost overruns associated with nuclear technologies demand
prudent regulation and innovation. Long-term isolation of highly radioactive
byproducts in geological repositories poses scientific and institutional
challenges on tens of thousands of year timescales. Incidents like Chernobyl
and Fukushima also remind of nuclear’s unforgiving realities if accidents
breach multiple safety barriers. Advancing novel reactor concepts and fuel
cycles to proliferate-resistant, walk-away safe and more resource efficient
designs therefore retains importance alongside non-nuclear climate
solutions. Public trust and transparent risk communication likewise matter
greatly for continued development. Overall, a balanced, evidence-based
approach is needed to maximize nuclear’s benefits judiciously, while
prioritizing safety, oversight, waste confinement and nonproliferation into the
deep future. With comprehensive management, nuclear science's peaceful
applications will likely expand to a technology for humanity as keen
understanding of the atom's power increases.
Nuclear chemistry is the study of how nuclei react and change. It involves
changes in the composition and structure of atomic nuclei. Many important
practical applications of nuclear chemistry have emerged that have
massively impacted medicine, industry, and energy production. This paper
will explore the diverse applications of nuclear chemistry across these three
domains and discuss both their benefits as well as some criticisms and
concerns about their use.
Part 1: Applications in Medicine
Medical imaging
One of the most widespread medical applications of nuclear chemistry is in
medical imaging techniques such as positron emission tomography (PET)
scans, single photon emission computed tomography (SPECT) scans, and
nuclear magnetic resonance (NMR) imaging. These techniques utilize
radioactive tracers, which are molecules that have been labeled with
radioactive isotopes. When these tracers are introduced into the body, they
can be detected by specialized cameras and used to form detailed 3D
images of tissues and organs.
PET scans use radioactive tracers that emit positrons. Common PET
radiotracers include fluorine-18, carbon-11, nitrogen-13, and oxygen-15.
These radioactive atoms are attached to molecules that are involved in
normal body processes like glucose metabolism, blood flow, and protein
synthesis. As the radiotracer accumulates in tissues, the positions of emitting
positrons can be detected and used to construct tomographic images of
metabolic activity in the body. PET scans provide extremely sensitive and
quantitative measurements and have revolutionized the detection, diagnosis,
and monitoring of many cancers as well as brain disorders like Alzheimer's
disease.
SPECT scans similarly use gamma-ray emitting radioactive tracers but form
lower resolution images than PET. Common SPECT radiotracers include
technetium-99m, thallium-201, gallium-67, and iodine-123. Like PET tracers,
these label molecules involved in key physiological processes. By monitoring
the distribution and movement of radiotracers in the body, SPECT scans can
identify abnormalities and lesions. For example, SPECT scans with thallium-
201 or technetium-99m can detect blood flow issues in the heart muscle to
diagnose heart disease. Iodine-123 scans are also useful for diagnosing
thyroid disease and cancers.
NMR imaging, more commonly known as magnetic resonance imaging (MRI),
uses the magnetic properties of atomic nuclei instead of radioactivity. Many
MRI scans utilize the hydrogen nuclei naturally present in water molecules in
the body. Powerful magnets and radiofrequency pulses are used to excite the
magnetic dipoles of these nuclei, causing them to emit radio signals that can
be used to construct diagnostic images. MRI provides excellent soft tissue
contrast and has become an invaluable tool for examining the brain, spine,
joints, and many other internal structures without exposure to radiation.
Contrast agents containing gadolinium can also be intravenously
administered to enhance MRI images.
Radioisotope therapy
In addition to diagnostics, some radionuclides have therapeutic applications
for treating various medical conditions. One of the most well established is
the use of iodine-131 to treat hyperthyroidism and thyroid cancer. Iodine-131
has similar chemical properties to stable iodine and readily accumulates in
the thyroid gland where it destroys remaining thyroid tissue through beta
radiation exposure. This reduces overproduction of hormones in
hyperthyroidism while also destroying any cancerous thyroid cells. Treatment
is usually very effective with few side effects.
Strontium-89 and samarium-153 are also effective medical radioisotopes for
treating bone metastases from cancers like prostate and breast cancer.
These beta emitters selectively concentrate in areas of increased bone
turnover like cancerous bone lesions. Their radiation can help strengthen
bones weakened by metastases and relieve pain by ablating the cancer cells
within bone tissue. Radioimmunotherapy uses antibodies tagged with short-
range alpha or beta-emitting radioisotopes to bind to and destroy cancer
cells at a molecular level. Targeted isotopes include yttrium-90, iodine-131,
lutetium-177 and bismuth-213.
Other promising therapeutic radionuclides in development include actinium-
225 and lead-212. Actinium-225 generates four alpha particle emissions in
its decay chain and shows potential for treating acute myeloid leukemia and
other cancers if attached to monoclonal antibodies. Lead-212 can also
generate alpha decays and has a very short half-life of only 10.6 hours,
allowing it to deliver highly localized radiation doses without traveling far
from tumors. As radiotherapeutics continue to be researched and refined,
selective internal radiation exposures may become viable alternatives or
supplements to external beam radiation treatments for various cancers and
other conditions.
Radiopharmaceutical production
The production of radiotracers and radiopharmaceuticals for medical
applications is a major industry that generates billions in revenue annually.
Common medical radioisotopes like technetium-99m, iodine-123 and -131,
gallium-67, thallium-201, fluorine-18 and others are produced globally in
specialized nuclear reactors, particle accelerators, or generators. Radioactive
milling and processing facilities purify and formulate radionuclides into stable
chemical compounds suitable for intravenous injection or ingestion by
patients before scanning or therapy. Stringent regulations and quality
controls ensure the radioactive drugs are manufactured under high purity,
sterility, and maximum specific radioactivity standards. Continuous fission
reactors like those in Canada routinely supply over 80% of the U.S. demand
for the workhorse technetium-99m isotope needed for tens of thousands of
SPECT scans every day. The global medical radioisotope market, dominated
by the top three firms, is projected to grow annually by over 5% through
2027 due to expanding clinical applications and replacements for aging
reactor infrastructure. Overall, nuclear medicine has revolutionized diagnosis
and treatment, helping improve millions of lives.
Part 2: Applications in Industry
Isotope production
In addition to medical uses, nuclear processes are employed industrially to
produce important stable and radioactive isotopes. Light water reactors
generate sizeable quantities of plutonium-239 as a byproduct of uranium-238
absorbing neutrons. Plutonium-239 has a half-life of 24,100 years and its
decay produces mostly alpha particles, making it well suited for
thermoelectric applications in radioisotope thermoelectric generators (RTGs).
RTGs powered U.S. space missions for over 50 years including Voyager,
Galileo, and Curiosity by using the heat from plutonium-238's radioactive
decay.
Tritium, a radioactive isotope of hydrogen, is primarily used in self-luminous
sights for firearms, emergency exit signs, and other low light applications. It
is commercially produced by irradiating a lithium target with neutrons in a
nuclear reactor, followed by chemical separation. Large quantities of
naturally occurring krypton-81 are also collected from gaseous fission
products extracted from reactor off-gases. This stable noble gas isotope finds
use as an inert filler for energy efficient light bulbs and flat panel displays.
Neutron activation analysis
Another nuclear technique employed in industry is neutron activation
analysis (NAA), which involves irradiating samples with neutrons in a nuclear
reactor. This process causes certain elements in the sample to become
radioactive via neutron capture. By precisely measuring the gamma radiation
signatures emitted as these artificially produced radioisotopes decay, it is
possible to quantitatively determine the elemental composition of even
complex industrial materials down to trace quantities. NAA is useful for
quality control in sectors like mining, metallurgy, electronics manufacturing
and more. It can rapidly screen bulk samples for contaminants or verify
purity in a non-destructive manner.
Industrial radiography
Industrial radiography utilizes penetrating gamma and X-rays from
radioactive isotopes to examine the internal structures and defects in large
industrial components without having to dismantle or destroy them.
Common radiographic sources include cobalt-60, iridium-192, selenium-75
and caesium-137. The images reveal flaws invisible from the surface like
cracks, voids, corrosion or faulty welds in critical infrastructure parts like
pipelines, pressure vessels, bridges and machinery. This allows issues to be
addressed before catastrophic failures occur. While X-ray machines can also
perform industrial radiography, radioactive sources provide more penetrating
power for larger and higher density objects. However, their encapsulated
sources must be carefully shielded and handled to prevent exposure when
not in use.
Sterilization
Today, over half of all medical devices and many food products worldwide are
sterilized using gamma or electron beam radiation from radioactive isotopes.
Cobalt-60 is a popular gamma source that can penetrate packaging and
thoroughly sterilize items. The high-energy photons destroy microbes like
bacteria and viruses without leaving chemical residues. As no thermal or
pressure factors are involved, radiation sterilization maintains product
integrity and is suitable for heat- and moisture-sensitive items. In addition to
consumables, radiation has widespread uses decontaminating medical
equipment and sterilizing surgical gowns, drapes and implants before they
reach hospitals and patients. When combined with strict quality controls,
radiation-based sterilization provides a safe, effective and environmentally-
friendly alternative to steam, EtO gas or other chemical sterilants.
Part 3: Applications in Energy Production
Nuclear fission power
Nuclear fission reactors harness the energy released during nuclear fission
chain reactions to generate electricity on a commercial scale. Fissile
uranium-235 or plutonium-239 atoms are bombarded with neutrons and then
split apart, releasing additional neutrons, heat in the form of kinetic energy,
and gamma radiation. In a nuclear power plant, the heat generated is used
to produce steam that drives turbines connected to electricity generators.
Over 450 nuclear reactors worldwide currently supply about 10% of the
global electricity demand and one-third of low-carbon power. Generation II
light water reactors dominate the global fleet while Generation III+ and IV
designs incorporate passive safety and materials innovations.
Proponents argue nuclear energy is a stable, reliable, low-carbon baseload
power source able to meet rising energy needs. Unlike intermittent
renewables, fission continuously operates 24/7 and maintains the grid
reliability required by modern societies and industries. The energy density
per unit fuel mass from fission vastly exceeds fossil or renewable
alternatives. However, nuclear faces challenges from high capital costs and
construction timescales, nuclear waste management and proliferation
concerns as well as safety risks if accidents occur. Nevertheless, many
experts see it as indispensable for climate goals given its clean attributes,
and over 50 new reactors are under construction worldwide. Ongoing
research aims to sustain a nuclear renaissance through new small modular,
advanced, and fast neutron reactors.
Nuclear fusion power
Nuclear fusion harnesses the energy from fusing atomic nuclei lighter than
iron, the opposite reaction to fission. The most promising approach is using
strong magnetic fields in doughnut-shaped tokamak reactors to heat and
compress hydrogen isotopes deuterium and tritium under extreme
conditions, where their nuclei fuse and release helium atoms along with
energetic neutrons. This fusion process occurs naturally in the cores of stars
and greatly outstrips any chemical energy source on an energy per unit mass
basis. Researchers envision inertial confinement fusion using lasers and
hypersonic z-pinches as alternatives to the magnetic confinement approach.
The International Thermonuclear Experimental Reactor (ITER) tokamak
project currently underway in France aims to demonstrate the scientific and
technical feasibility of fusion power by generating net energy from fusion for
periods of several minutes by 2035. Beyond ITER, commercial fusion reactors
would not emit greenhouse gases, deplete resources or create long-lived
nuclear waste. With hydrogen as fuel, worldwide reserves could last for
millions of years. However, achieving economically viable and self-sustaining
fusion remains an immense technical challenge still far in the future given
difficulty in maintaining plasma stability, tailoring magnetic fields or focusing
laser energy precisely enough for efficient fusion conditions. Yet many think
mastering fusion could revolutionize future energy production sustainably if
the scientific obstacles are overcome.
Nuclear batteries
Radioisotope thermoelectric generators (RTGs) that operate on the heat from
radioactive decay have powered interplanetary spacecraft explorations since
the 1960s. Efforts are underway by companies to design small modular
nuclear batteries optimized to decentralize electricity access for off-grid
communities, charging electric vehicles, powering remote infrastructure
stations and more on Earth. Proposed designs use uranium or plutonium-
based heat sources coupled to micro-CHP engines that convert heat to
electricity via thermoelectrics or Stirling engines. The multi-decade long
operating lifetimes from self-contained and sealed devices could enable
independent power for areas without transmission grids. However nuclear
batteries face commercialization barriers from public acceptance issues,
developing long-term waste storage and obtaining regulatory approvals for
small-scale reactors despite inherent safety advantages versus larger plants.
Their potential role in energy access remains an open question.
Nuclear waste management
Effectively managing nuclear waste produced from both power generation
and medical/research applications remains an outstanding technical
challenge requiring long-term geological isolation. Most waste solutions
center around deep geologic repositories that exploit low water flow and
geochemically stable formations to contain radionuclides for thousands of
years. Engineered thick concrete barriers and steel casks provide multiple
redundant levels of containment and isolation deep underground where the
heat from radioactive decay can dissipate harmlessly. Waste matrices like
glass or ceramics immobilize radionuclides, while advanced monitoring
systems track any subsurface fluid movement. Some countries like Finland
have made significant progress developing permanent nuclear waste
repositories with regulatory approval and community consent. However
political opposition and siting difficulties have stalled other repository
programs worldwide. Advanced reprocessing to reduce long-term
radionuclide inventories and transmute select actinides into shorter-lived
isotopes represent alternatives still under research. Considering the
enormous quantities of long-lived nuclear waste that must be properly
entombed, developing safe geological storage solutions on the timescales of
human civilization remains an unfinished story of high importance.
Conclusion
In conclusion, nuclear chemistry technologies applied across medicine,
industry and energy have greatly benefited humanity but also present
unique challenges that must be soundly addressed. Medical applications of
radioactive tracers and radiotherapeutics have revolutionized diagnosis and
treatment by non-invasively imaging physiological processes in vivo and
selectively targeting diseased tissue. Industrial processes make use of
radioisotopes for isotope production, materials analysis, non-destructive
testing and sterilization under strictly controlled conditions. Nuclear power
already supplies massive amounts of reliable low-carbon energy worldwide,
with the possibility of fusion and modular fission batteries decentralizing
access if technical obstacles are one day overcome.
However, issues from waste management, safety risks, weapons proliferation
linkage and cost overruns associated with nuclear technologies demand
prudent regulation and innovation. Long-term isolation of highly radioactive
byproducts in geological repositories poses scientific and institutional
challenges on tens of thousands of year timescales. Incidents like Chernobyl
and Fukushima also remind of nuclear’s unforgiving realities if accidents
breach multiple safety barriers. Advancing novel reactor concepts and fuel
cycles to proliferate-resistant, walk-away safe and more resource efficient
designs therefore retains importance alongside non-nuclear climate
solutions. Public trust and transparent risk communication likewise matter
greatly for continued development. Overall, a balanced, evidence-based
approach is needed to maximize nuclear’s benefits judiciously, while
prioritizing safety, oversight, waste confinement and nonproliferation into the
deep future. With comprehensive management, nuclear science's peaceful
applications will likely expand to a technology for humanity as keen
understanding of the atom's power increases.
Nuclear chemistry is the study of how nuclei react and change. It involves
changes in the composition and structure of atomic nuclei. Many important
practical applications of nuclear chemistry have emerged that have
massively impacted medicine, industry, and energy production. This paper
will explore the diverse applications of nuclear chemistry across these three
domains and discuss both their benefits as well as some criticisms and
concerns about their use.
Part 1: Applications in Medicine
Medical imaging
One of the most widespread medical applications of nuclear chemistry is in
medical imaging techniques such as positron emission tomography (PET)
scans, single photon emission computed tomography (SPECT) scans, and
nuclear magnetic resonance (NMR) imaging. These techniques utilize
radioactive tracers, which are molecules that have been labeled with
radioactive isotopes. When these tracers are introduced into the body, they
can be detected by specialized cameras and used to form detailed 3D
images of tissues and organs.
PET scans use radioactive tracers that emit positrons. Common PET
radiotracers include fluorine-18, carbon-11, nitrogen-13, and oxygen-15.
These radioactive atoms are attached to molecules that are involved in
normal body processes like glucose metabolism, blood flow, and protein
synthesis. As the radiotracer accumulates in tissues, the positions of emitting
positrons can be detected and used to construct tomographic images of
metabolic activity in the body. PET scans provide extremely sensitive and
quantitative measurements and have revolutionized the detection, diagnosis,
and monitoring of many cancers as well as brain disorders like Alzheimer's
disease.
SPECT scans similarly use gamma-ray emitting radioactive tracers but form
lower resolution images than PET. Common SPECT radiotracers include
technetium-99m, thallium-201, gallium-67, and iodine-123. Like PET tracers,
these label molecules involved in key physiological processes. By monitoring
the distribution and movement of radiotracers in the body, SPECT scans can
identify abnormalities and lesions. For example, SPECT scans with thallium-
201 or technetium-99m can detect blood flow issues in the heart muscle to
diagnose heart disease. Iodine-123 scans are also useful for diagnosing
thyroid disease and cancers.
NMR imaging, more commonly known as magnetic resonance imaging (MRI),
uses the magnetic properties of atomic nuclei instead of radioactivity. Many
MRI scans utilize the hydrogen nuclei naturally present in water molecules in
the body. Powerful magnets and radiofrequency pulses are used to excite the
magnetic dipoles of these nuclei, causing them to emit radio signals that can
be used to construct diagnostic images. MRI provides excellent soft tissue
contrast and has become an invaluable tool for examining the brain, spine,
joints, and many other internal structures without exposure to radiation.
Contrast agents containing gadolinium can also be intravenously
administered to enhance MRI images.
Radioisotope therapy
In addition to diagnostics, some radionuclides have therapeutic applications
for treating various medical conditions. One of the most well established is
the use of iodine-131 to treat hyperthyroidism and thyroid cancer. Iodine-131
has similar chemical properties to stable iodine and readily accumulates in
the thyroid gland where it destroys remaining thyroid tissue through beta
radiation exposure. This reduces overproduction of hormones in
hyperthyroidism while also destroying any cancerous thyroid cells. Treatment
is usually very effective with few side effects.
Strontium-89 and samarium-153 are also effective medical radioisotopes for
treating bone metastases from cancers like prostate and breast cancer.
These beta emitters selectively concentrate in areas of increased bone
turnover like cancerous bone lesions. Their radiation can help strengthen
bones weakened by metastases and relieve pain by ablating the cancer cells
within bone tissue. Radioimmunotherapy uses antibodies tagged with short-
range alpha or beta-emitting radioisotopes to bind to and destroy cancer
cells at a molecular level. Targeted isotopes include yttrium-90, iodine-131,
lutetium-177 and bismuth-213.
Other promising therapeutic radionuclides in development include actinium-
225 and lead-212. Actinium-225 generates four alpha particle emissions in
its decay chain and shows potential for treating acute myeloid leukemia and
other cancers if attached to monoclonal antibodies. Lead-212 can also
generate alpha decays and has a very short half-life of only 10.6 hours,
allowing it to deliver highly localized radiation doses without traveling far
from tumors. As radiotherapeutics continue to be researched and refined,
selective internal radiation exposures may become viable alternatives or
supplements to external beam radiation treatments for various cancers and
other conditions.
Radiopharmaceutical production
The production of radiotracers and radiopharmaceuticals for medical
applications is a major industry that generates billions in revenue annually.
Common medical radioisotopes like technetium-99m, iodine-123 and -131,
gallium-67, thallium-201, fluorine-18 and others are produced globally in
specialized nuclear reactors, particle accelerators, or generators. Radioactive
milling and processing facilities purify and formulate radionuclides into stable
chemical compounds suitable for intravenous injection or ingestion by
patients before scanning or therapy. Stringent regulations and quality
controls ensure the radioactive drugs are manufactured under high purity,
sterility, and maximum specific radioactivity standards. Continuous fission
reactors like those in Canada routinely supply over 80% of the U.S. demand
for the workhorse technetium-99m isotope needed for tens of thousands of
SPECT scans every day. The global medical radioisotope market, dominated
by the top three firms, is projected to grow annually by over 5% through
2027 due to expanding clinical applications and replacements for aging
reactor infrastructure. Overall, nuclear medicine has revolutionized diagnosis
and treatment, helping improve millions of lives.
Part 2: Applications in Industry
Isotope production
In addition to medical uses, nuclear processes are employed industrially to
produce important stable and radioactive isotopes. Light water reactors
generate sizeable quantities of plutonium-239 as a byproduct of uranium-238
absorbing neutrons. Plutonium-239 has a half-life of 24,100 years and its
decay produces mostly alpha particles, making it well suited for
thermoelectric applications in radioisotope thermoelectric generators (RTGs).
RTGs powered U.S. space missions for over 50 years including Voyager,
Galileo, and Curiosity by using the heat from plutonium-238's radioactive
decay.
Tritium, a radioactive isotope of hydrogen, is primarily used in self-luminous
sights for firearms, emergency exit signs, and other low light applications. It
is commercially produced by irradiating a lithium target with neutrons in a
nuclear reactor, followed by chemical separation. Large quantities of
naturally occurring krypton-81 are also collected from gaseous fission
products extracted from reactor off-gases. This stable noble gas isotope finds
use as an inert filler for energy efficient light bulbs and flat panel displays.
Neutron activation analysis
Another nuclear technique employed in industry is neutron activation
analysis (NAA), which involves irradiating samples with neutrons in a nuclear
reactor. This process causes certain elements in the sample to become
radioactive via neutron capture. By precisely measuring the gamma radiation
signatures emitted as these artificially produced radioisotopes decay, it is
possible to quantitatively determine the elemental composition of even
complex industrial materials down to trace quantities. NAA is useful for
quality control in sectors like mining, metallurgy, electronics manufacturing
and more. It can rapidly screen bulk samples for contaminants or verify
purity in a non-destructive manner.
Industrial radiography
Industrial radiography utilizes penetrating gamma and X-rays from
radioactive isotopes to examine the internal structures and defects in large
industrial components without having to dismantle or destroy them.
Common radiographic sources include cobalt-60, iridium-192, selenium-75
and caesium-137. The images reveal flaws invisible from the surface like
cracks, voids, corrosion or faulty welds in critical infrastructure parts like
pipelines, pressure vessels, bridges and machinery. This allows issues to be
addressed before catastrophic failures occur. While X-ray machines can also
perform industrial radiography, radioactive sources provide more penetrating
power for larger and higher density objects. However, their encapsulated
sources must be carefully shielded and handled to prevent exposure when
not in use.
Sterilization
Today, over half of all medical devices and many food products worldwide are
sterilized using gamma or electron beam radiation from radioactive isotopes.
Cobalt-60 is a popular gamma source that can penetrate packaging and
thoroughly sterilize items. The high-energy photons destroy microbes like
bacteria and viruses without leaving chemical residues. As no thermal or
pressure factors are involved, radiation sterilization maintains product
integrity and is suitable for heat- and moisture-sensitive items. In addition to
consumables, radiation has widespread uses decontaminating medical
equipment and sterilizing surgical gowns, drapes and implants before they
reach hospitals and patients. When combined with strict quality controls,
radiation-based sterilization provides a safe, effective and environmentally-
friendly alternative to steam, EtO gas or other chemical sterilants.
Part 3: Applications in Energy Production
Nuclear fission power
Nuclear fission reactors harness the energy released during nuclear fission
chain reactions to generate electricity on a commercial scale. Fissile
uranium-235 or plutonium-239 atoms are bombarded with neutrons and then
split apart, releasing additional neutrons, heat in the form of kinetic energy,
and gamma radiation. In a nuclear power plant, the heat generated is used
to produce steam that drives turbines connected to electricity generators.
Over 450 nuclear reactors worldwide currently supply about 10% of the
global electricity demand and one-third of low-carbon power. Generation II
light water reactors dominate the global fleet while Generation III+ and IV
designs incorporate passive safety and materials innovations.
Proponents argue nuclear energy is a stable, reliable, low-carbon baseload
power source able to meet rising energy needs. Unlike intermittent
renewables, fission continuously operates 24/7 and maintains the grid
reliability required by modern societies and industries. The energy density
per unit fuel mass from fission vastly exceeds fossil or renewable
alternatives. However, nuclear faces challenges from high capital costs and
construction timescales, nuclear waste management and proliferation
concerns as well as safety risks if accidents occur. Nevertheless, many
experts see it as indispensable for climate goals given its clean attributes,
and over 50 new reactors are under construction worldwide. Ongoing
research aims to sustain a nuclear renaissance through new small modular,
advanced, and fast neutron reactors.
Nuclear fusion power
Nuclear fusion harnesses the energy from fusing atomic nuclei lighter than
iron, the opposite reaction to fission. The most promising approach is using
strong magnetic fields in doughnut-shaped tokamak reactors to heat and
compress hydrogen isotopes deuterium and tritium under extreme
conditions, where their nuclei fuse and release helium atoms along with
energetic neutrons. This fusion process occurs naturally in the cores of stars
and greatly outstrips any chemical energy source on an energy per unit mass
basis. Researchers envision inertial confinement fusion using lasers and
hypersonic z-pinches as alternatives to the magnetic confinement approach.
The International Thermonuclear Experimental Reactor (ITER) tokamak
project currently underway in France aims to demonstrate the scientific and
technical feasibility of fusion power by generating net energy from fusion for
periods of several minutes by 2035. Beyond ITER, commercial fusion reactors
would not emit greenhouse gases, deplete resources or create long-lived
nuclear waste. With hydrogen as fuel, worldwide reserves could last for
millions of years. However, achieving economically viable and self-sustaining
fusion remains an immense technical challenge still far in the future given
difficulty in maintaining plasma stability, tailoring magnetic fields or focusing
laser energy precisely enough for efficient fusion conditions. Yet many think
mastering fusion could revolutionize future energy production sustainably if
the scientific obstacles are overcome.
Nuclear batteries
Radioisotope thermoelectric generators (RTGs) that operate on the heat from
radioactive decay have powered interplanetary spacecraft explorations since
the 1960s. Efforts are underway by companies to design small modular
nuclear batteries optimized to decentralize electricity access for off-grid
communities, charging electric vehicles, powering remote infrastructure
stations and more on Earth. Proposed designs use uranium or plutonium-
based heat sources coupled to micro-CHP engines that convert heat to
electricity via thermoelectrics or Stirling engines. The multi-decade long
operating lifetimes from self-contained and sealed devices could enable
independent power for areas without transmission grids. However nuclear
batteries face commercialization barriers from public acceptance issues,
developing long-term waste storage and obtaining regulatory approvals for
small-scale reactors despite inherent safety advantages versus larger plants.
Their potential role in energy access remains an open question.
Nuclear waste management
Effectively managing nuclear waste produced from both power generation
and medical/research applications remains an outstanding technical
challenge requiring long-term geological isolation. Most waste solutions
center around deep geologic repositories that exploit low water flow and
geochemically stable formations to contain radionuclides for thousands of
years. Engineered thick concrete barriers and steel casks provide multiple
redundant levels of containment and isolation deep underground where the
heat from radioactive decay can dissipate harmlessly. Waste matrices like
glass or ceramics immobilize radionuclides, while advanced monitoring
systems track any subsurface fluid movement. Some countries like Finland
have made significant progress developing permanent nuclear waste
repositories with regulatory approval and community consent. However
political opposition and siting difficulties have stalled other repository
programs worldwide. Advanced reprocessing to reduce long-term
radionuclide inventories and transmute select actinides into shorter-lived
isotopes represent alternatives still under research. Considering the
enormous quantities of long-lived nuclear waste that must be properly
entombed, developing safe geological storage solutions on the timescales of
human civilization remains an unfinished story of high importance.
Conclusion
In conclusion, nuclear chemistry technologies applied across medicine,
industry and energy have greatly benefited humanity but also present
unique challenges that must be soundly addressed. Medical applications of
radioactive tracers and radiotherapeutics have revolutionized diagnosis and
treatment by non-invasively imaging physiological processes in vivo and
selectively targeting diseased tissue. Industrial processes make use of
radioisotopes for isotope production, materials analysis, non-destructive
testing and sterilization under strictly controlled conditions. Nuclear power
already supplies massive amounts of reliable low-carbon energy worldwide,
with the possibility of fusion and modular fission batteries decentralizing
access if technical obstacles are one day overcome.
However, issues from waste management, safety risks, weapons proliferation
linkage and cost overruns associated with nuclear technologies demand
prudent regulation and innovation. Long-term isolation of highly radioactive
byproducts in geological repositories poses scientific and institutional
challenges on tens of thousands of year timescales. Incidents like Chernobyl
and Fukushima also remind of nuclear’s unforgiving realities if accidents
breach multiple safety barriers. Advancing novel reactor concepts and fuel
cycles to proliferate-resistant, walk-away safe and more resource efficient
designs therefore retains importance alongside non-nuclear climate
solutions. Public trust and transparent risk communication likewise matter
greatly for continued development. Overall, a balanced, evidence-based
approach is needed to maximize nuclear’s benefits judiciously, while
prioritizing safety, oversight, waste confinement and nonproliferation into the
deep future. With comprehensive management, nuclear science's peaceful
applications will likely expand to a technology for humanity as keen
understanding of the atom's power increases.
Nuclear chemistry is the study of how nuclei react and change. It involves
changes in the composition and structure of atomic nuclei. Many important
practical applications of nuclear chemistry have emerged that have
massively impacted medicine, industry, and energy production. This paper
will explore the diverse applications of nuclear chemistry across these three
domains and discuss both their benefits as well as some criticisms and
concerns about their use.
Part 1: Applications in Medicine
Medical imaging
One of the most widespread medical applications of nuclear chemistry is in
medical imaging techniques such as positron emission tomography (PET)
scans, single photon emission computed tomography (SPECT) scans, and
nuclear magnetic resonance (NMR) imaging. These techniques utilize
radioactive tracers, which are molecules that have been labeled with
radioactive isotopes. When these tracers are introduced into the body, they
can be detected by specialized cameras and used to form detailed 3D
images of tissues and organs.
PET scans use radioactive tracers that emit positrons. Common PET
radiotracers include fluorine-18, carbon-11, nitrogen-13, and oxygen-15.
These radioactive atoms are attached to molecules that are involved in
normal body processes like glucose metabolism, blood flow, and protein
synthesis. As the radiotracer accumulates in tissues, the positions of emitting
positrons can be detected and used to construct tomographic images of
metabolic activity in the body. PET scans provide extremely sensitive and
quantitative measurements and have revolutionized the detection, diagnosis,
and monitoring of many cancers as well as brain disorders like Alzheimer's
disease.
SPECT scans similarly use gamma-ray emitting radioactive tracers but form
lower resolution images than PET. Common SPECT radiotracers include
technetium-99m, thallium-201, gallium-67, and iodine-123. Like PET tracers,
these label molecules involved in key physiological processes. By monitoring
the distribution and movement of radiotracers in the body, SPECT scans can
identify abnormalities and lesions. For example, SPECT scans with thallium-
201 or technetium-99m can detect blood flow issues in the heart muscle to
diagnose heart disease. Iodine-123 scans are also useful for diagnosing
thyroid disease and cancers.
NMR imaging, more commonly known as magnetic resonance imaging (MRI),
uses the magnetic properties of atomic nuclei instead of radioactivity. Many
MRI scans utilize the hydrogen nuclei naturally present in water molecules in
the body. Powerful magnets and radiofrequency pulses are used to excite the
magnetic dipoles of these nuclei, causing them to emit radio signals that can
be used to construct diagnostic images. MRI provides excellent soft tissue
contrast and has become an invaluable tool for examining the brain, spine,
joints, and many other internal structures without exposure to radiation.
Contrast agents containing gadolinium can also be intravenously
administered to enhance MRI images.
Radioisotope therapy
In addition to diagnostics, some radionuclides have therapeutic applications
for treating various medical conditions. One of the most well established is
the use of iodine-131 to treat hyperthyroidism and thyroid cancer. Iodine-131
has similar chemical properties to stable iodine and readily accumulates in
the thyroid gland where it destroys remaining thyroid tissue through beta
radiation exposure. This reduces overproduction of hormones in
hyperthyroidism while also destroying any cancerous thyroid cells. Treatment
is usually very effective with few side effects.
Strontium-89 and samarium-153 are also effective medical radioisotopes for
treating bone metastases from cancers like prostate and breast cancer.
These beta emitters selectively concentrate in areas of increased bone
turnover like cancerous bone lesions. Their radiation can help strengthen
bones weakened by metastases and relieve pain by ablating the cancer cells
within bone tissue. Radioimmunotherapy uses antibodies tagged with short-
range alpha or beta-emitting radioisotopes to bind to and destroy cancer
cells at a molecular level. Targeted isotopes include yttrium-90, iodine-131,
lutetium-177 and bismuth-213.
Other promising therapeutic radionuclides in development include actinium-
225 and lead-212. Actinium-225 generates four alpha particle emissions in
its decay chain and shows potential for treating acute myeloid leukemia and
other cancers if attached to monoclonal antibodies. Lead-212 can also
generate alpha decays and has a very short half-life of only 10.6 hours,
allowing it to deliver highly localized radiation doses without traveling far
from tumors. As radiotherapeutics continue to be researched and refined,
selective internal radiation exposures may become viable alternatives or
supplements to external beam radiation treatments for various cancers and
other conditions.
Radiopharmaceutical production
The production of radiotracers and radiopharmaceuticals for medical
applications is a major industry that generates billions in revenue annually.
Common medical radioisotopes like technetium-99m, iodine-123 and -131,
gallium-67, thallium-201, fluorine-18 and others are produced globally in
specialized nuclear reactors, particle accelerators, or generators. Radioactive
milling and processing facilities purify and formulate radionuclides into stable
chemical compounds suitable for intravenous injection or ingestion by
patients before scanning or therapy. Stringent regulations and quality
controls ensure the radioactive drugs are manufactured under high purity,
sterility, and maximum specific radioactivity standards. Continuous fission
reactors like those in Canada routinely supply over 80% of the U.S. demand
for the workhorse technetium-99m isotope needed for tens of thousands of
SPECT scans every day. The global medical radioisotope market, dominated
by the top three firms, is projected to grow annually by over 5% through
2027 due to expanding clinical applications and replacements for aging
reactor infrastructure. Overall, nuclear medicine has revolutionized diagnosis
and treatment, helping improve millions of lives.
Part 2: Applications in Industry
Isotope production
In addition to medical uses, nuclear processes are employed industrially to
produce important stable and radioactive isotopes. Light water reactors
generate sizeable quantities of plutonium-239 as a byproduct of uranium-238
absorbing neutrons. Plutonium-239 has a half-life of 24,100 years and its
decay produces mostly alpha particles, making it well suited for
thermoelectric applications in radioisotope thermoelectric generators (RTGs).
RTGs powered U.S. space missions for over 50 years including Voyager,
Galileo, and Curiosity by using the heat from plutonium-238's radioactive
decay.
Tritium, a radioactive isotope of hydrogen, is primarily used in self-luminous
sights for firearms, emergency exit signs, and other low light applications. It
is commercially produced by irradiating a lithium target with neutrons in a
nuclear reactor, followed by chemical separation. Large quantities of
naturally occurring krypton-81 are also collected from gaseous fission
products extracted from reactor off-gases. This stable noble gas isotope finds
use as an inert filler for energy efficient light bulbs and flat panel displays.
Neutron activation analysis
Another nuclear technique employed in industry is neutron activation
analysis (NAA), which involves irradiating samples with neutrons in a nuclear
reactor. This process causes certain elements in the sample to become
radioactive via neutron capture. By precisely measuring the gamma radiation
signatures emitted as these artificially produced radioisotopes decay, it is
possible to quantitatively determine the elemental composition of even
complex industrial materials down to trace quantities. NAA is useful for
quality control in sectors like mining, metallurgy, electronics manufacturing
and more. It can rapidly screen bulk samples for contaminants or verify
purity in a non-destructive manner.
Industrial radiography
Industrial radiography utilizes penetrating gamma and X-rays from
radioactive isotopes to examine the internal structures and defects in large
industrial components without having to dismantle or destroy them.
Common radiographic sources include cobalt-60, iridium-192, selenium-75
and caesium-137. The images reveal flaws invisible from the surface like
cracks, voids, corrosion or faulty welds in critical infrastructure parts like
pipelines, pressure vessels, bridges and machinery. This allows issues to be
addressed before catastrophic failures occur. While X-ray machines can also
perform industrial radiography, radioactive sources provide more penetrating
power for larger and higher density objects. However, their encapsulated
sources must be carefully shielded and handled to prevent exposure when
not in use.
Sterilization
Today, over half of all medical devices and many food products worldwide are
sterilized using gamma or electron beam radiation from radioactive isotopes.
Cobalt-60 is a popular gamma source that can penetrate packaging and
thoroughly sterilize items. The high-energy photons destroy microbes like
bacteria and viruses without leaving chemical residues. As no thermal or
pressure factors are involved, radiation sterilization maintains product
integrity and is suitable for heat- and moisture-sensitive items. In addition to
consumables, radiation has widespread uses decontaminating medical
equipment and sterilizing surgical gowns, drapes and implants before they
reach hospitals and patients. When combined with strict quality controls,
radiation-based sterilization provides a safe, effective and environmentally-
friendly alternative to steam, EtO gas or other chemical sterilants.
Part 3: Applications in Energy Production
Nuclear fission power
Nuclear fission reactors harness the energy released during nuclear fission
chain reactions to generate electricity on a commercial scale. Fissile
uranium-235 or plutonium-239 atoms are bombarded with neutrons and then
split apart, releasing additional neutrons, heat in the form of kinetic energy,
and gamma radiation. In a nuclear power plant, the heat generated is used
to produce steam that drives turbines connected to electricity generators.
Over 450 nuclear reactors worldwide currently supply about 10% of the
global electricity demand and one-third of low-carbon power. Generation II
light water reactors dominate the global fleet while Generation III+ and IV
designs incorporate passive safety and materials innovations.
Proponents argue nuclear energy is a stable, reliable, low-carbon baseload
power source able to meet rising energy needs. Unlike intermittent
renewables, fission continuously operates 24/7 and maintains the grid
reliability required by modern societies and industries. The energy density
per unit fuel mass from fission vastly exceeds fossil or renewable
alternatives. However, nuclear faces challenges from high capital costs and
construction timescales, nuclear waste management and proliferation
concerns as well as safety risks if accidents occur. Nevertheless, many
experts see it as indispensable for climate goals given its clean attributes,
and over 50 new reactors are under construction worldwide. Ongoing
research aims to sustain a nuclear renaissance through new small modular,
advanced, and fast neutron reactors.
Nuclear fusion power
Nuclear fusion harnesses the energy from fusing atomic nuclei lighter than
iron, the opposite reaction to fission. The most promising approach is using
strong magnetic fields in doughnut-shaped tokamak reactors to heat and
compress hydrogen isotopes deuterium and tritium under extreme
conditions, where their nuclei fuse and release helium atoms along with
energetic neutrons. This fusion process occurs naturally in the cores of stars
and greatly outstrips any chemical energy source on an energy per unit mass
basis. Researchers envision inertial confinement fusion using lasers and
hypersonic z-pinches as alternatives to the magnetic confinement approach.
The International Thermonuclear Experimental Reactor (ITER) tokamak
project currently underway in France aims to demonstrate the scientific and
technical feasibility of fusion power by generating net energy from fusion for
periods of several minutes by 2035. Beyond ITER, commercial fusion reactors
would not emit greenhouse gases, deplete resources or create long-lived
nuclear waste. With hydrogen as fuel, worldwide reserves could last for
millions of years. However, achieving economically viable and self-sustaining
fusion remains an immense technical challenge still far in the future given
difficulty in maintaining plasma stability, tailoring magnetic fields or focusing
laser energy precisely enough for efficient fusion conditions. Yet many think
mastering fusion could revolutionize future energy production sustainably if
the scientific obstacles are overcome.
Nuclear batteries
Radioisotope thermoelectric generators (RTGs) that operate on the heat from
radioactive decay have powered interplanetary spacecraft explorations since
the 1960s. Efforts are underway by companies to design small modular
nuclear batteries optimized to decentralize electricity access for off-grid
communities, charging electric vehicles, powering remote infrastructure
stations and more on Earth. Proposed designs use uranium or plutonium-
based heat sources coupled to micro-CHP engines that convert heat to
electricity via thermoelectrics or Stirling engines. The multi-decade long
operating lifetimes from self-contained and sealed devices could enable
independent power for areas without transmission grids. However nuclear
batteries face commercialization barriers from public acceptance issues,
developing long-term waste storage and obtaining regulatory approvals for
small-scale reactors despite inherent safety advantages versus larger plants.
Their potential role in energy access remains an open question.
Nuclear waste management
Effectively managing nuclear waste produced from both power generation
and medical/research applications remains an outstanding technical
challenge requiring long-term geological isolation. Most waste solutions
center around deep geologic repositories that exploit low water flow and
geochemically stable formations to contain radionuclides for thousands of
years. Engineered thick concrete barriers and steel casks provide multiple
redundant levels of containment and isolation deep underground where the
heat from radioactive decay can dissipate harmlessly. Waste matrices like
glass or ceramics immobilize radionuclides, while advanced monitoring
systems track any subsurface fluid movement. Some countries like Finland
have made significant progress developing permanent nuclear waste
repositories with regulatory approval and community consent. However
political opposition and siting difficulties have stalled other repository
programs worldwide. Advanced reprocessing to reduce long-term
radionuclide inventories and transmute select actinides into shorter-lived
isotopes represent alternatives still under research. Considering the
enormous quantities of long-lived nuclear waste that must be properly
entombed, developing safe geological storage solutions on the timescales of
human civilization remains an unfinished story of high importance.
Conclusion
In conclusion, nuclear chemistry technologies applied across medicine,
industry and energy have greatly benefited humanity but also present
unique challenges that must be soundly addressed. Medical applications of
radioactive tracers and radiotherapeutics have revolutionized diagnosis and
treatment by non-invasively imaging physiological processes in vivo and
selectively targeting diseased tissue. Industrial processes make use of
radioisotopes for isotope production, materials analysis, non-destructive
testing and sterilization under strictly controlled conditions. Nuclear power
already supplies massive amounts of reliable low-carbon energy worldwide,
with the possibility of fusion and modular fission batteries decentralizing
access if technical obstacles are one day overcome.
However, issues from waste management, safety risks, weapons proliferation
linkage and cost overruns associated with nuclear technologies demand
prudent regulation and innovation. Long-term isolation of highly radioactive
byproducts in geological repositories poses scientific and institutional
challenges on tens of thousands of year timescales. Incidents like Chernobyl
and Fukushima also remind of nuclear’s unforgiving realities if accidents
breach multiple safety barriers. Advancing novel reactor concepts and fuel
cycles to proliferate-resistant, walk-away safe and more resource efficient
designs therefore retains importance alongside non-nuclear climate
solutions. Public trust and transparent risk communication likewise matter
greatly for continued development. Overall, a balanced, evidence-based
approach is needed to maximize nuclear’s benefits judiciously, while
prioritizing safety, oversight, waste confinement and nonproliferation into the
deep future. With comprehensive management, nuclear science's peaceful
applications will likely expand to a technology for humanity as keen
understanding of the atom's power increases.
Nuclear chemistry is the study of how nuclei react and change. It involves
changes in the composition and structure of atomic nuclei. Many important
practical applications of nuclear chemistry have emerged that have
massively impacted medicine, industry, and energy production. This paper
will explore the diverse applications of nuclear chemistry across these three
domains and discuss both their benefits as well as some criticisms and
concerns about their use.
Part 1: Applications in Medicine
Medical imaging
One of the most widespread medical applications of nuclear chemistry is in
medical imaging techniques such as positron emission tomography (PET)
scans, single photon emission computed tomography (SPECT) scans, and
nuclear magnetic resonance (NMR) imaging. These techniques utilize
radioactive tracers, which are molecules that have been labeled with
radioactive isotopes. When these tracers are introduced into the body, they
can be detected by specialized cameras and used to form detailed 3D
images of tissues and organs.
PET scans use radioactive tracers that emit positrons. Common PET
radiotracers include fluorine-18, carbon-11, nitrogen-13, and oxygen-15.
These radioactive atoms are attached to molecules that are involved in
normal body processes like glucose metabolism, blood flow, and protein
synthesis. As the radiotracer accumulates in tissues, the positions of emitting
positrons can be detected and used to construct tomographic images of
metabolic activity in the body. PET scans provide extremely sensitive and
quantitative measurements and have revolutionized the detection, diagnosis,
and monitoring of many cancers as well as brain disorders like Alzheimer's
disease.
SPECT scans similarly use gamma-ray emitting radioactive tracers but form
lower resolution images than PET. Common SPECT radiotracers include
technetium-99m, thallium-201, gallium-67, and iodine-123. Like PET tracers,
these label molecules involved in key physiological processes. By monitoring
the distribution and movement of radiotracers in the body, SPECT scans can
identify abnormalities and lesions. For example, SPECT scans with thallium-
201 or technetium-99m can detect blood flow issues in the heart muscle to
diagnose heart disease. Iodine-123 scans are also useful for diagnosing
thyroid disease and cancers.
NMR imaging, more commonly known as magnetic resonance imaging (MRI),
uses the magnetic properties of atomic nuclei instead of radioactivity. Many
MRI scans utilize the hydrogen nuclei naturally present in water molecules in
the body. Powerful magnets and radiofrequency pulses are used to excite the
magnetic dipoles of these nuclei, causing them to emit radio signals that can
be used to construct diagnostic images. MRI provides excellent soft tissue
contrast and has become an invaluable tool for examining the brain, spine,
joints, and many other internal structures without exposure to radiation.
Contrast agents containing gadolinium can also be intravenously
administered to enhance MRI images.
Radioisotope therapy
In addition to diagnostics, some radionuclides have therapeutic applications
for treating various medical conditions. One of the most well established is
the use of iodine-131 to treat hyperthyroidism and thyroid cancer. Iodine-131
has similar chemical properties to stable iodine and readily accumulates in
the thyroid gland where it destroys remaining thyroid tissue through beta
radiation exposure. This reduces overproduction of hormones in
hyperthyroidism while also destroying any cancerous thyroid cells. Treatment
is usually very effective with few side effects.
Strontium-89 and samarium-153 are also effective medical radioisotopes for
treating bone metastases from cancers like prostate and breast cancer.
These beta emitters selectively concentrate in areas of increased bone
turnover like cancerous bone lesions. Their radiation can help strengthen
bones weakened by metastases and relieve pain by ablating the cancer cells
within bone tissue. Radioimmunotherapy uses antibodies tagged with short-
range alpha or beta-emitting radioisotopes to bind to and destroy cancer
cells at a molecular level. Targeted isotopes include yttrium-90, iodine-131,
lutetium-177 and bismuth-213.
Other promising therapeutic radionuclides in development include actinium-
225 and lead-212. Actinium-225 generates four alpha particle emissions in
its decay chain and shows potential for treating acute myeloid leukemia and
other cancers if attached to monoclonal antibodies. Lead-212 can also
generate alpha decays and has a very short half-life of only 10.6 hours,
allowing it to deliver highly localized radiation doses without traveling far
from tumors. As radiotherapeutics continue to be researched and refined,
selective internal radiation exposures may become viable alternatives or
supplements to external beam radiation treatments for various cancers and
other conditions.
Radiopharmaceutical production
The production of radiotracers and radiopharmaceuticals for medical
applications is a major industry that generates billions in revenue annually.
Common medical radioisotopes like technetium-99m, iodine-123 and -131,
gallium-67, thallium-201, fluorine-18 and others are produced globally in
specialized nuclear reactors, particle accelerators, or generators. Radioactive
milling and processing facilities purify and formulate radionuclides into stable
chemical compounds suitable for intravenous injection or ingestion by
patients before scanning or therapy. Stringent regulations and quality
controls ensure the radioactive drugs are manufactured under high purity,
sterility, and maximum specific radioactivity standards. Continuous fission
reactors like those in Canada routinely supply over 80% of the U.S. demand
for the workhorse technetium-99m isotope needed for tens of thousands of
SPECT scans every day. The global medical radioisotope market, dominated
by the top three firms, is projected to grow annually by over 5% through
2027 due to expanding clinical applications and replacements for aging
reactor infrastructure. Overall, nuclear medicine has revolutionized diagnosis
and treatment, helping improve millions of lives.
Part 2: Applications in Industry
Isotope production
In addition to medical uses, nuclear processes are employed industrially to
produce important stable and radioactive isotopes. Light water reactors
generate sizeable quantities of plutonium-239 as a byproduct of uranium-238
absorbing neutrons. Plutonium-239 has a half-life of 24,100 years and its
decay produces mostly alpha particles, making it well suited for
thermoelectric applications in radioisotope thermoelectric generators (RTGs).
RTGs powered U.S. space missions for over 50 years including Voyager,
Galileo, and Curiosity by using the heat from plutonium-238's radioactive
decay.
Tritium, a radioactive isotope of hydrogen, is primarily used in self-luminous
sights for firearms, emergency exit signs, and other low light applications. It
is commercially produced by irradiating a lithium target with neutrons in a
nuclear reactor, followed by chemical separation. Large quantities of
naturally occurring krypton-81 are also collected from gaseous fission
products extracted from reactor off-gases. This stable noble gas isotope finds
use as an inert filler for energy efficient light bulbs and flat panel displays.
Neutron activation analysis
Another nuclear technique employed in industry is neutron activation
analysis (NAA), which involves irradiating samples with neutrons in a nuclear
reactor. This process causes certain elements in the sample to become
radioactive via neutron capture. By precisely measuring the gamma radiation
signatures emitted as these artificially produced radioisotopes decay, it is
possible to quantitatively determine the elemental composition of even
complex industrial materials down to trace quantities. NAA is useful for
quality control in sectors like mining, metallurgy, electronics manufacturing
and more. It can rapidly screen bulk samples for contaminants or verify
purity in a non-destructive manner.
Industrial radiography
Industrial radiography utilizes penetrating gamma and X-rays from
radioactive isotopes to examine the internal structures and defects in large
industrial components without having to dismantle or destroy them.
Common radiographic sources include cobalt-60, iridium-192, selenium-75
and caesium-137. The images reveal flaws invisible from the surface like
cracks, voids, corrosion or faulty welds in critical infrastructure parts like
pipelines, pressure vessels, bridges and machinery. This allows issues to be
addressed before catastrophic failures occur. While X-ray machines can also
perform industrial radiography, radioactive sources provide more penetrating
power for larger and higher density objects. However, their encapsulated
sources must be carefully shielded and handled to prevent exposure when
not in use.
Sterilization
Today, over half of all medical devices and many food products worldwide are
sterilized using gamma or electron beam radiation from radioactive isotopes.
Cobalt-60 is a popular gamma source that can penetrate packaging and
thoroughly sterilize items. The high-energy photons destroy microbes like
bacteria and viruses without leaving chemical residues. As no thermal or
pressure factors are involved, radiation sterilization maintains product
integrity and is suitable for heat- and moisture-sensitive items. In addition to
consumables, radiation has widespread uses decontaminating medical
equipment and sterilizing surgical gowns, drapes and implants before they
reach hospitals and patients. When combined with strict quality controls,
radiation-based sterilization provides a safe, effective and environmentally-
friendly alternative to steam, EtO gas or other chemical sterilants.
Part 3: Applications in Energy Production
Nuclear fission power
Nuclear fission reactors harness the energy released during nuclear fission
chain reactions to generate electricity on a commercial scale. Fissile
uranium-235 or plutonium-239 atoms are bombarded with neutrons and then
split apart, releasing additional neutrons, heat in the form of kinetic energy,
and gamma radiation. In a nuclear power plant, the heat generated is used
to produce steam that drives turbines connected to electricity generators.
Over 450 nuclear reactors worldwide currently supply about 10% of the
global electricity demand and one-third of low-carbon power. Generation II
light water reactors dominate the global fleet while Generation III+ and IV
designs incorporate passive safety and materials innovations.
Proponents argue nuclear energy is a stable, reliable, low-carbon baseload
power source able to meet rising energy needs. Unlike intermittent
renewables, fission continuously operates 24/7 and maintains the grid
reliability required by modern societies and industries. The energy density
per unit fuel mass from fission vastly exceeds fossil or renewable
alternatives. However, nuclear faces challenges from high capital costs and
construction timescales, nuclear waste management and proliferation
concerns as well as safety risks if accidents occur. Nevertheless, many
experts see it as indispensable for climate goals given its clean attributes,
and over 50 new reactors are under construction worldwide. Ongoing
research aims to sustain a nuclear renaissance through new small modular,
advanced, and fast neutron reactors.
Nuclear fusion power
Nuclear fusion harnesses the energy from fusing atomic nuclei lighter than
iron, the opposite reaction to fission. The most promising approach is using
strong magnetic fields in doughnut-shaped tokamak reactors to heat and
compress hydrogen isotopes deuterium and tritium under extreme
conditions, where their nuclei fuse and release helium atoms along with
energetic neutrons. This fusion process occurs naturally in the cores of stars
and greatly outstrips any chemical energy source on an energy per unit mass
basis. Researchers envision inertial confinement fusion using lasers and
hypersonic z-pinches as alternatives to the magnetic confinement approach.
The International Thermonuclear Experimental Reactor (ITER) tokamak
project currently underway in France aims to demonstrate the scientific and
technical feasibility of fusion power by generating net energy from fusion for
periods of several minutes by 2035. Beyond ITER, commercial fusion reactors
would not emit greenhouse gases, deplete resources or create long-lived
nuclear waste. With hydrogen as fuel, worldwide reserves could last for
millions of years. However, achieving economically viable and self-sustaining
fusion remains an immense technical challenge still far in the future given
difficulty in maintaining plasma stability, tailoring magnetic fields or focusing
laser energy precisely enough for efficient fusion conditions. Yet many think
mastering fusion could revolutionize future energy production sustainably if
the scientific obstacles are overcome.
Nuclear batteries
Radioisotope thermoelectric generators (RTGs) that operate on the heat from
radioactive decay have powered interplanetary spacecraft explorations since
the 1960s. Efforts are underway by companies to design small modular
nuclear batteries optimized to decentralize electricity access for off-grid
communities, charging electric vehicles, powering remote infrastructure
stations and more on Earth. Proposed designs use uranium or plutonium-
based heat sources coupled to micro-CHP engines that convert heat to
electricity via thermoelectrics or Stirling engines. The multi-decade long
operating lifetimes from self-contained and sealed devices could enable
independent power for areas without transmission grids. However nuclear
batteries face commercialization barriers from public acceptance issues,
developing long-term waste storage and obtaining regulatory approvals for
small-scale reactors despite inherent safety advantages versus larger plants.
Their potential role in energy access remains an open question.
Nuclear waste management
Effectively managing nuclear waste produced from both power generation
and medical/research applications remains an outstanding technical
challenge requiring long-term geological isolation. Most waste solutions
center around deep geologic repositories that exploit low water flow and
geochemically stable formations to contain radionuclides for thousands of
years. Engineered thick concrete barriers and steel casks provide multiple
redundant levels of containment and isolation deep underground where the
heat from radioactive decay can dissipate harmlessly. Waste matrices like
glass or ceramics immobilize radionuclides, while advanced monitoring
systems track any subsurface fluid movement. Some countries like Finland
have made significant progress developing permanent nuclear waste
repositories with regulatory approval and community consent. However
political opposition and siting difficulties have stalled other repository
programs worldwide. Advanced reprocessing to reduce long-term
radionuclide inventories and transmute select actinides into shorter-lived
isotopes represent alternatives still under research. Considering the
enormous quantities of long-lived nuclear waste that must be properly
entombed, developing safe geological storage solutions on the timescales of
human civilization remains an unfinished story of high importance.
Conclusion
In conclusion, nuclear chemistry technologies applied across medicine,
industry and energy have greatly benefited humanity but also present
unique challenges that must be soundly addressed. Medical applications of
radioactive tracers and radiotherapeutics have revolutionized diagnosis and
treatment by non-invasively imaging physiological processes in vivo and
selectively targeting diseased tissue. Industrial processes make use of
radioisotopes for isotope production, materials analysis, non-destructive
testing and sterilization under strictly controlled conditions. Nuclear power
already supplies massive amounts of reliable low-carbon energy worldwide,
with the possibility of fusion and modular fission batteries decentralizing
access if technical obstacles are one day overcome.
However, issues from waste management, safety risks, weapons proliferation
linkage and cost overruns associated with nuclear technologies demand
prudent regulation and innovation. Long-term isolation of highly radioactive
byproducts in geological repositories poses scientific and institutional
challenges on tens of thousands of year timescales. Incidents like Chernobyl
and Fukushima also remind of nuclear’s unforgiving realities if accidents
breach multiple safety barriers. Advancing novel reactor concepts and fuel
cycles to proliferate-resistant, walk-away safe and more resource efficient
designs therefore retains importance alongside non-nuclear climate
solutions. Public trust and transparent risk communication likewise matter
greatly for continued development. Overall, a balanced, evidence-based
approach is needed to maximize nuclear’s benefits judiciously, while
prioritizing safety, oversight, waste confinement and nonproliferation into the
deep future. With comprehensive management, nuclear science's peaceful
applications will likely expand to a technology for humanity as keen
understanding of the atom's power increases.
Nuclear chemistry is the study of how nuclei react and change. It involves
changes in the composition and structure of atomic nuclei. Many important
practical applications of nuclear chemistry have emerged that have
massively impacted medicine, industry, and energy production. This paper
will explore the diverse applications of nuclear chemistry across these three
domains and discuss both their benefits as well as some criticisms and
concerns about their use.
Part 1: Applications in Medicine
Medical imaging
One of the most widespread medical applications of nuclear chemistry is in
medical imaging techniques such as positron emission tomography (PET)
scans, single photon emission computed tomography (SPECT) scans, and
nuclear magnetic resonance (NMR) imaging. These techniques utilize
radioactive tracers, which are molecules that have been labeled with
radioactive isotopes. When these tracers are introduced into the body, they
can be detected by specialized cameras and used to form detailed 3D
images of tissues and organs.
PET scans use radioactive tracers that emit positrons. Common PET
radiotracers include fluorine-18, carbon-11, nitrogen-13, and oxygen-15.
These radioactive atoms are attached to molecules that are involved in
normal body processes like glucose metabolism, blood flow, and protein
synthesis. As the radiotracer accumulates in tissues, the positions of emitting
positrons can be detected and used to construct tomographic images of
metabolic activity in the body. PET scans provide extremely sensitive and
quantitative measurements and have revolutionized the detection, diagnosis,
and monitoring of many cancers as well as brain disorders like Alzheimer's
disease.
SPECT scans similarly use gamma-ray emitting radioactive tracers but form
lower resolution images than PET. Common SPECT radiotracers include
technetium-99m, thallium-201, gallium-67, and iodine-123. Like PET tracers,
these label molecules involved in key physiological processes. By monitoring
the distribution and movement of radiotracers in the body, SPECT scans can
identify abnormalities and lesions. For example, SPECT scans with thallium-
201 or technetium-99m can detect blood flow issues in the heart muscle to
diagnose heart disease. Iodine-123 scans are also useful for diagnosing
thyroid disease and cancers.
NMR imaging, more commonly known as magnetic resonance imaging (MRI),
uses the magnetic properties of atomic nuclei instead of radioactivity. Many
MRI scans utilize the hydrogen nuclei naturally present in water molecules in
the body. Powerful magnets and radiofrequency pulses are used to excite the
magnetic dipoles of these nuclei, causing them to emit radio signals that can
be used to construct diagnostic images. MRI provides excellent soft tissue
contrast and has become an invaluable tool for examining the brain, spine,
joints, and many other internal structures without exposure to radiation.
Contrast agents containing gadolinium can also be intravenously
administered to enhance MRI images.
Radioisotope therapy
In addition to diagnostics, some radionuclides have therapeutic applications
for treating various medical conditions. One of the most well established is
the use of iodine-131 to treat hyperthyroidism and thyroid cancer. Iodine-131
has similar chemical properties to stable iodine and readily accumulates in
the thyroid gland where it destroys remaining thyroid tissue through beta
radiation exposure. This reduces overproduction of hormones in
hyperthyroidism while also destroying any cancerous thyroid cells. Treatment
is usually very effective with few side effects.
Strontium-89 and samarium-153 are also effective medical radioisotopes for
treating bone metastases from cancers like prostate and breast cancer.
These beta emitters selectively concentrate in areas of increased bone
turnover like cancerous bone lesions. Their radiation can help strengthen
bones weakened by metastases and relieve pain by ablating the cancer cells
within bone tissue. Radioimmunotherapy uses antibodies tagged with short-
range alpha or beta-emitting radioisotopes to bind to and destroy cancer
cells at a molecular level. Targeted isotopes include yttrium-90, iodine-131,
lutetium-177 and bismuth-213.
Other promising therapeutic radionuclides in development include actinium-
225 and lead-212. Actinium-225 generates four alpha particle emissions in
its decay chain and shows potential for treating acute myeloid leukemia and
other cancers if attached to monoclonal antibodies. Lead-212 can also
generate alpha decays and has a very short half-life of only 10.6 hours,
allowing it to deliver highly localized radiation doses without traveling far
from tumors. As radiotherapeutics continue to be researched and refined,
selective internal radiation exposures may become viable alternatives or
supplements to external beam radiation treatments for various cancers and
other conditions.
Radiopharmaceutical production
The production of radiotracers and radiopharmaceuticals for medical
applications is a major industry that generates billions in revenue annually.
Common medical radioisotopes like technetium-99m, iodine-123 and -131,
gallium-67, thallium-201, fluorine-18 and others are produced globally in
specialized nuclear reactors, particle accelerators, or generators. Radioactive
milling and processing facilities purify and formulate radionuclides into stable
chemical compounds suitable for intravenous injection or ingestion by
patients before scanning or therapy. Stringent regulations and quality
controls ensure the radioactive drugs are manufactured under high purity,
sterility, and maximum specific radioactivity standards. Continuous fission
reactors like those in Canada routinely supply over 80% of the U.S. demand
for the workhorse technetium-99m isotope needed for tens of thousands of
SPECT scans every day. The global medical radioisotope market, dominated
by the top three firms, is projected to grow annually by over 5% through
2027 due to expanding clinical applications and replacements for aging
reactor infrastructure. Overall, nuclear medicine has revolutionized diagnosis
and treatment, helping improve millions of lives.
Part 2: Applications in Industry
Isotope production
In addition to medical uses, nuclear processes are employed industrially to
produce important stable and radioactive isotopes. Light water reactors
generate sizeable quantities of plutonium-239 as a byproduct of uranium-238
absorbing neutrons. Plutonium-239 has a half-life of 24,100 years and its
decay produces mostly alpha particles, making it well suited for
thermoelectric applications in radioisotope thermoelectric generators (RTGs).
RTGs powered U.S. space missions for over 50 years including Voyager,
Galileo, and Curiosity by using the heat from plutonium-238's radioactive
decay.
Tritium, a radioactive isotope of hydrogen, is primarily used in self-luminous
sights for firearms, emergency exit signs, and other low light applications. It
is commercially produced by irradiating a lithium target with neutrons in a
nuclear reactor, followed by chemical separation. Large quantities of
naturally occurring krypton-81 are also collected from gaseous fission
products extracted from reactor off-gases. This stable noble gas isotope finds
use as an inert filler for energy efficient light bulbs and flat panel displays.
Neutron activation analysis
Another nuclear technique employed in industry is neutron activation
analysis (NAA), which involves irradiating samples with neutrons in a nuclear
reactor. This process causes certain elements in the sample to become
radioactive via neutron capture. By precisely measuring the gamma radiation
signatures emitted as these artificially produced radioisotopes decay, it is
possible to quantitatively determine the elemental composition of even
complex industrial materials down to trace quantities. NAA is useful for
quality control in sectors like mining, metallurgy, electronics manufacturing
and more. It can rapidly screen bulk samples for contaminants or verify
purity in a non-destructive manner.
Industrial radiography
Industrial radiography utilizes penetrating gamma and X-rays from
radioactive isotopes to examine the internal structures and defects in large
industrial components without having to dismantle or destroy them.
Common radiographic sources include cobalt-60, iridium-192, selenium-75
and caesium-137. The images reveal flaws invisible from the surface like
cracks, voids, corrosion or faulty welds in critical infrastructure parts like
pipelines, pressure vessels, bridges and machinery. This allows issues to be
addressed before catastrophic failures occur. While X-ray machines can also
perform industrial radiography, radioactive sources provide more penetrating
power for larger and higher density objects. However, their encapsulated
sources must be carefully shielded and handled to prevent exposure when
not in use.
Sterilization
Today, over half of all medical devices and many food products worldwide are
sterilized using gamma or electron beam radiation from radioactive isotopes.
Cobalt-60 is a popular gamma source that can penetrate packaging and
thoroughly sterilize items. The high-energy photons destroy microbes like
bacteria and viruses without leaving chemical residues. As no thermal or
pressure factors are involved, radiation sterilization maintains product
integrity and is suitable for heat- and moisture-sensitive items. In addition to
consumables, radiation has widespread uses decontaminating medical
equipment and sterilizing surgical gowns, drapes and implants before they
reach hospitals and patients. When combined with strict quality controls,
radiation-based sterilization provides a safe, effective and environmentally-
friendly alternative to steam, EtO gas or other chemical sterilants.
Part 3: Applications in Energy Production
Nuclear fission power
Nuclear fission reactors harness the energy released during nuclear fission
chain reactions to generate electricity on a commercial scale. Fissile
uranium-235 or plutonium-239 atoms are bombarded with neutrons and then
split apart, releasing additional neutrons, heat in the form of kinetic energy,
and gamma radiation. In a nuclear power plant, the heat generated is used
to produce steam that drives turbines connected to electricity generators.
Over 450 nuclear reactors worldwide currently supply about 10% of the
global electricity demand and one-third of low-carbon power. Generation II
light water reactors dominate the global fleet while Generation III+ and IV
designs incorporate passive safety and materials innovations.
Proponents argue nuclear energy is a stable, reliable, low-carbon baseload
power source able to meet rising energy needs. Unlike intermittent
renewables, fission continuously operates 24/7 and maintains the grid
reliability required by modern societies and industries. The energy density
per unit fuel mass from fission vastly exceeds fossil or renewable
alternatives. However, nuclear faces challenges from high capital costs and
construction timescales, nuclear waste management and proliferation
concerns as well as safety risks if accidents occur. Nevertheless, many
experts see it as indispensable for climate goals given its clean attributes,
and over 50 new reactors are under construction worldwide. Ongoing
research aims to sustain a nuclear renaissance through new small modular,
advanced, and fast neutron reactors.
Nuclear fusion power
Nuclear fusion harnesses the energy from fusing atomic nuclei lighter than
iron, the opposite reaction to fission. The most promising approach is using
strong magnetic fields in doughnut-shaped tokamak reactors to heat and
compress hydrogen isotopes deuterium and tritium under extreme
conditions, where their nuclei fuse and release helium atoms along with
energetic neutrons. This fusion process occurs naturally in the cores of stars
and greatly outstrips any chemical energy source on an energy per unit mass
basis. Researchers envision inertial confinement fusion using lasers and
hypersonic z-pinches as alternatives to the magnetic confinement approach.
The International Thermonuclear Experimental Reactor (ITER) tokamak
project currently underway in France aims to demonstrate the scientific and
technical feasibility of fusion power by generating net energy from fusion for
periods of several minutes by 2035. Beyond ITER, commercial fusion reactors
would not emit greenhouse gases, deplete resources or create long-lived
nuclear waste. With hydrogen as fuel, worldwide reserves could last for
millions of years. However, achieving economically viable and self-sustaining
fusion remains an immense technical challenge still far in the future given
difficulty in maintaining plasma stability, tailoring magnetic fields or focusing
laser energy precisely enough for efficient fusion conditions. Yet many think
mastering fusion could revolutionize future energy production sustainably if
the scientific obstacles are overcome.
Nuclear batteries
Radioisotope thermoelectric generators (RTGs) that operate on the heat from
radioactive decay have powered interplanetary spacecraft explorations since
the 1960s. Efforts are underway by companies to design small modular
nuclear batteries optimized to decentralize electricity access for off-grid
communities, charging electric vehicles, powering remote infrastructure
stations and more on Earth. Proposed designs use uranium or plutonium-
based heat sources coupled to micro-CHP engines that convert heat to
electricity via thermoelectrics or Stirling engines. The multi-decade long
operating lifetimes from self-contained and sealed devices could enable
independent power for areas without transmission grids. However nuclear
batteries face commercialization barriers from public acceptance issues,
developing long-term waste storage and obtaining regulatory approvals for
small-scale reactors despite inherent safety advantages versus larger plants.
Their potential role in energy access remains an open question.
Nuclear waste management
Effectively managing nuclear waste produced from both power generation
and medical/research applications remains an outstanding technical
challenge requiring long-term geological isolation. Most waste solutions
center around deep geologic repositories that exploit low water flow and
geochemically stable formations to contain radionuclides for thousands of
years. Engineered thick concrete barriers and steel casks provide multiple
redundant levels of containment and isolation deep underground where the
heat from radioactive decay can dissipate harmlessly. Waste matrices like
glass or ceramics immobilize radionuclides, while advanced monitoring
systems track any subsurface fluid movement. Some countries like Finland
have made significant progress developing permanent nuclear waste
repositories with regulatory approval and community consent. However
political opposition and siting difficulties have stalled other repository
programs worldwide. Advanced reprocessing to reduce long-term
radionuclide inventories and transmute select actinides into shorter-lived
isotopes represent alternatives still under research. Considering the
enormous quantities of long-lived nuclear waste that must be properly
entombed, developing safe geological storage solutions on the timescales of
human civilization remains an unfinished story of high importance.
Conclusion
In conclusion, nuclear chemistry technologies applied across medicine,
industry and energy have greatly benefited humanity but also present
unique challenges that must be soundly addressed. Medical applications of
radioactive tracers and radiotherapeutics have revolutionized diagnosis and
treatment by non-invasively imaging physiological processes in vivo and
selectively targeting diseased tissue. Industrial processes make use of
radioisotopes for isotope production, materials analysis, non-destructive
testing and sterilization under strictly controlled conditions. Nuclear power
already supplies massive amounts of reliable low-carbon energy worldwide,
with the possibility of fusion and modular fission batteries decentralizing
access if technical obstacles are one day overcome.
However, issues from waste management, safety risks, weapons proliferation
linkage and cost overruns associated with nuclear technologies demand
prudent regulation and innovation. Long-term isolation of highly radioactive
byproducts in geological repositories poses scientific and institutional
challenges on tens of thousands of year timescales. Incidents like Chernobyl
and Fukushima also remind of nuclear’s unforgiving realities if accidents
breach multiple safety barriers. Advancing novel reactor concepts and fuel
cycles to proliferate-resistant, walk-away safe and more resource efficient
designs therefore retains importance alongside non-nuclear climate
solutions. Public trust and transparent risk communication likewise matter
greatly for continued development. Overall, a balanced, evidence-based
approach is needed to maximize nuclear’s benefits judiciously, while
prioritizing safety, oversight, waste confinement and nonproliferation into the
deep future. With comprehensive management, nuclear science's peaceful
applications will likely expand to a technology for humanity as keen
understanding of the atom's power increases.
Nuclear chemistry is the study of how nuclei react and change. It involves
changes in the composition and structure of atomic nuclei. Many important
practical applications of nuclear chemistry have emerged that have
massively impacted medicine, industry, and energy production. This paper
will explore the diverse applications of nuclear chemistry across these three
domains and discuss both their benefits as well as some criticisms and
concerns about their use.
Part 1: Applications in Medicine
Medical imaging
One of the most widespread medical applications of nuclear chemistry is in
medical imaging techniques such as positron emission tomography (PET)
scans, single photon emission computed tomography (SPECT) scans, and
nuclear magnetic resonance (NMR) imaging. These techniques utilize
radioactive tracers, which are molecules that have been labeled with
radioactive isotopes. When these tracers are introduced into the body, they
can be detected by specialized cameras and used to form detailed 3D
images of tissues and organs.
PET scans use radioactive tracers that emit positrons. Common PET
radiotracers include fluorine-18, carbon-11, nitrogen-13, and oxygen-15.
These radioactive atoms are attached to molecules that are involved in
normal body processes like glucose metabolism, blood flow, and protein
synthesis. As the radiotracer accumulates in tissues, the positions of emitting
positrons can be detected and used to construct tomographic images of
metabolic activity in the body. PET scans provide extremely sensitive and
quantitative measurements and have revolutionized the detection, diagnosis,
and monitoring of many cancers as well as brain disorders like Alzheimer's
disease.
SPECT scans similarly use gamma-ray emitting radioactive tracers but form
lower resolution images than PET. Common SPECT radiotracers include
technetium-99m, thallium-201, gallium-67, and iodine-123. Like PET tracers,
these label molecules involved in key physiological processes. By monitoring
the distribution and movement of radiotracers in the body, SPECT scans can
identify abnormalities and lesions. For example, SPECT scans with thallium-
201 or technetium-99m can detect blood flow issues in the heart muscle to
diagnose heart disease. Iodine-123 scans are also useful for diagnosing
thyroid disease and cancers.
NMR imaging, more commonly known as magnetic resonance imaging (MRI),
uses the magnetic properties of atomic nuclei instead of radioactivity. Many
MRI scans utilize the hydrogen nuclei naturally present in water molecules in
the body. Powerful magnets and radiofrequency pulses are used to excite the
magnetic dipoles of these nuclei, causing them to emit radio signals that can
be used to construct diagnostic images. MRI provides excellent soft tissue
contrast and has become an invaluable tool for examining the brain, spine,
joints, and many other internal structures without exposure to radiation.
Contrast agents containing gadolinium can also be intravenously
administered to enhance MRI images.
Radioisotope therapy
In addition to diagnostics, some radionuclides have therapeutic applications
for treating various medical conditions. One of the most well established is
the use of iodine-131 to treat hyperthyroidism and thyroid cancer. Iodine-131
has similar chemical properties to stable iodine and readily accumulates in
the thyroid gland where it destroys remaining thyroid tissue through beta
radiation exposure. This reduces overproduction of hormones in
hyperthyroidism while also destroying any cancerous thyroid cells. Treatment
is usually very effective with few side effects.
Strontium-89 and samarium-153 are also effective medical radioisotopes for
treating bone metastases from cancers like prostate and breast cancer.
These beta emitters selectively concentrate in areas of increased bone
turnover like cancerous bone lesions. Their radiation can help strengthen
bones weakened by metastases and relieve pain by ablating the cancer cells
within bone tissue. Radioimmunotherapy uses antibodies tagged with short-
range alpha or beta-emitting radioisotopes to bind to and destroy cancer
cells at a molecular level. Targeted isotopes include yttrium-90, iodine-131,
lutetium-177 and bismuth-213.
Other promising therapeutic radionuclides in development include actinium-
225 and lead-212. Actinium-225 generates four alpha particle emissions in
its decay chain and shows potential for treating acute myeloid leukemia and
other cancers if attached to monoclonal antibodies. Lead-212 can also
generate alpha decays and has a very short half-life of only 10.6 hours,
allowing it to deliver highly localized radiation doses without traveling far
from tumors. As radiotherapeutics continue to be researched and refined,
selective internal radiation exposures may become viable alternatives or
supplements to external beam radiation treatments for various cancers and
other conditions.
Radiopharmaceutical production
The production of radiotracers and radiopharmaceuticals for medical
applications is a major industry that generates billions in revenue annually.
Common medical radioisotopes like technetium-99m, iodine-123 and -131,
gallium-67, thallium-201, fluorine-18 and others are produced globally in
specialized nuclear reactors, particle accelerators, or generators. Radioactive
milling and processing facilities purify and formulate radionuclides into stable
chemical compounds suitable for intravenous injection or ingestion by
patients before scanning or therapy. Stringent regulations and quality
controls ensure the radioactive drugs are manufactured under high purity,
sterility, and maximum specific radioactivity standards. Continuous fission
reactors like those in Canada routinely supply over 80% of the U.S. demand
for the workhorse technetium-99m isotope needed for tens of thousands of
SPECT scans every day. The global medical radioisotope market, dominated
by the top three firms, is projected to grow annually by over 5% through
2027 due to expanding clinical applications and replacements for aging
reactor infrastructure. Overall, nuclear medicine has revolutionized diagnosis
and treatment, helping improve millions of lives.
Part 2: Applications in Industry
Isotope production
In addition to medical uses, nuclear processes are employed industrially to
produce important stable and radioactive isotopes. Light water reactors
generate sizeable quantities of plutonium-239 as a byproduct of uranium-238
absorbing neutrons. Plutonium-239 has a half-life of 24,100 years and its
decay produces mostly alpha particles, making it well suited for
thermoelectric applications in radioisotope thermoelectric generators (RTGs).
RTGs powered U.S. space missions for over 50 years including Voyager,
Galileo, and Curiosity by using the heat from plutonium-238's radioactive
decay.
Tritium, a radioactive isotope of hydrogen, is primarily used in self-luminous
sights for firearms, emergency exit signs, and other low light applications. It
is commercially produced by irradiating a lithium target with neutrons in a
nuclear reactor, followed by chemical separation. Large quantities of
naturally occurring krypton-81 are also collected from gaseous fission
products extracted from reactor off-gases. This stable noble gas isotope finds
use as an inert filler for energy efficient light bulbs and flat panel displays.
Neutron activation analysis
Another nuclear technique employed in industry is neutron activation
analysis (NAA), which involves irradiating samples with neutrons in a nuclear
reactor. This process causes certain elements in the sample to become
radioactive via neutron capture. By precisely measuring the gamma radiation
signatures emitted as these artificially produced radioisotopes decay, it is
possible to quantitatively determine the elemental composition of even
complex industrial materials down to trace quantities. NAA is useful for
quality control in sectors like mining, metallurgy, electronics manufacturing
and more. It can rapidly screen bulk samples for contaminants or verify
purity in a non-destructive manner.
Industrial radiography
Industrial radiography utilizes penetrating gamma and X-rays from
radioactive isotopes to examine the internal structures and defects in large
industrial components without having to dismantle or destroy them.
Common radiographic sources include cobalt-60, iridium-192, selenium-75
and caesium-137. The images reveal flaws invisible from the surface like
cracks, voids, corrosion or faulty welds in critical infrastructure parts like
pipelines, pressure vessels, bridges and machinery. This allows issues to be
addressed before catastrophic failures occur. While X-ray machines can also
perform industrial radiography, radioactive sources provide more penetrating
power for larger and higher density objects. However, their encapsulated
sources must be carefully shielded and handled to prevent exposure when
not in use.
Sterilization
Today, over half of all medical devices and many food products worldwide are
sterilized using gamma or electron beam radiation from radioactive isotopes.
Cobalt-60 is a popular gamma source that can penetrate packaging and
thoroughly sterilize items. The high-energy photons destroy microbes like
bacteria and viruses without leaving chemical residues. As no thermal or
pressure factors are involved, radiation sterilization maintains product
integrity and is suitable for heat- and moisture-sensitive items. In addition to
consumables, radiation has widespread uses decontaminating medical
equipment and sterilizing surgical gowns, drapes and implants before they
reach hospitals and patients. When combined with strict quality controls,
radiation-based sterilization provides a safe, effective and environmentally-
friendly alternative to steam, EtO gas or other chemical sterilants.
Part 3: Applications in Energy Production
Nuclear fission power
Nuclear fission reactors harness the energy released during nuclear fission
chain reactions to generate electricity on a commercial scale. Fissile
uranium-235 or plutonium-239 atoms are bombarded with neutrons and then
split apart, releasing additional neutrons, heat in the form of kinetic energy,
and gamma radiation. In a nuclear power plant, the heat generated is used
to produce steam that drives turbines connected to electricity generators.
Over 450 nuclear reactors worldwide currently supply about 10% of the
global electricity demand and one-third of low-carbon power. Generation II
light water reactors dominate the global fleet while Generation III+ and IV
designs incorporate passive safety and materials innovations.
Proponents argue nuclear energy is a stable, reliable, low-carbon baseload
power source able to meet rising energy needs. Unlike intermittent
renewables, fission continuously operates 24/7 and maintains the grid
reliability required by modern societies and industries. The energy density
per unit fuel mass from fission vastly exceeds fossil or renewable
alternatives. However, nuclear faces challenges from high capital costs and
construction timescales, nuclear waste management and proliferation
concerns as well as safety risks if accidents occur. Nevertheless, many
experts see it as indispensable for climate goals given its clean attributes,
and over 50 new reactors are under construction worldwide. Ongoing
research aims to sustain a nuclear renaissance through new small modular,
advanced, and fast neutron reactors.
Nuclear fusion power
Nuclear fusion harnesses the energy from fusing atomic nuclei lighter than
iron, the opposite reaction to fission. The most promising approach is using
strong magnetic fields in doughnut-shaped tokamak reactors to heat and
compress hydrogen isotopes deuterium and tritium under extreme
conditions, where their nuclei fuse and release helium atoms along with
energetic neutrons. This fusion process occurs naturally in the cores of stars
and greatly outstrips any chemical energy source on an energy per unit mass
basis. Researchers envision inertial confinement fusion using lasers and
hypersonic z-pinches as alternatives to the magnetic confinement approach.
The International Thermonuclear Experimental Reactor (ITER) tokamak
project currently underway in France aims to demonstrate the scientific and
technical feasibility of fusion power by generating net energy from fusion for
periods of several minutes by 2035. Beyond ITER, commercial fusion reactors
would not emit greenhouse gases, deplete resources or create long-lived
nuclear waste. With hydrogen as fuel, worldwide reserves could last for
millions of years. However, achieving economically viable and self-sustaining
fusion remains an immense technical challenge still far in the future given
difficulty in maintaining plasma stability, tailoring magnetic fields or focusing
laser energy precisely enough for efficient fusion conditions. Yet many think
mastering fusion could revolutionize future energy production sustainably if
the scientific obstacles are overcome.
Nuclear batteries
Radioisotope thermoelectric generators (RTGs) that operate on the heat from
radioactive decay have powered interplanetary spacecraft explorations since
the 1960s. Efforts are underway by companies to design small modular
nuclear batteries optimized to decentralize electricity access for off-grid
communities, charging electric vehicles, powering remote infrastructure
stations and more on Earth. Proposed designs use uranium or plutonium-
based heat sources coupled to micro-CHP engines that convert heat to
electricity via thermoelectrics or Stirling engines. The multi-decade long
operating lifetimes from self-contained and sealed devices could enable
independent power for areas without transmission grids. However nuclear
batteries face commercialization barriers from public acceptance issues,
developing long-term waste storage and obtaining regulatory approvals for
small-scale reactors despite inherent safety advantages versus larger plants.
Their potential role in energy access remains an open question.
Nuclear waste management
Effectively managing nuclear waste produced from both power generation
and medical/research applications remains an outstanding technical
challenge requiring long-term geological isolation. Most waste solutions
center around deep geologic repositories that exploit low water flow and
geochemically stable formations to contain radionuclides for thousands of
years. Engineered thick concrete barriers and steel casks provide multiple
redundant levels of containment and isolation deep underground where the
heat from radioactive decay can dissipate harmlessly. Waste matrices like
glass or ceramics immobilize radionuclides, while advanced monitoring
systems track any subsurface fluid movement. Some countries like Finland
have made significant progress developing permanent nuclear waste
repositories with regulatory approval and community consent. However
political opposition and siting difficulties have stalled other repository
programs worldwide. Advanced reprocessing to reduce long-term
radionuclide inventories and transmute select actinides into shorter-lived
isotopes represent alternatives still under research. Considering the
enormous quantities of long-lived nuclear waste that must be properly
entombed, developing safe geological storage solutions on the timescales of
human civilization remains an unfinished story of high importance.
Conclusion
In conclusion, nuclear chemistry technologies applied across medicine,
industry and energy have greatly benefited humanity but also present
unique challenges that must be soundly addressed. Medical applications of
radioactive tracers and radiotherapeutics have revolutionized diagnosis and
treatment by non-invasively imaging physiological processes in vivo and
selectively targeting diseased tissue. Industrial processes make use of
radioisotopes for isotope production, materials analysis, non-destructive
testing and sterilization under strictly controlled conditions. Nuclear power
already supplies massive amounts of reliable low-carbon energy worldwide,
with the possibility of fusion and modular fission batteries decentralizing
access if technical obstacles are one day overcome.
However, issues from waste management, safety risks, weapons proliferation
linkage and cost overruns associated with nuclear technologies demand
prudent regulation and innovation. Long-term isolation of highly radioactive
byproducts in geological repositories poses scientific and institutional
challenges on tens of thousands of year timescales. Incidents like Chernobyl
and Fukushima also remind of nuclear’s unforgiving realities if accidents
breach multiple safety barriers. Advancing novel reactor concepts and fuel
cycles to proliferate-resistant, walk-away safe and more resource efficient
designs therefore retains importance alongside non-nuclear climate
solutions. Public trust and transparent risk communication likewise matter
greatly for continued development. Overall, a balanced, evidence-based
approach is needed to maximize nuclear’s benefits judiciously, while
prioritizing safety, oversight, waste confinement and nonproliferation into the
deep future. With comprehensive management, nuclear science's peaceful
applications will likely expand to a technology for humanity as keen
understanding of the atom's power increases.
Nuclear chemistry is the study of how nuclei react and change. It involves
changes in the composition and structure of atomic nuclei. Many important
practical applications of nuclear chemistry have emerged that have
massively impacted medicine, industry, and energy production. This paper
will explore the diverse applications of nuclear chemistry across these three
domains and discuss both their benefits as well as some criticisms and
concerns about their use.
Part 1: Applications in Medicine
Medical imaging
One of the most widespread medical applications of nuclear chemistry is in
medical imaging techniques such as positron emission tomography (PET)
scans, single photon emission computed tomography (SPECT) scans, and
nuclear magnetic resonance (NMR) imaging. These techniques utilize
radioactive tracers, which are molecules that have been labeled with
radioactive isotopes. When these tracers are introduced into the body, they
can be detected by specialized cameras and used to form detailed 3D
images of tissues and organs.
PET scans use radioactive tracers that emit positrons. Common PET
radiotracers include fluorine-18, carbon-11, nitrogen-13, and oxygen-15.
These radioactive atoms are attached to molecules that are involved in
normal body processes like glucose metabolism, blood flow, and protein
synthesis. As the radiotracer accumulates in tissues, the positions of emitting
positrons can be detected and used to construct tomographic images of
metabolic activity in the body. PET scans provide extremely sensitive and
quantitative measurements and have revolutionized the detection, diagnosis,
and monitoring of many cancers as well as brain disorders like Alzheimer's
disease.
SPECT scans similarly use gamma-ray emitting radioactive tracers but form
lower resolution images than PET. Common SPECT radiotracers include
technetium-99m, thallium-201, gallium-67, and iodine-123. Like PET tracers,
these label molecules involved in key physiological processes. By monitoring
the distribution and movement of radiotracers in the body, SPECT scans can
identify abnormalities and lesions. For example, SPECT scans with thallium-
201 or technetium-99m can detect blood flow issues in the heart muscle to
diagnose heart disease. Iodine-123 scans are also useful for diagnosing
thyroid disease and cancers.
NMR imaging, more commonly known as magnetic resonance imaging (MRI),
uses the magnetic properties of atomic nuclei instead of radioactivity. Many
MRI scans utilize the hydrogen nuclei naturally present in water molecules in
the body. Powerful magnets and radiofrequency pulses are used to excite the
magnetic dipoles of these nuclei, causing them to emit radio signals that can
be used to construct diagnostic images. MRI provides excellent soft tissue
contrast and has become an invaluable tool for examining the brain, spine,
joints, and many other internal structures without exposure to radiation.
Contrast agents containing gadolinium can also be intravenously
administered to enhance MRI images.
Radioisotope therapy
In addition to diagnostics, some radionuclides have therapeutic applications
for treating various medical conditions. One of the most well established is
the use of iodine-131 to treat hyperthyroidism and thyroid cancer. Iodine-131
has similar chemical properties to stable iodine and readily accumulates in
the thyroid gland where it destroys remaining thyroid tissue through beta
radiation exposure. This reduces overproduction of hormones in
hyperthyroidism while also destroying any cancerous thyroid cells. Treatment
is usually very effective with few side effects.
Strontium-89 and samarium-153 are also effective medical radioisotopes for
treating bone metastases from cancers like prostate and breast cancer.
These beta emitters selectively concentrate in areas of increased bone
turnover like cancerous bone lesions. Their radiation can help strengthen
bones weakened by metastases and relieve pain by ablating the cancer cells
within bone tissue. Radioimmunotherapy uses antibodies tagged with short-
range alpha or beta-emitting radioisotopes to bind to and destroy cancer
cells at a molecular level. Targeted isotopes include yttrium-90, iodine-131,
lutetium-177 and bismuth-213.
Other promising therapeutic radionuclides in development include actinium-
225 and lead-212. Actinium-225 generates four alpha particle emissions in
its decay chain and shows potential for treating acute myeloid leukemia and
other cancers if attached to monoclonal antibodies. Lead-212 can also
generate alpha decays and has a very short half-life of only 10.6 hours,
allowing it to deliver highly localized radiation doses without traveling far
from tumors. As radiotherapeutics continue to be researched and refined,
selective internal radiation exposures may become viable alternatives or
supplements to external beam radiation treatments for various cancers and
other conditions.
Radiopharmaceutical production
The production of radiotracers and radiopharmaceuticals for medical
applications is a major industry that generates billions in revenue annually.
Common medical radioisotopes like technetium-99m, iodine-123 and -131,
gallium-67, thallium-201, fluorine-18 and others are produced globally in
specialized nuclear reactors, particle accelerators, or generators. Radioactive
milling and processing facilities purify and formulate radionuclides into stable
chemical compounds suitable for intravenous injection or ingestion by
patients before scanning or therapy. Stringent regulations and quality
controls ensure the radioactive drugs are manufactured under high purity,
sterility, and maximum specific radioactivity standards. Continuous fission
reactors like those in Canada routinely supply over 80% of the U.S. demand
for the workhorse technetium-99m isotope needed for tens of thousands of
SPECT scans every day. The global medical radioisotope market, dominated
by the top three firms, is projected to grow annually by over 5% through
2027 due to expanding clinical applications and replacements for aging
reactor infrastructure. Overall, nuclear medicine has revolutionized diagnosis
and treatment, helping improve millions of lives.
Part 2: Applications in Industry
Isotope production
In addition to medical uses, nuclear processes are employed industrially to
produce important stable and radioactive isotopes. Light water reactors
generate sizeable quantities of plutonium-239 as a byproduct of uranium-238
absorbing neutrons. Plutonium-239 has a half-life of 24,100 years and its
decay produces mostly alpha particles, making it well suited for
thermoelectric applications in radioisotope thermoelectric generators (RTGs).
RTGs powered U.S. space missions for over 50 years including Voyager,
Galileo, and Curiosity by using the heat from plutonium-238's radioactive
decay.
Tritium, a radioactive isotope of hydrogen, is primarily used in self-luminous
sights for firearms, emergency exit signs, and other low light applications. It
is commercially produced by irradiating a lithium target with neutrons in a
nuclear reactor, followed by chemical separation. Large quantities of
naturally occurring krypton-81 are also collected from gaseous fission
products extracted from reactor off-gases. This stable noble gas isotope finds
use as an inert filler for energy efficient light bulbs and flat panel displays.
Neutron activation analysis
Another nuclear technique employed in industry is neutron activation
analysis (NAA), which involves irradiating samples with neutrons in a nuclear
reactor. This process causes certain elements in the sample to become
radioactive via neutron capture. By precisely measuring the gamma radiation
signatures emitted as these artificially produced radioisotopes decay, it is
possible to quantitatively determine the elemental composition of even
complex industrial materials down to trace quantities. NAA is useful for
quality control in sectors like mining, metallurgy, electronics manufacturing
and more. It can rapidly screen bulk samples for contaminants or verify
purity in a non-destructive manner.
Industrial radiography
Industrial radiography utilizes penetrating gamma and X-rays from
radioactive isotopes to examine the internal structures and defects in large
industrial components without having to dismantle or destroy them.
Common radiographic sources include cobalt-60, iridium-192, selenium-75
and caesium-137. The images reveal flaws invisible from the surface like
cracks, voids, corrosion or faulty welds in critical infrastructure parts like
pipelines, pressure vessels, bridges and machinery. This allows issues to be
addressed before catastrophic failures occur. While X-ray machines can also
perform industrial radiography, radioactive sources provide more penetrating
power for larger and higher density objects. However, their encapsulated
sources must be carefully shielded and handled to prevent exposure when
not in use.
Sterilization
Today, over half of all medical devices and many food products worldwide are
sterilized using gamma or electron beam radiation from radioactive isotopes.
Cobalt-60 is a popular gamma source that can penetrate packaging and
thoroughly sterilize items. The high-energy photons destroy microbes like
bacteria and viruses without leaving chemical residues. As no thermal or
pressure factors are involved, radiation sterilization maintains product
integrity and is suitable for heat- and moisture-sensitive items. In addition to
consumables, radiation has widespread uses decontaminating medical
equipment and sterilizing surgical gowns, drapes and implants before they
reach hospitals and patients. When combined with strict quality controls,
radiation-based sterilization provides a safe, effective and environmentally-
friendly alternative to steam, EtO gas or other chemical sterilants.
Part 3: Applications in Energy Production
Nuclear fission power
Nuclear fission reactors harness the energy released during nuclear fission
chain reactions to generate electricity on a commercial scale. Fissile
uranium-235 or plutonium-239 atoms are bombarded with neutrons and then
split apart, releasing additional neutrons, heat in the form of kinetic energy,
and gamma radiation. In a nuclear power plant, the heat generated is used
to produce steam that drives turbines connected to electricity generators.
Over 450 nuclear reactors worldwide currently supply about 10% of the
global electricity demand and one-third of low-carbon power. Generation II
light water reactors dominate the global fleet while Generation III+ and IV
designs incorporate passive safety and materials innovations.
Proponents argue nuclear energy is a stable, reliable, low-carbon baseload
power source able to meet rising energy needs. Unlike intermittent
renewables, fission continuously operates 24/7 and maintains the grid
reliability required by modern societies and industries. The energy density
per unit fuel mass from fission vastly exceeds fossil or renewable
alternatives. However, nuclear faces challenges from high capital costs and
construction timescales, nuclear waste management and proliferation
concerns as well as safety risks if accidents occur. Nevertheless, many
experts see it as indispensable for climate goals given its clean attributes,
and over 50 new reactors are under construction worldwide. Ongoing
research aims to sustain a nuclear renaissance through new small modular,
advanced, and fast neutron reactors.
Nuclear fusion power
Nuclear fusion harnesses the energy from fusing atomic nuclei lighter than
iron, the opposite reaction to fission. The most promising approach is using
strong magnetic fields in doughnut-shaped tokamak reactors to heat and
compress hydrogen isotopes deuterium and tritium under extreme
conditions, where their nuclei fuse and release helium atoms along with
energetic neutrons. This fusion process occurs naturally in the cores of stars
and greatly outstrips any chemical energy source on an energy per unit mass
basis. Researchers envision inertial confinement fusion using lasers and
hypersonic z-pinches as alternatives to the magnetic confinement approach.
The International Thermonuclear Experimental Reactor (ITER) tokamak
project currently underway in France aims to demonstrate the scientific and
technical feasibility of fusion power by generating net energy from fusion for
periods of several minutes by 2035. Beyond ITER, commercial fusion reactors
would not emit greenhouse gases, deplete resources or create long-lived
nuclear waste. With hydrogen as fuel, worldwide reserves could last for
millions of years. However, achieving economically viable and self-sustaining
fusion remains an immense technical challenge still far in the future given
difficulty in maintaining plasma stability, tailoring magnetic fields or focusing
laser energy precisely enough for efficient fusion conditions. Yet many think
mastering fusion could revolutionize future energy production sustainably if
the scientific obstacles are overcome.
Nuclear batteries
Radioisotope thermoelectric generators (RTGs) that operate on the heat from
radioactive decay have powered interplanetary spacecraft explorations since
the 1960s. Efforts are underway by companies to design small modular
nuclear batteries optimized to decentralize electricity access for off-grid
communities, charging electric vehicles, powering remote infrastructure
stations and more on Earth. Proposed designs use uranium or plutonium-
based heat sources coupled to micro-CHP engines that convert heat to
electricity via thermoelectrics or Stirling engines. The multi-decade long
operating lifetimes from self-contained and sealed devices could enable
independent power for areas without transmission grids. However nuclear
batteries face commercialization barriers from public acceptance issues,
developing long-term waste storage and obtaining regulatory approvals for
small-scale reactors despite inherent safety advantages versus larger plants.
Their potential role in energy access remains an open question.
Nuclear waste management
Effectively managing nuclear waste produced from both power generation
and medical/research applications remains an outstanding technical
challenge requiring long-term geological isolation. Most waste solutions
center around deep geologic repositories that exploit low water flow and
geochemically stable formations to contain radionuclides for thousands of
years. Engineered thick concrete barriers and steel casks provide multiple
redundant levels of containment and isolation deep underground where the
heat from radioactive decay can dissipate harmlessly. Waste matrices like
glass or ceramics immobilize radionuclides, while advanced monitoring
systems track any subsurface fluid movement. Some countries like Finland
have made significant progress developing permanent nuclear waste
repositories with regulatory approval and community consent. However
political opposition and siting difficulties have stalled other repository
programs worldwide. Advanced reprocessing to reduce long-term
radionuclide inventories and transmute select actinides into shorter-lived
isotopes represent alternatives still under research. Considering the
enormous quantities of long-lived nuclear waste that must be properly
entombed, developing safe geological storage solutions on the timescales of
human civilization remains an unfinished story of high importance.
Conclusion
In conclusion, nuclear chemistry technologies applied across medicine,
industry and energy have greatly benefited humanity but also present
unique challenges that must be soundly addressed. Medical applications of
radioactive tracers and radiotherapeutics have revolutionized diagnosis and
treatment by non-invasively imaging physiological processes in vivo and
selectively targeting diseased tissue. Industrial processes make use of
radioisotopes for isotope production, materials analysis, non-destructive
testing and sterilization under strictly controlled conditions. Nuclear power
already supplies massive amounts of reliable low-carbon energy worldwide,
with the possibility of fusion and modular fission batteries decentralizing
access if technical obstacles are one day overcome.
However, issues from waste management, safety risks, weapons proliferation
linkage and cost overruns associated with nuclear technologies demand
prudent regulation and innovation. Long-term isolation of highly radioactive
byproducts in geological repositories poses scientific and institutional
challenges on tens of thousands of year timescales. Incidents like Chernobyl
and Fukushima also remind of nuclear’s unforgiving realities if accidents
breach multiple safety barriers. Advancing novel reactor concepts and fuel
cycles to proliferate-resistant, walk-away safe and more resource efficient
designs therefore retains importance alongside non-nuclear climate
solutions. Public trust and transparent risk communication likewise matter
greatly for continued development. Overall, a balanced, evidence-based
approach is needed to maximize nuclear’s benefits judiciously, while
prioritizing safety, oversight, waste confinement and nonproliferation into the
deep future. With comprehensive management, nuclear science's peaceful
applications will likely expand to a technology for humanity as keen
understanding of the atom's power increases.
Nuclear chemistry is the study of how nuclei react and change. It involves
changes in the composition and structure of atomic nuclei. Many important
practical applications of nuclear chemistry have emerged that have
massively impacted medicine, industry, and energy production. This paper
will explore the diverse applications of nuclear chemistry across these three
domains and discuss both their benefits as well as some criticisms and
concerns about their use.
Part 1: Applications in Medicine
Medical imaging
One of the most widespread medical applications of nuclear chemistry is in
medical imaging techniques such as positron emission tomography (PET)
scans, single photon emission computed tomography (SPECT) scans, and
nuclear magnetic resonance (NMR) imaging. These techniques utilize
radioactive tracers, which are molecules that have been labeled with
radioactive isotopes. When these tracers are introduced into the body, they
can be detected by specialized cameras and used to form detailed 3D
images of tissues and organs.
PET scans use radioactive tracers that emit positrons. Common PET
radiotracers include fluorine-18, carbon-11, nitrogen-13, and oxygen-15.
These radioactive atoms are attached to molecules that are involved in
normal body processes like glucose metabolism, blood flow, and protein
synthesis. As the radiotracer accumulates in tissues, the positions of emitting
positrons can be detected and used to construct tomographic images of
metabolic activity in the body. PET scans provide extremely sensitive and
quantitative measurements and have revolutionized the detection, diagnosis,
and monitoring of many cancers as well as brain disorders like Alzheimer's
disease.
SPECT scans similarly use gamma-ray emitting radioactive tracers but form
lower resolution images than PET. Common SPECT radiotracers include
technetium-99m, thallium-201, gallium-67, and iodine-123. Like PET tracers,
these label molecules involved in key physiological processes. By monitoring
the distribution and movement of radiotracers in the body, SPECT scans can
identify abnormalities and lesions. For example, SPECT scans with thallium-
201 or technetium-99m can detect blood flow issues in the heart muscle to
diagnose heart disease. Iodine-123 scans are also useful for diagnosing
thyroid disease and cancers.
NMR imaging, more commonly known as magnetic resonance imaging (MRI),
uses the magnetic properties of atomic nuclei instead of radioactivity. Many
MRI scans utilize the hydrogen nuclei naturally present in water molecules in
the body. Powerful magnets and radiofrequency pulses are used to excite the
magnetic dipoles of these nuclei, causing them to emit radio signals that can
be used to construct diagnostic images. MRI provides excellent soft tissue
contrast and has become an invaluable tool for examining the brain, spine,
joints, and many other internal structures without exposure to radiation.
Contrast agents containing gadolinium can also be intravenously
administered to enhance MRI images.
Radioisotope therapy
In addition to diagnostics, some radionuclides have therapeutic applications
for treating various medical conditions. One of the most well established is
the use of iodine-131 to treat hyperthyroidism and thyroid cancer. Iodine-131
has similar chemical properties to stable iodine and readily accumulates in
the thyroid gland where it destroys remaining thyroid tissue through beta
radiation exposure. This reduces overproduction of hormones in
hyperthyroidism while also destroying any cancerous thyroid cells. Treatment
is usually very effective with few side effects.
Strontium-89 and samarium-153 are also effective medical radioisotopes for
treating bone metastases from cancers like prostate and breast cancer.
These beta emitters selectively concentrate in areas of increased bone
turnover like cancerous bone lesions. Their radiation can help strengthen
bones weakened by metastases and relieve pain by ablating the cancer cells
within bone tissue. Radioimmunotherapy uses antibodies tagged with short-
range alpha or beta-emitting radioisotopes to bind to and destroy cancer
cells at a molecular level. Targeted isotopes include yttrium-90, iodine-131,
lutetium-177 and bismuth-213.
Other promising therapeutic radionuclides in development include actinium-
225 and lead-212. Actinium-225 generates four alpha particle emissions in
its decay chain and shows potential for treating acute myeloid leukemia and
other cancers if attached to monoclonal antibodies. Lead-212 can also
generate alpha decays and has a very short half-life of only 10.6 hours,
allowing it to deliver highly localized radiation doses without traveling far
from tumors. As radiotherapeutics continue to be researched and refined,
selective internal radiation exposures may become viable alternatives or
supplements to external beam radiation treatments for various cancers and
other conditions.
Radiopharmaceutical production
The production of radiotracers and radiopharmaceuticals for medical
applications is a major industry that generates billions in revenue annually.
Common medical radioisotopes like technetium-99m, iodine-123 and -131,
gallium-67, thallium-201, fluorine-18 and others are produced globally in
specialized nuclear reactors, particle accelerators, or generators. Radioactive
milling and processing facilities purify and formulate radionuclides into stable
chemical compounds suitable for intravenous injection or ingestion by
patients before scanning or therapy. Stringent regulations and quality
controls ensure the radioactive drugs are manufactured under high purity,
sterility, and maximum specific radioactivity standards. Continuous fission
reactors like those in Canada routinely supply over 80% of the U.S. demand
for the workhorse technetium-99m isotope needed for tens of thousands of
SPECT scans every day. The global medical radioisotope market, dominated
by the top three firms, is projected to grow annually by over 5% through
2027 due to expanding clinical applications and replacements for aging
reactor infrastructure. Overall, nuclear medicine has revolutionized diagnosis
and treatment, helping improve millions of lives.
Part 2: Applications in Industry
Isotope production
In addition to medical uses, nuclear processes are employed industrially to
produce important stable and radioactive isotopes. Light water reactors
generate sizeable quantities of plutonium-239 as a byproduct of uranium-238
absorbing neutrons. Plutonium-239 has a half-life of 24,100 years and its
decay produces mostly alpha particles, making it well suited for
thermoelectric applications in radioisotope thermoelectric generators (RTGs).
RTGs powered U.S. space missions for over 50 years including Voyager,
Galileo, and Curiosity by using the heat from plutonium-238's radioactive
decay.
Tritium, a radioactive isotope of hydrogen, is primarily used in self-luminous
sights for firearms, emergency exit signs, and other low light applications. It
is commercially produced by irradiating a lithium target with neutrons in a
nuclear reactor, followed by chemical separation. Large quantities of
naturally occurring krypton-81 are also collected from gaseous fission
products extracted from reactor off-gases. This stable noble gas isotope finds
use as an inert filler for energy efficient light bulbs and flat panel displays.
Neutron activation analysis
Another nuclear technique employed in industry is neutron activation
analysis (NAA), which involves irradiating samples with neutrons in a nuclear
reactor. This process causes certain elements in the sample to become
radioactive via neutron capture. By precisely measuring the gamma radiation
signatures emitted as these artificially produced radioisotopes decay, it is
possible to quantitatively determine the elemental composition of even
complex industrial materials down to trace quantities. NAA is useful for
quality control in sectors like mining, metallurgy, electronics manufacturing
and more. It can rapidly screen bulk samples for contaminants or verify
purity in a non-destructive manner.
Industrial radiography
Industrial radiography utilizes penetrating gamma and X-rays from
radioactive isotopes to examine the internal structures and defects in large
industrial components without having to dismantle or destroy them.
Common radiographic sources include cobalt-60, iridium-192, selenium-75
and caesium-137. The images reveal flaws invisible from the surface like
cracks, voids, corrosion or faulty welds in critical infrastructure parts like
pipelines, pressure vessels, bridges and machinery. This allows issues to be
addressed before catastrophic failures occur. While X-ray machines can also
perform industrial radiography, radioactive sources provide more penetrating
power for larger and higher density objects. However, their encapsulated
sources must be carefully shielded and handled to prevent exposure when
not in use.
Sterilization
Today, over half of all medical devices and many food products worldwide are
sterilized using gamma or electron beam radiation from radioactive isotopes.
Cobalt-60 is a popular gamma source that can penetrate packaging and
thoroughly sterilize items. The high-energy photons destroy microbes like
bacteria and viruses without leaving chemical residues. As no thermal or
pressure factors are involved, radiation sterilization maintains product
integrity and is suitable for heat- and moisture-sensitive items. In addition to
consumables, radiation has widespread uses decontaminating medical
equipment and sterilizing surgical gowns, drapes and implants before they
reach hospitals and patients. When combined with strict quality controls,
radiation-based sterilization provides a safe, effective and environmentally-
friendly alternative to steam, EtO gas or other chemical sterilants.
Part 3: Applications in Energy Production
Nuclear fission power
Nuclear fission reactors harness the energy released during nuclear fission
chain reactions to generate electricity on a commercial scale. Fissile
uranium-235 or plutonium-239 atoms are bombarded with neutrons and then
split apart, releasing additional neutrons, heat in the form of kinetic energy,
and gamma radiation. In a nuclear power plant, the heat generated is used
to produce steam that drives turbines connected to electricity generators.
Over 450 nuclear reactors worldwide currently supply about 10% of the
global electricity demand and one-third of low-carbon power. Generation II
light water reactors dominate the global fleet while Generation III+ and IV
designs incorporate passive safety and materials innovations.
Proponents argue nuclear energy is a stable, reliable, low-carbon baseload
power source able to meet rising energy needs. Unlike intermittent
renewables, fission continuously operates 24/7 and maintains the grid
reliability required by modern societies and industries. The energy density
per unit fuel mass from fission vastly exceeds fossil or renewable
alternatives. However, nuclear faces challenges from high capital costs and
construction timescales, nuclear waste management and proliferation
concerns as well as safety risks if accidents occur. Nevertheless, many
experts see it as indispensable for climate goals given its clean attributes,
and over 50 new reactors are under construction worldwide. Ongoing
research aims to sustain a nuclear renaissance through new small modular,
advanced, and fast neutron reactors.
Nuclear fusion power
Nuclear fusion harnesses the energy from fusing atomic nuclei lighter than
iron, the opposite reaction to fission. The most promising approach is using
strong magnetic fields in doughnut-shaped tokamak reactors to heat and
compress hydrogen isotopes deuterium and tritium under extreme
conditions, where their nuclei fuse and release helium atoms along with
energetic neutrons. This fusion process occurs naturally in the cores of stars
and greatly outstrips any chemical energy source on an energy per unit mass
basis. Researchers envision inertial confinement fusion using lasers and
hypersonic z-pinches as alternatives to the magnetic confinement approach.
The International Thermonuclear Experimental Reactor (ITER) tokamak
project currently underway in France aims to demonstrate the scientific and
technical feasibility of fusion power by generating net energy from fusion for
periods of several minutes by 2035. Beyond ITER, commercial fusion reactors
would not emit greenhouse gases, deplete resources or create long-lived
nuclear waste. With hydrogen as fuel, worldwide reserves could last for
millions of years. However, achieving economically viable and self-sustaining
fusion remains an immense technical challenge still far in the future given
difficulty in maintaining plasma stability, tailoring magnetic fields or focusing
laser energy precisely enough for efficient fusion conditions. Yet many think
mastering fusion could revolutionize future energy production sustainably if
the scientific obstacles are overcome.
Nuclear batteries
Radioisotope thermoelectric generators (RTGs) that operate on the heat from
radioactive decay have powered interplanetary spacecraft explorations since
the 1960s. Efforts are underway by companies to design small modular
nuclear batteries optimized to decentralize electricity access for off-grid
communities, charging electric vehicles, powering remote infrastructure
stations and more on Earth. Proposed designs use uranium or plutonium-
based heat sources coupled to micro-CHP engines that convert heat to
electricity via thermoelectrics or Stirling engines. The multi-decade long
operating lifetimes from self-contained and sealed devices could enable
independent power for areas without transmission grids. However nuclear
batteries face commercialization barriers from public acceptance issues,
developing long-term waste storage and obtaining regulatory approvals for
small-scale reactors despite inherent safety advantages versus larger plants.
Their potential role in energy access remains an open question.
Nuclear waste management
Effectively managing nuclear waste produced from both power generation
and medical/research applications remains an outstanding technical
challenge requiring long-term geological isolation. Most waste solutions
center around deep geologic repositories that exploit low water flow and
geochemically stable formations to contain radionuclides for thousands of
years. Engineered thick concrete barriers and steel casks provide multiple
redundant levels of containment and isolation deep underground where the
heat from radioactive decay can dissipate harmlessly. Waste matrices like
glass or ceramics immobilize radionuclides, while advanced monitoring
systems track any subsurface fluid movement. Some countries like Finland
have made significant progress developing permanent nuclear waste
repositories with regulatory approval and community consent. However
political opposition and siting difficulties have stalled other repository
programs worldwide. Advanced reprocessing to reduce long-term
radionuclide inventories and transmute select actinides into shorter-lived
isotopes represent alternatives still under research. Considering the
enormous quantities of long-lived nuclear waste that must be properly
entombed, developing safe geological storage solutions on the timescales of
human civilization remains an unfinished story of high importance.
Conclusion
In conclusion, nuclear chemistry technologies applied across medicine,
industry and energy have greatly benefited humanity but also present
unique challenges that must be soundly addressed. Medical applications of
radioactive tracers and radiotherapeutics have revolutionized diagnosis and
treatment by non-invasively imaging physiological processes in vivo and
selectively targeting diseased tissue. Industrial processes make use of
radioisotopes for isotope production, materials analysis, non-destructive
testing and sterilization under strictly controlled conditions. Nuclear power
already supplies massive amounts of reliable low-carbon energy worldwide,
with the possibility of fusion and modular fission batteries decentralizing
access if technical obstacles are one day overcome.
However, issues from waste management, safety risks, weapons proliferation
linkage and cost overruns associated with nuclear technologies demand
prudent regulation and innovation. Long-term isolation of highly radioactive
byproducts in geological repositories poses scientific and institutional
challenges on tens of thousands of year timescales. Incidents like Chernobyl
and Fukushima also remind of nuclear’s unforgiving realities if accidents
breach multiple safety barriers. Advancing novel reactor concepts and fuel
cycles to proliferate-resistant, walk-away safe and more resource efficient
designs therefore retains importance alongside non-nuclear climate
solutions. Public trust and transparent risk communication likewise matter
greatly for continued development. Overall, a balanced, evidence-based
approach is needed to maximize nuclear’s benefits judiciously, while
prioritizing safety, oversight, waste confinement and nonproliferation into the
deep future. With comprehensive management, nuclear science's peaceful
applications will likely expand to a technology for humanity as keen
understanding of the atom's power increases.
Nuclear chemistry is the study of how nuclei react and change. It involves
changes in the composition and structure of atomic nuclei. Many important
practical applications of nuclear chemistry have emerged that have
massively impacted medicine, industry, and energy production. This paper
will explore the diverse applications of nuclear chemistry across these three
domains and discuss both their benefits as well as some criticisms and
concerns about their use.
Part 1: Applications in Medicine
Medical imaging
One of the most widespread medical applications of nuclear chemistry is in
medical imaging techniques such as positron emission tomography (PET)
scans, single photon emission computed tomography (SPECT) scans, and
nuclear magnetic resonance (NMR) imaging. These techniques utilize
radioactive tracers, which are molecules that have been labeled with
radioactive isotopes. When these tracers are introduced into the body, they
can be detected by specialized cameras and used to form detailed 3D
images of tissues and organs.
PET scans use radioactive tracers that emit positrons. Common PET
radiotracers include fluorine-18, carbon-11, nitrogen-13, and oxygen-15.
These radioactive atoms are attached to molecules that are involved in
normal body processes like glucose metabolism, blood flow, and protein
synthesis. As the radiotracer accumulates in tissues, the positions of emitting
positrons can be detected and used to construct tomographic images of
metabolic activity in the body. PET scans provide extremely sensitive and
quantitative measurements and have revolutionized the detection, diagnosis,
and monitoring of many cancers as well as brain disorders like Alzheimer's
disease.
SPECT scans similarly use gamma-ray emitting radioactive tracers but form
lower resolution images than PET. Common SPECT radiotracers include
technetium-99m, thallium-201, gallium-67, and iodine-123. Like PET tracers,
these label molecules involved in key physiological processes. By monitoring
the distribution and movement of radiotracers in the body, SPECT scans can
identify abnormalities and lesions. For example, SPECT scans with thallium-
201 or technetium-99m can detect blood flow issues in the heart muscle to
diagnose heart disease. Iodine-123 scans are also useful for diagnosing
thyroid disease and cancers.
NMR imaging, more commonly known as magnetic resonance imaging (MRI),
uses the magnetic properties of atomic nuclei instead of radioactivity. Many
MRI scans utilize the hydrogen nuclei naturally present in water molecules in
the body. Powerful magnets and radiofrequency pulses are used to excite the
magnetic dipoles of these nuclei, causing them to emit radio signals that can
be used to construct diagnostic images. MRI provides excellent soft tissue
contrast and has become an invaluable tool for examining the brain, spine,
joints, and many other internal structures without exposure to radiation.
Contrast agents containing gadolinium can also be intravenously
administered to enhance MRI images.
Radioisotope therapy
In addition to diagnostics, some radionuclides have therapeutic applications
for treating various medical conditions. One of the most well established is
the use of iodine-131 to treat hyperthyroidism and thyroid cancer. Iodine-131
has similar chemical properties to stable iodine and readily accumulates in
the thyroid gland where it destroys remaining thyroid tissue through beta
radiation exposure. This reduces overproduction of hormones in
hyperthyroidism while also destroying any cancerous thyroid cells. Treatment
is usually very effective with few side effects.
Strontium-89 and samarium-153 are also effective medical radioisotopes for
treating bone metastases from cancers like prostate and breast cancer.
These beta emitters selectively concentrate in areas of increased bone
turnover like cancerous bone lesions. Their radiation can help strengthen
bones weakened by metastases and relieve pain by ablating the cancer cells
within bone tissue. Radioimmunotherapy uses antibodies tagged with short-
range alpha or beta-emitting radioisotopes to bind to and destroy cancer
cells at a molecular level. Targeted isotopes include yttrium-90, iodine-131,
lutetium-177 and bismuth-213.
Other promising therapeutic radionuclides in development include actinium-
225 and lead-212. Actinium-225 generates four alpha particle emissions in
its decay chain and shows potential for treating acute myeloid leukemia and
other cancers if attached to monoclonal antibodies. Lead-212 can also
generate alpha decays and has a very short half-life of only 10.6 hours,
allowing it to deliver highly localized radiation doses without traveling far
from tumors. As radiotherapeutics continue to be researched and refined,
selective internal radiation exposures may become viable alternatives or
supplements to external beam radiation treatments for various cancers and
other conditions.
Radiopharmaceutical production
The production of radiotracers and radiopharmaceuticals for medical
applications is a major industry that generates billions in revenue annually.
Common medical radioisotopes like technetium-99m, iodine-123 and -131,
gallium-67, thallium-201, fluorine-18 and others are produced globally in
specialized nuclear reactors, particle accelerators, or generators. Radioactive
milling and processing facilities purify and formulate radionuclides into stable
chemical compounds suitable for intravenous injection or ingestion by
patients before scanning or therapy. Stringent regulations and quality
controls ensure the radioactive drugs are manufactured under high purity,
sterility, and maximum specific radioactivity standards. Continuous fission
reactors like those in Canada routinely supply over 80% of the U.S. demand
for the workhorse technetium-99m isotope needed for tens of thousands of
SPECT scans every day. The global medical radioisotope market, dominated
by the top three firms, is projected to grow annually by over 5% through
2027 due to expanding clinical applications and replacements for aging
reactor infrastructure. Overall, nuclear medicine has revolutionized diagnosis
and treatment, helping improve millions of lives.
Part 2: Applications in Industry
Isotope production
In addition to medical uses, nuclear processes are employed industrially to
produce important stable and radioactive isotopes. Light water reactors
generate sizeable quantities of plutonium-239 as a byproduct of uranium-238
absorbing neutrons. Plutonium-239 has a half-life of 24,100 years and its
decay produces mostly alpha particles, making it well suited for
thermoelectric applications in radioisotope thermoelectric generators (RTGs).
RTGs powered U.S. space missions for over 50 years including Voyager,
Galileo, and Curiosity by using the heat from plutonium-238's radioactive
decay.
Tritium, a radioactive isotope of hydrogen, is primarily used in self-luminous
sights for firearms, emergency exit signs, and other low light applications. It
is commercially produced by irradiating a lithium target with neutrons in a
nuclear reactor, followed by chemical separation. Large quantities of
naturally occurring krypton-81 are also collected from gaseous fission
products extracted from reactor off-gases. This stable noble gas isotope finds
use as an inert filler for energy efficient light bulbs and flat panel displays.
Neutron activation analysis
Another nuclear technique employed in industry is neutron activation
analysis (NAA), which involves irradiating samples with neutrons in a nuclear
reactor. This process causes certain elements in the sample to become
radioactive via neutron capture. By precisely measuring the gamma radiation
signatures emitted as these artificially produced radioisotopes decay, it is
possible to quantitatively determine the elemental composition of even
complex industrial materials down to trace quantities. NAA is useful for
quality control in sectors like mining, metallurgy, electronics manufacturing
and more. It can rapidly screen bulk samples for contaminants or verify
purity in a non-destructive manner.
Industrial radiography
Industrial radiography utilizes penetrating gamma and X-rays from
radioactive isotopes to examine the internal structures and defects in large
industrial components without having to dismantle or destroy them.
Common radiographic sources include cobalt-60, iridium-192, selenium-75
and caesium-137. The images reveal flaws invisible from the surface like
cracks, voids, corrosion or faulty welds in critical infrastructure parts like
pipelines, pressure vessels, bridges and machinery. This allows issues to be
addressed before catastrophic failures occur. While X-ray machines can also
perform industrial radiography, radioactive sources provide more penetrating
power for larger and higher density objects. However, their encapsulated
sources must be carefully shielded and handled to prevent exposure when
not in use.
Sterilization
Today, over half of all medical devices and many food products worldwide are
sterilized using gamma or electron beam radiation from radioactive isotopes.
Cobalt-60 is a popular gamma source that can penetrate packaging and
thoroughly sterilize items. The high-energy photons destroy microbes like
bacteria and viruses without leaving chemical residues. As no thermal or
pressure factors are involved, radiation sterilization maintains product
integrity and is suitable for heat- and moisture-sensitive items. In addition to
consumables, radiation has widespread uses decontaminating medical
equipment and sterilizing surgical gowns, drapes and implants before they
reach hospitals and patients. When combined with strict quality controls,
radiation-based sterilization provides a safe, effective and environmentally-
friendly alternative to steam, EtO gas or other chemical sterilants.
Part 3: Applications in Energy Production
Nuclear fission power
Nuclear fission reactors harness the energy released during nuclear fission
chain reactions to generate electricity on a commercial scale. Fissile
uranium-235 or plutonium-239 atoms are bombarded with neutrons and then
split apart, releasing additional neutrons, heat in the form of kinetic energy,
and gamma radiation. In a nuclear power plant, the heat generated is used
to produce steam that drives turbines connected to electricity generators.
Over 450 nuclear reactors worldwide currently supply about 10% of the
global electricity demand and one-third of low-carbon power. Generation II
light water reactors dominate the global fleet while Generation III+ and IV
designs incorporate passive safety and materials innovations.
Proponents argue nuclear energy is a stable, reliable, low-carbon baseload
power source able to meet rising energy needs. Unlike intermittent
renewables, fission continuously operates 24/7 and maintains the grid
reliability required by modern societies and industries. The energy density
per unit fuel mass from fission vastly exceeds fossil or renewable
alternatives. However, nuclear faces challenges from high capital costs and
construction timescales, nuclear waste management and proliferation
concerns as well as safety risks if accidents occur. Nevertheless, many
experts see it as indispensable for climate goals given its clean attributes,
and over 50 new reactors are under construction worldwide. Ongoing
research aims to sustain a nuclear renaissance through new small modular,
advanced, and fast neutron reactors.
Nuclear fusion power
Nuclear fusion harnesses the energy from fusing atomic nuclei lighter than
iron, the opposite reaction to fission. The most promising approach is using
strong magnetic fields in doughnut-shaped tokamak reactors to heat and
compress hydrogen isotopes deuterium and tritium under extreme
conditions, where their nuclei fuse and release helium atoms along with
energetic neutrons. This fusion process occurs naturally in the cores of stars
and greatly outstrips any chemical energy source on an energy per unit mass
basis. Researchers envision inertial confinement fusion using lasers and
hypersonic z-pinches as alternatives to the magnetic confinement approach.
The International Thermonuclear Experimental Reactor (ITER) tokamak
project currently underway in France aims to demonstrate the scientific and
technical feasibility of fusion power by generating net energy from fusion for
periods of several minutes by 2035. Beyond ITER, commercial fusion reactors
would not emit greenhouse gases, deplete resources or create long-lived
nuclear waste. With hydrogen as fuel, worldwide reserves could last for
millions of years. However, achieving economically viable and self-sustaining
fusion remains an immense technical challenge still far in the future given
difficulty in maintaining plasma stability, tailoring magnetic fields or focusing
laser energy precisely enough for efficient fusion conditions. Yet many think
mastering fusion could revolutionize future energy production sustainably if
the scientific obstacles are overcome.
Nuclear batteries
Radioisotope thermoelectric generators (RTGs) that operate on the heat from
radioactive decay have powered interplanetary spacecraft explorations since
the 1960s. Efforts are underway by companies to design small modular
nuclear batteries optimized to decentralize electricity access for off-grid
communities, charging electric vehicles, powering remote infrastructure
stations and more on Earth. Proposed designs use uranium or plutonium-
based heat sources coupled to micro-CHP engines that convert heat to
electricity via thermoelectrics or Stirling engines. The multi-decade long
operating lifetimes from self-contained and sealed devices could enable
independent power for areas without transmission grids. However nuclear
batteries face commercialization barriers from public acceptance issues,
developing long-term waste storage and obtaining regulatory approvals for
small-scale reactors despite inherent safety advantages versus larger plants.
Their potential role in energy access remains an open question.
Nuclear waste management
Effectively managing nuclear waste produced from both power generation
and medical/research applications remains an outstanding technical
challenge requiring long-term geological isolation. Most waste solutions
center around deep geologic repositories that exploit low water flow and
geochemically stable formations to contain radionuclides for thousands of
years. Engineered thick concrete barriers and steel casks provide multiple
redundant levels of containment and isolation deep underground where the
heat from radioactive decay can dissipate harmlessly. Waste matrices like
glass or ceramics immobilize radionuclides, while advanced monitoring
systems track any subsurface fluid movement. Some countries like Finland
have made significant progress developing permanent nuclear waste
repositories with regulatory approval and community consent. However
political opposition and siting difficulties have stalled other repository
programs worldwide. Advanced reprocessing to reduce long-term
radionuclide inventories and transmute select actinides into shorter-lived
isotopes represent alternatives still under research. Considering the
enormous quantities of long-lived nuclear waste that must be properly
entombed, developing safe geological storage solutions on the timescales of
human civilization remains an unfinished story of high importance.
Conclusion
In conclusion, nuclear chemistry technologies applied across medicine,
industry and energy have greatly benefited humanity but also present
unique challenges that must be soundly addressed. Medical applications of
radioactive tracers and radiotherapeutics have revolutionized diagnosis and
treatment by non-invasively imaging physiological processes in vivo and
selectively targeting diseased tissue. Industrial processes make use of
radioisotopes for isotope production, materials analysis, non-destructive
testing and sterilization under strictly controlled conditions. Nuclear power
already supplies massive amounts of reliable low-carbon energy worldwide,
with the possibility of fusion and modular fission batteries decentralizing
access if technical obstacles are one day overcome.
However, issues from waste management, safety risks, weapons proliferation
linkage and cost overruns associated with nuclear technologies demand
prudent regulation and innovation. Long-term isolation of highly radioactive
byproducts in geological repositories poses scientific and institutional
challenges on tens of thousands of year timescales. Incidents like Chernobyl
and Fukushima also remind of nuclear’s unforgiving realities if accidents
breach multiple safety barriers. Advancing novel reactor concepts and fuel
cycles to proliferate-resistant, walk-away safe and more resource efficient
designs therefore retains importance alongside non-nuclear climate
solutions. Public trust and transparent risk communication likewise matter
greatly for continued development. Overall, a balanced, evidence-based
approach is needed to maximize nuclear’s benefits judiciously, while
prioritizing safety, oversight, waste confinement and nonproliferation into the
deep future. With comprehensive management, nuclear science's peaceful
applications will likely expand to a technology for humanity as keen
understanding of the atom's power increases.
Nuclear chemistry is the study of how nuclei react and change. It involves
changes in the composition and structure of atomic nuclei. Many important
practical applications of nuclear chemistry have emerged that have
massively impacted medicine, industry, and energy production. This paper
will explore the diverse applications of nuclear chemistry across these three
domains and discuss both their benefits as well as some criticisms and
concerns about their use.
Part 1: Applications in Medicine
Medical imaging
One of the most widespread medical applications of nuclear chemistry is in
medical imaging techniques such as positron emission tomography (PET)
scans, single photon emission computed tomography (SPECT) scans, and
nuclear magnetic resonance (NMR) imaging. These techniques utilize
radioactive tracers, which are molecules that have been labeled with
radioactive isotopes. When these tracers are introduced into the body, they
can be detected by specialized cameras and used to form detailed 3D
images of tissues and organs.
PET scans use radioactive tracers that emit positrons. Common PET
radiotracers include fluorine-18, carbon-11, nitrogen-13, and oxygen-15.
These radioactive atoms are attached to molecules that are involved in
normal body processes like glucose metabolism, blood flow, and protein
synthesis. As the radiotracer accumulates in tissues, the positions of emitting
positrons can be detected and used to construct tomographic images of
metabolic activity in the body. PET scans provide extremely sensitive and
quantitative measurements and have revolutionized the detection, diagnosis,
and monitoring of many cancers as well as brain disorders like Alzheimer's
disease.
SPECT scans similarly use gamma-ray emitting radioactive tracers but form
lower resolution images than PET. Common SPECT radiotracers include
technetium-99m, thallium-201, gallium-67, and iodine-123. Like PET tracers,
these label molecules involved in key physiological processes. By monitoring
the distribution and movement of radiotracers in the body, SPECT scans can
identify abnormalities and lesions. For example, SPECT scans with thallium-
201 or technetium-99m can detect blood flow issues in the heart muscle to
diagnose heart disease. Iodine-123 scans are also useful for diagnosing
thyroid disease and cancers.
NMR imaging, more commonly known as magnetic resonance imaging (MRI),
uses the magnetic properties of atomic nuclei instead of radioactivity. Many
MRI scans utilize the hydrogen nuclei naturally present in water molecules in
the body. Powerful magnets and radiofrequency pulses are used to excite the
magnetic dipoles of these nuclei, causing them to emit radio signals that can
be used to construct diagnostic images. MRI provides excellent soft tissue
contrast and has become an invaluable tool for examining the brain, spine,
joints, and many other internal structures without exposure to radiation.
Contrast agents containing gadolinium can also be intravenously
administered to enhance MRI images.
Radioisotope therapy
In addition to diagnostics, some radionuclides have therapeutic applications
for treating various medical conditions. One of the most well established is
the use of iodine-131 to treat hyperthyroidism and thyroid cancer. Iodine-131
has similar chemical properties to stable iodine and readily accumulates in
the thyroid gland where it destroys remaining thyroid tissue through beta
radiation exposure. This reduces overproduction of hormones in
hyperthyroidism while also destroying any cancerous thyroid cells. Treatment
is usually very effective with few side effects.
Strontium-89 and samarium-153 are also effective medical radioisotopes for
treating bone metastases from cancers like prostate and breast cancer.
These beta emitters selectively concentrate in areas of increased bone
turnover like cancerous bone lesions. Their radiation can help strengthen
bones weakened by metastases and relieve pain by ablating the cancer cells
within bone tissue. Radioimmunotherapy uses antibodies tagged with short-
range alpha or beta-emitting radioisotopes to bind to and destroy cancer
cells at a molecular level. Targeted isotopes include yttrium-90, iodine-131,
lutetium-177 and bismuth-213.
Other promising therapeutic radionuclides in development include actinium-
225 and lead-212. Actinium-225 generates four alpha particle emissions in
its decay chain and shows potential for treating acute myeloid leukemia and
other cancers if attached to monoclonal antibodies. Lead-212 can also
generate alpha decays and has a very short half-life of only 10.6 hours,
allowing it to deliver highly localized radiation doses without traveling far
from tumors. As radiotherapeutics continue to be researched and refined,
selective internal radiation exposures may become viable alternatives or
supplements to external beam radiation treatments for various cancers and
other conditions.
Radiopharmaceutical production
The production of radiotracers and radiopharmaceuticals for medical
applications is a major industry that generates billions in revenue annually.
Common medical radioisotopes like technetium-99m, iodine-123 and -131,
gallium-67, thallium-201, fluorine-18 and others are produced globally in
specialized nuclear reactors, particle accelerators, or generators. Radioactive
milling and processing facilities purify and formulate radionuclides into stable
chemical compounds suitable for intravenous injection or ingestion by
patients before scanning or therapy. Stringent regulations and quality
controls ensure the radioactive drugs are manufactured under high purity,
sterility, and maximum specific radioactivity standards. Continuous fission
reactors like those in Canada routinely supply over 80% of the U.S. demand
for the workhorse technetium-99m isotope needed for tens of thousands of
SPECT scans every day. The global medical radioisotope market, dominated
by the top three firms, is projected to grow annually by over 5% through
2027 due to expanding clinical applications and replacements for aging
reactor infrastructure. Overall, nuclear medicine has revolutionized diagnosis
and treatment, helping improve millions of lives.
Part 2: Applications in Industry
Isotope production
In addition to medical uses, nuclear processes are employed industrially to
produce important stable and radioactive isotopes. Light water reactors
generate sizeable quantities of plutonium-239 as a byproduct of uranium-238
absorbing neutrons. Plutonium-239 has a half-life of 24,100 years and its
decay produces mostly alpha particles, making it well suited for
thermoelectric applications in radioisotope thermoelectric generators (RTGs).
RTGs powered U.S. space missions for over 50 years including Voyager,
Galileo, and Curiosity by using the heat from plutonium-238's radioactive
decay.
Tritium, a radioactive isotope of hydrogen, is primarily used in self-luminous
sights for firearms, emergency exit signs, and other low light applications. It
is commercially produced by irradiating a lithium target with neutrons in a
nuclear reactor, followed by chemical separation. Large quantities of
naturally occurring krypton-81 are also collected from gaseous fission
products extracted from reactor off-gases. This stable noble gas isotope finds
use as an inert filler for energy efficient light bulbs and flat panel displays.
Neutron activation analysis
Another nuclear technique employed in industry is neutron activation
analysis (NAA), which involves irradiating samples with neutrons in a nuclear
reactor. This process causes certain elements in the sample to become
radioactive via neutron capture. By precisely measuring the gamma radiation
signatures emitted as these artificially produced radioisotopes decay, it is
possible to quantitatively determine the elemental composition of even
complex industrial materials down to trace quantities. NAA is useful for
quality control in sectors like mining, metallurgy, electronics manufacturing
and more. It can rapidly screen bulk samples for contaminants or verify
purity in a non-destructive manner.
Industrial radiography
Industrial radiography utilizes penetrating gamma and X-rays from
radioactive isotopes to examine the internal structures and defects in large
industrial components without having to dismantle or destroy them.
Common radiographic sources include cobalt-60, iridium-192, selenium-75
and caesium-137. The images reveal flaws invisible from the surface like
cracks, voids, corrosion or faulty welds in critical infrastructure parts like
pipelines, pressure vessels, bridges and machinery. This allows issues to be
addressed before catastrophic failures occur. While X-ray machines can also
perform industrial radiography, radioactive sources provide more penetrating
power for larger and higher density objects. However, their encapsulated
sources must be carefully shielded and handled to prevent exposure when
not in use.
Sterilization
Today, over half of all medical devices and many food products worldwide are
sterilized using gamma or electron beam radiation from radioactive isotopes.
Cobalt-60 is a popular gamma source that can penetrate packaging and
thoroughly sterilize items. The high-energy photons destroy microbes like
bacteria and viruses without leaving chemical residues. As no thermal or
pressure factors are involved, radiation sterilization maintains product
integrity and is suitable for heat- and moisture-sensitive items. In addition to
consumables, radiation has widespread uses decontaminating medical
equipment and sterilizing surgical gowns, drapes and implants before they
reach hospitals and patients. When combined with strict quality controls,
radiation-based sterilization provides a safe, effective and environmentally-
friendly alternative to steam, EtO gas or other chemical sterilants.
Part 3: Applications in Energy Production
Nuclear fission power
Nuclear fission reactors harness the energy released during nuclear fission
chain reactions to generate electricity on a commercial scale. Fissile
uranium-235 or plutonium-239 atoms are bombarded with neutrons and then
split apart, releasing additional neutrons, heat in the form of kinetic energy,
and gamma radiation. In a nuclear power plant, the heat generated is used
to produce steam that drives turbines connected to electricity generators.
Over 450 nuclear reactors worldwide currently supply about 10% of the
global electricity demand and one-third of low-carbon power. Generation II
light water reactors dominate the global fleet while Generation III+ and IV
designs incorporate passive safety and materials innovations.
Proponents argue nuclear energy is a stable, reliable, low-carbon baseload
power source able to meet rising energy needs. Unlike intermittent
renewables, fission continuously operates 24/7 and maintains the grid
reliability required by modern societies and industries. The energy density
per unit fuel mass from fission vastly exceeds fossil or renewable
alternatives. However, nuclear faces challenges from high capital costs and
construction timescales, nuclear waste management and proliferation
concerns as well as safety risks if accidents occur. Nevertheless, many
experts see it as indispensable for climate goals given its clean attributes,
and over 50 new reactors are under construction worldwide. Ongoing
research aims to sustain a nuclear renaissance through new small modular,
advanced, and fast neutron reactors.
Nuclear fusion power
Nuclear fusion harnesses the energy from fusing atomic nuclei lighter than
iron, the opposite reaction to fission. The most promising approach is using
strong magnetic fields in doughnut-shaped tokamak reactors to heat and
compress hydrogen isotopes deuterium and tritium under extreme
conditions, where their nuclei fuse and release helium atoms along with
energetic neutrons. This fusion process occurs naturally in the cores of stars
and greatly outstrips any chemical energy source on an energy per unit mass
basis. Researchers envision inertial confinement fusion using lasers and
hypersonic z-pinches as alternatives to the magnetic confinement approach.
The International Thermonuclear Experimental Reactor (ITER) tokamak
project currently underway in France aims to demonstrate the scientific and
technical feasibility of fusion power by generating net energy from fusion for
periods of several minutes by 2035. Beyond ITER, commercial fusion reactors
would not emit greenhouse gases, deplete resources or create long-lived
nuclear waste. With hydrogen as fuel, worldwide reserves could last for
millions of years. However, achieving economically viable and self-sustaining
fusion remains an immense technical challenge still far in the future given
difficulty in maintaining plasma stability, tailoring magnetic fields or focusing
laser energy precisely enough for efficient fusion conditions. Yet many think
mastering fusion could revolutionize future energy production sustainably if
the scientific obstacles are overcome.
Nuclear batteries
Radioisotope thermoelectric generators (RTGs) that operate on the heat from
radioactive decay have powered interplanetary spacecraft explorations since
the 1960s. Efforts are underway by companies to design small modular
nuclear batteries optimized to decentralize electricity access for off-grid
communities, charging electric vehicles, powering remote infrastructure
stations and more on Earth. Proposed designs use uranium or plutonium-
based heat sources coupled to micro-CHP engines that convert heat to
electricity via thermoelectrics or Stirling engines. The multi-decade long
operating lifetimes from self-contained and sealed devices could enable
independent power for areas without transmission grids. However nuclear
batteries face commercialization barriers from public acceptance issues,
developing long-term waste storage and obtaining regulatory approvals for
small-scale reactors despite inherent safety advantages versus larger plants.
Their potential role in energy access remains an open question.
Nuclear waste management
Effectively managing nuclear waste produced from both power generation
and medical/research applications remains an outstanding technical
challenge requiring long-term geological isolation. Most waste solutions
center around deep geologic repositories that exploit low water flow and
geochemically stable formations to contain radionuclides for thousands of
years. Engineered thick concrete barriers and steel casks provide multiple
redundant levels of containment and isolation deep underground where the
heat from radioactive decay can dissipate harmlessly. Waste matrices like
glass or ceramics immobilize radionuclides, while advanced monitoring
systems track any subsurface fluid movement. Some countries like Finland
have made significant progress developing permanent nuclear waste
repositories with regulatory approval and community consent. However
political opposition and siting difficulties have stalled other repository
programs worldwide. Advanced reprocessing to reduce long-term
radionuclide inventories and transmute select actinides into shorter-lived
isotopes represent alternatives still under research. Considering the
enormous quantities of long-lived nuclear waste that must be properly
entombed, developing safe geological storage solutions on the timescales of
human civilization remains an unfinished story of high importance.
Conclusion
In conclusion, nuclear chemistry technologies applied across medicine,
industry and energy have greatly benefited humanity but also present
unique challenges that must be soundly addressed. Medical applications of
radioactive tracers and radiotherapeutics have revolutionized diagnosis and
treatment by non-invasively imaging physiological processes in vivo and
selectively targeting diseased tissue. Industrial processes make use of
radioisotopes for isotope production, materials analysis, non-destructive
testing and sterilization under strictly controlled conditions. Nuclear power
already supplies massive amounts of reliable low-carbon energy worldwide,
with the possibility of fusion and modular fission batteries decentralizing
access if technical obstacles are one day overcome.
However, issues from waste management, safety risks, weapons proliferation
linkage and cost overruns associated with nuclear technologies demand
prudent regulation and innovation. Long-term isolation of highly radioactive
byproducts in geological repositories poses scientific and institutional
challenges on tens of thousands of year timescales. Incidents like Chernobyl
and Fukushima also remind of nuclear’s unforgiving realities if accidents
breach multiple safety barriers. Advancing novel reactor concepts and fuel
cycles to proliferate-resistant, walk-away safe and more resource efficient
designs therefore retains importance alongside non-nuclear climate
solutions. Public trust and transparent risk communication likewise matter
greatly for continued development. Overall, a balanced, evidence-based
approach is needed to maximize nuclear’s benefits judiciously, while
prioritizing safety, oversight, waste confinement and nonproliferation into the
deep future. With comprehensive management, nuclear science's peaceful
applications will likely expand to a technology for humanity as keen
understanding of the atom's power increases.
Nuclear chemistry is the study of how nuclei react and change. It involves
changes in the composition and structure of atomic nuclei. Many important
practical applications of nuclear chemistry have emerged that have
massively impacted medicine, industry, and energy production. This paper
will explore the diverse applications of nuclear chemistry across these three
domains and discuss both their benefits as well as some criticisms and
concerns about their use.
Part 1: Applications in Medicine
Medical imaging
One of the most widespread medical applications of nuclear chemistry is in
medical imaging techniques such as positron emission tomography (PET)
scans, single photon emission computed tomography (SPECT) scans, and
nuclear magnetic resonance (NMR) imaging. These techniques utilize
radioactive tracers, which are molecules that have been labeled with
radioactive isotopes. When these tracers are introduced into the body, they
can be detected by specialized cameras and used to form detailed 3D
images of tissues and organs.
PET scans use radioactive tracers that emit positrons. Common PET
radiotracers include fluorine-18, carbon-11, nitrogen-13, and oxygen-15.
These radioactive atoms are attached to molecules that are involved in
normal body processes like glucose metabolism, blood flow, and protein
synthesis. As the radiotracer accumulates in tissues, the positions of emitting
positrons can be detected and used to construct tomographic images of
metabolic activity in the body. PET scans provide extremely sensitive and
quantitative measurements and have revolutionized the detection, diagnosis,
and monitoring of many cancers as well as brain disorders like Alzheimer's
disease.
SPECT scans similarly use gamma-ray emitting radioactive tracers but form
lower resolution images than PET. Common SPECT radiotracers include
technetium-99m, thallium-201, gallium-67, and iodine-123. Like PET tracers,
these label molecules involved in key physiological processes. By monitoring
the distribution and movement of radiotracers in the body, SPECT scans can
identify abnormalities and lesions. For example, SPECT scans with thallium-
201 or technetium-99m can detect blood flow issues in the heart muscle to
diagnose heart disease. Iodine-123 scans are also useful for diagnosing
thyroid disease and cancers.
NMR imaging, more commonly known as magnetic resonance imaging (MRI),
uses the magnetic properties of atomic nuclei instead of radioactivity. Many
MRI scans utilize the hydrogen nuclei naturally present in water molecules in
the body. Powerful magnets and radiofrequency pulses are used to excite the
magnetic dipoles of these nuclei, causing them to emit radio signals that can
be used to construct diagnostic images. MRI provides excellent soft tissue
contrast and has become an invaluable tool for examining the brain, spine,
joints, and many other internal structures without exposure to radiation.
Contrast agents containing gadolinium can also be intravenously
administered to enhance MRI images.
Radioisotope therapy
In addition to diagnostics, some radionuclides have therapeutic applications
for treating various medical conditions. One of the most well established is
the use of iodine-131 to treat hyperthyroidism and thyroid cancer. Iodine-131
has similar chemical properties to stable iodine and readily accumulates in
the thyroid gland where it destroys remaining thyroid tissue through beta
radiation exposure. This reduces overproduction of hormones in
hyperthyroidism while also destroying any cancerous thyroid cells. Treatment
is usually very effective with few side effects.
Strontium-89 and samarium-153 are also effective medical radioisotopes for
treating bone metastases from cancers like prostate and breast cancer.
These beta emitters selectively concentrate in areas of increased bone
turnover like cancerous bone lesions. Their radiation can help strengthen
bones weakened by metastases and relieve pain by ablating the cancer cells
within bone tissue. Radioimmunotherapy uses antibodies tagged with short-
range alpha or beta-emitting radioisotopes to bind to and destroy cancer
cells at a molecular level. Targeted isotopes include yttrium-90, iodine-131,
lutetium-177 and bismuth-213.
Other promising therapeutic radionuclides in development include actinium-
225 and lead-212. Actinium-225 generates four alpha particle emissions in
its decay chain and shows potential for treating acute myeloid leukemia and
other cancers if attached to monoclonal antibodies. Lead-212 can also
generate alpha decays and has a very short half-life of only 10.6 hours,
allowing it to deliver highly localized radiation doses without traveling far
from tumors. As radiotherapeutics continue to be researched and refined,
selective internal radiation exposures may become viable alternatives or
supplements to external beam radiation treatments for various cancers and
other conditions.
Radiopharmaceutical production
The production of radiotracers and radiopharmaceuticals for medical
applications is a major industry that generates billions in revenue annually.
Common medical radioisotopes like technetium-99m, iodine-123 and -131,
gallium-67, thallium-201, fluorine-18 and others are produced globally in
specialized nuclear reactors, particle accelerators, or generators. Radioactive
milling and processing facilities purify and formulate radionuclides into stable
chemical compounds suitable for intravenous injection or ingestion by
patients before scanning or therapy. Stringent regulations and quality
controls ensure the radioactive drugs are manufactured under high purity,
sterility, and maximum specific radioactivity standards. Continuous fission
reactors like those in Canada routinely supply over 80% of the U.S. demand
for the workhorse technetium-99m isotope needed for tens of thousands of
SPECT scans every day. The global medical radioisotope market, dominated
by the top three firms, is projected to grow annually by over 5% through
2027 due to expanding clinical applications and replacements for aging
reactor infrastructure. Overall, nuclear medicine has revolutionized diagnosis
and treatment, helping improve millions of lives.
Part 2: Applications in Industry
Isotope production
In addition to medical uses, nuclear processes are employed industrially to
produce important stable and radioactive isotopes. Light water reactors
generate sizeable quantities of plutonium-239 as a byproduct of uranium-238
absorbing neutrons. Plutonium-239 has a half-life of 24,100 years and its
decay produces mostly alpha particles, making it well suited for
thermoelectric applications in radioisotope thermoelectric generators (RTGs).
RTGs powered U.S. space missions for over 50 years including Voyager,
Galileo, and Curiosity by using the heat from plutonium-238's radioactive
decay.
Tritium, a radioactive isotope of hydrogen, is primarily used in self-luminous
sights for firearms, emergency exit signs, and other low light applications. It
is commercially produced by irradiating a lithium target with neutrons in a
nuclear reactor, followed by chemical separation. Large quantities of
naturally occurring krypton-81 are also collected from gaseous fission
products extracted from reactor off-gases. This stable noble gas isotope finds
use as an inert filler for energy efficient light bulbs and flat panel displays.
Neutron activation analysis
Another nuclear technique employed in industry is neutron activation
analysis (NAA), which involves irradiating samples with neutrons in a nuclear
reactor. This process causes certain elements in the sample to become
radioactive via neutron capture. By precisely measuring the gamma radiation
signatures emitted as these artificially produced radioisotopes decay, it is
possible to quantitatively determine the elemental composition of even
complex industrial materials down to trace quantities. NAA is useful for
quality control in sectors like mining, metallurgy, electronics manufacturing
and more. It can rapidly screen bulk samples for contaminants or verify
purity in a non-destructive manner.
Industrial radiography
Industrial radiography utilizes penetrating gamma and X-rays from
radioactive isotopes to examine the internal structures and defects in large
industrial components without having to dismantle or destroy them.
Common radiographic sources include cobalt-60, iridium-192, selenium-75
and caesium-137. The images reveal flaws invisible from the surface like
cracks, voids, corrosion or faulty welds in critical infrastructure parts like
pipelines, pressure vessels, bridges and machinery. This allows issues to be
addressed before catastrophic failures occur. While X-ray machines can also
perform industrial radiography, radioactive sources provide more penetrating
power for larger and higher density objects. However, their encapsulated
sources must be carefully shielded and handled to prevent exposure when
not in use.
Sterilization
Today, over half of all medical devices and many food products worldwide are
sterilized using gamma or electron beam radiation from radioactive isotopes.
Cobalt-60 is a popular gamma source that can penetrate packaging and
thoroughly sterilize items. The high-energy photons destroy microbes like
bacteria and viruses without leaving chemical residues. As no thermal or
pressure factors are involved, radiation sterilization maintains product
integrity and is suitable for heat- and moisture-sensitive items. In addition to
consumables, radiation has widespread uses decontaminating medical
equipment and sterilizing surgical gowns, drapes and implants before they
reach hospitals and patients. When combined with strict quality controls,
radiation-based sterilization provides a safe, effective and environmentally-
friendly alternative to steam, EtO gas or other chemical sterilants.
Part 3: Applications in Energy Production
Nuclear fission power
Nuclear fission reactors harness the energy released during nuclear fission
chain reactions to generate electricity on a commercial scale. Fissile
uranium-235 or plutonium-239 atoms are bombarded with neutrons and then
split apart, releasing additional neutrons, heat in the form of kinetic energy,
and gamma radiation. In a nuclear power plant, the heat generated is used
to produce steam that drives turbines connected to electricity generators.
Over 450 nuclear reactors worldwide currently supply about 10% of the
global electricity demand and one-third of low-carbon power. Generation II
light water reactors dominate the global fleet while Generation III+ and IV
designs incorporate passive safety and materials innovations.
Proponents argue nuclear energy is a stable, reliable, low-carbon baseload
power source able to meet rising energy needs. Unlike intermittent
renewables, fission continuously operates 24/7 and maintains the grid
reliability required by modern societies and industries. The energy density
per unit fuel mass from fission vastly exceeds fossil or renewable
alternatives. However, nuclear faces challenges from high capital costs and
construction timescales, nuclear waste management and proliferation
concerns as well as safety risks if accidents occur. Nevertheless, many
experts see it as indispensable for climate goals given its clean attributes,
and over 50 new reactors are under construction worldwide. Ongoing
research aims to sustain a nuclear renaissance through new small modular,
advanced, and fast neutron reactors.
Nuclear fusion power
Nuclear fusion harnesses the energy from fusing atomic nuclei lighter than
iron, the opposite reaction to fission. The most promising approach is using
strong magnetic fields in doughnut-shaped tokamak reactors to heat and
compress hydrogen isotopes deuterium and tritium under extreme
conditions, where their nuclei fuse and release helium atoms along with
energetic neutrons. This fusion process occurs naturally in the cores of stars
and greatly outstrips any chemical energy source on an energy per unit mass
basis. Researchers envision inertial confinement fusion using lasers and
hypersonic z-pinches as alternatives to the magnetic confinement approach.
The International Thermonuclear Experimental Reactor (ITER) tokamak
project currently underway in France aims to demonstrate the scientific and
technical feasibility of fusion power by generating net energy from fusion for
periods of several minutes by 2035. Beyond ITER, commercial fusion reactors
would not emit greenhouse gases, deplete resources or create long-lived
nuclear waste. With hydrogen as fuel, worldwide reserves could last for
millions of years. However, achieving economically viable and self-sustaining
fusion remains an immense technical challenge still far in the future given
difficulty in maintaining plasma stability, tailoring magnetic fields or focusing
laser energy precisely enough for efficient fusion conditions. Yet many think
mastering fusion could revolutionize future energy production sustainably if
the scientific obstacles are overcome.
Nuclear batteries
Radioisotope thermoelectric generators (RTGs) that operate on the heat from
radioactive decay have powered interplanetary spacecraft explorations since
the 1960s. Efforts are underway by companies to design small modular
nuclear batteries optimized to decentralize electricity access for off-grid
communities, charging electric vehicles, powering remote infrastructure
stations and more on Earth. Proposed designs use uranium or plutonium-
based heat sources coupled to micro-CHP engines that convert heat to
electricity via thermoelectrics or Stirling engines. The multi-decade long
operating lifetimes from self-contained and sealed devices could enable
independent power for areas without transmission grids. However nuclear
batteries face commercialization barriers from public acceptance issues,
developing long-term waste storage and obtaining regulatory approvals for
small-scale reactors despite inherent safety advantages versus larger plants.
Their potential role in energy access remains an open question.
Nuclear waste management
Effectively managing nuclear waste produced from both power generation
and medical/research applications remains an outstanding technical
challenge requiring long-term geological isolation. Most waste solutions
center around deep geologic repositories that exploit low water flow and
geochemically stable formations to contain radionuclides for thousands of
years. Engineered thick concrete barriers and steel casks provide multiple
redundant levels of containment and isolation deep underground where the
heat from radioactive decay can dissipate harmlessly. Waste matrices like
glass or ceramics immobilize radionuclides, while advanced monitoring
systems track any subsurface fluid movement. Some countries like Finland
have made significant progress developing permanent nuclear waste
repositories with regulatory approval and community consent. However
political opposition and siting difficulties have stalled other repository
programs worldwide. Advanced reprocessing to reduce long-term
radionuclide inventories and transmute select actinides into shorter-lived
isotopes represent alternatives still under research. Considering the
enormous quantities of long-lived nuclear waste that must be properly
entombed, developing safe geological storage solutions on the timescales of
human civilization remains an unfinished story of high importance.
Conclusion
In conclusion, nuclear chemistry technologies applied across medicine,
industry and energy have greatly benefited humanity but also present
unique challenges that must be soundly addressed. Medical applications of
radioactive tracers and radiotherapeutics have revolutionized diagnosis and
treatment by non-invasively imaging physiological processes in vivo and
selectively targeting diseased tissue. Industrial processes make use of
radioisotopes for isotope production, materials analysis, non-destructive
testing and sterilization under strictly controlled conditions. Nuclear power
already supplies massive amounts of reliable low-carbon energy worldwide,
with the possibility of fusion and modular fission batteries decentralizing
access if technical obstacles are one day overcome.
However, issues from waste management, safety risks, weapons proliferation
linkage and cost overruns associated with nuclear technologies demand
prudent regulation and innovation. Long-term isolation of highly radioactive
byproducts in geological repositories poses scientific and institutional
challenges on tens of thousands of year timescales. Incidents like Chernobyl
and Fukushima also remind of nuclear’s unforgiving realities if accidents
breach multiple safety barriers. Advancing novel reactor concepts and fuel
cycles to proliferate-resistant, walk-away safe and more resource efficient
designs therefore retains importance alongside non-nuclear climate
solutions. Public trust and transparent risk communication likewise matter
greatly for continued development. Overall, a balanced, evidence-based
approach is needed to maximize nuclear’s benefits judiciously, while
prioritizing safety, oversight, waste confinement and nonproliferation into the
deep future. With comprehensive management, nuclear science's peaceful
applications will likely expand to a technology for humanity as keen
understanding of the atom's power increases.
Nuclear chemistry is the study of how nuclei react and change. It involves
changes in the composition and structure of atomic nuclei. Many important
practical applications of nuclear chemistry have emerged that have
massively impacted medicine, industry, and energy production. This paper
will explore the diverse applications of nuclear chemistry across these three
domains and discuss both their benefits as well as some criticisms and
concerns about their use.
Part 1: Applications in Medicine
Medical imaging
One of the most widespread medical applications of nuclear chemistry is in
medical imaging techniques such as positron emission tomography (PET)
scans, single photon emission computed tomography (SPECT) scans, and
nuclear magnetic resonance (NMR) imaging. These techniques utilize
radioactive tracers, which are molecules that have been labeled with
radioactive isotopes. When these tracers are introduced into the body, they
can be detected by specialized cameras and used to form detailed 3D
images of tissues and organs.
PET scans use radioactive tracers that emit positrons. Common PET
radiotracers include fluorine-18, carbon-11, nitrogen-13, and oxygen-15.
These radioactive atoms are attached to molecules that are involved in
normal body processes like glucose metabolism, blood flow, and protein
synthesis. As the radiotracer accumulates in tissues, the positions of emitting
positrons can be detected and used to construct tomographic images of
metabolic activity in the body. PET scans provide extremely sensitive and
quantitative measurements and have revolutionized the detection, diagnosis,
and monitoring of many cancers as well as brain disorders like Alzheimer's
disease.
SPECT scans similarly use gamma-ray emitting radioactive tracers but form
lower resolution images than PET. Common SPECT radiotracers include
technetium-99m, thallium-201, gallium-67, and iodine-123. Like PET tracers,
these label molecules involved in key physiological processes. By monitoring
the distribution and movement of radiotracers in the body, SPECT scans can
identify abnormalities and lesions. For example, SPECT scans with thallium-
201 or technetium-99m can detect blood flow issues in the heart muscle to
diagnose heart disease. Iodine-123 scans are also useful for diagnosing
thyroid disease and cancers.
NMR imaging, more commonly known as magnetic resonance imaging (MRI),
uses the magnetic properties of atomic nuclei instead of radioactivity. Many
MRI scans utilize the hydrogen nuclei naturally present in water molecules in
the body. Powerful magnets and radiofrequency pulses are used to excite the
magnetic dipoles of these nuclei, causing them to emit radio signals that can
be used to construct diagnostic images. MRI provides excellent soft tissue
contrast and has become an invaluable tool for examining the brain, spine,
joints, and many other internal structures without exposure to radiation.
Contrast agents containing gadolinium can also be intravenously
administered to enhance MRI images.
Radioisotope therapy
In addition to diagnostics, some radionuclides have therapeutic applications
for treating various medical conditions. One of the most well established is
the use of iodine-131 to treat hyperthyroidism and thyroid cancer. Iodine-131
has similar chemical properties to stable iodine and readily accumulates in
the thyroid gland where it destroys remaining thyroid tissue through beta
radiation exposure. This reduces overproduction of hormones in
hyperthyroidism while also destroying any cancerous thyroid cells. Treatment
is usually very effective with few side effects.
Strontium-89 and samarium-153 are also effective medical radioisotopes for
treating bone metastases from cancers like prostate and breast cancer.
These beta emitters selectively concentrate in areas of increased bone
turnover like cancerous bone lesions. Their radiation can help strengthen
bones weakened by metastases and relieve pain by ablating the cancer cells
within bone tissue. Radioimmunotherapy uses antibodies tagged with short-
range alpha or beta-emitting radioisotopes to bind to and destroy cancer
cells at a molecular level. Targeted isotopes include yttrium-90, iodine-131,
lutetium-177 and bismuth-213.
Other promising therapeutic radionuclides in development include actinium-
225 and lead-212. Actinium-225 generates four alpha particle emissions in
its decay chain and shows potential for treating acute myeloid leukemia and
other cancers if attached to monoclonal antibodies. Lead-212 can also
generate alpha decays and has a very short half-life of only 10.6 hours,
allowing it to deliver highly localized radiation doses without traveling far
from tumors. As radiotherapeutics continue to be researched and refined,
selective internal radiation exposures may become viable alternatives or
supplements to external beam radiation treatments for various cancers and
other conditions.
Radiopharmaceutical production
The production of radiotracers and radiopharmaceuticals for medical
applications is a major industry that generates billions in revenue annually.
Common medical radioisotopes like technetium-99m, iodine-123 and -131,
gallium-67, thallium-201, fluorine-18 and others are produced globally in
specialized nuclear reactors, particle accelerators, or generators. Radioactive
milling and processing facilities purify and formulate radionuclides into stable
chemical compounds suitable for intravenous injection or ingestion by
patients before scanning or therapy. Stringent regulations and quality
controls ensure the radioactive drugs are manufactured under high purity,
sterility, and maximum specific radioactivity standards. Continuous fission
reactors like those in Canada routinely supply over 80% of the U.S. demand
for the workhorse technetium-99m isotope needed for tens of thousands of
SPECT scans every day. The global medical radioisotope market, dominated
by the top three firms, is projected to grow annually by over 5% through
2027 due to expanding clinical applications and replacements for aging
reactor infrastructure. Overall, nuclear medicine has revolutionized diagnosis
and treatment, helping improve millions of lives.
Part 2: Applications in Industry
Isotope production
In addition to medical uses, nuclear processes are employed industrially to
produce important stable and radioactive isotopes. Light water reactors
generate sizeable quantities of plutonium-239 as a byproduct of uranium-238
absorbing neutrons. Plutonium-239 has a half-life of 24,100 years and its
decay produces mostly alpha particles, making it well suited for
thermoelectric applications in radioisotope thermoelectric generators (RTGs).
RTGs powered U.S. space missions for over 50 years including Voyager,
Galileo, and Curiosity by using the heat from plutonium-238's radioactive
decay.
Tritium, a radioactive isotope of hydrogen, is primarily used in self-luminous
sights for firearms, emergency exit signs, and other low light applications. It
is commercially produced by irradiating a lithium target with neutrons in a
nuclear reactor, followed by chemical separation. Large quantities of
naturally occurring krypton-81 are also collected from gaseous fission
products extracted from reactor off-gases. This stable noble gas isotope finds
use as an inert filler for energy efficient light bulbs and flat panel displays.
Neutron activation analysis
Another nuclear technique employed in industry is neutron activation
analysis (NAA), which involves irradiating samples with neutrons in a nuclear
reactor. This process causes certain elements in the sample to become
radioactive via neutron capture. By precisely measuring the gamma radiation
signatures emitted as these artificially produced radioisotopes decay, it is
possible to quantitatively determine the elemental composition of even
complex industrial materials down to trace quantities. NAA is useful for
quality control in sectors like mining, metallurgy, electronics manufacturing
and more. It can rapidly screen bulk samples for contaminants or verify
purity in a non-destructive manner.
Industrial radiography
Industrial radiography utilizes penetrating gamma and X-rays from
radioactive isotopes to examine the internal structures and defects in large
industrial components without having to dismantle or destroy them.
Common radiographic sources include cobalt-60, iridium-192, selenium-75
and caesium-137. The images reveal flaws invisible from the surface like
cracks, voids, corrosion or faulty welds in critical infrastructure parts like
pipelines, pressure vessels, bridges and machinery. This allows issues to be
addressed before catastrophic failures occur. While X-ray machines can also
perform industrial radiography, radioactive sources provide more penetrating
power for larger and higher density objects. However, their encapsulated
sources must be carefully shielded and handled to prevent exposure when
not in use.
Sterilization
Today, over half of all medical devices and many food products worldwide are
sterilized using gamma or electron beam radiation from radioactive isotopes.
Cobalt-60 is a popular gamma source that can penetrate packaging and
thoroughly sterilize items. The high-energy photons destroy microbes like
bacteria and viruses without leaving chemical residues. As no thermal or
pressure factors are involved, radiation sterilization maintains product
integrity and is suitable for heat- and moisture-sensitive items. In addition to
consumables, radiation has widespread uses decontaminating medical
equipment and sterilizing surgical gowns, drapes and implants before they
reach hospitals and patients. When combined with strict quality controls,
radiation-based sterilization provides a safe, effective and environmentally-
friendly alternative to steam, EtO gas or other chemical sterilants.
Part 3: Applications in Energy Production
Nuclear fission power
Nuclear fission reactors harness the energy released during nuclear fission
chain reactions to generate electricity on a commercial scale. Fissile
uranium-235 or plutonium-239 atoms are bombarded with neutrons and then
split apart, releasing additional neutrons, heat in the form of kinetic energy,
and gamma radiation. In a nuclear power plant, the heat generated is used
to produce steam that drives turbines connected to electricity generators.
Over 450 nuclear reactors worldwide currently supply about 10% of the
global electricity demand and one-third of low-carbon power. Generation II
light water reactors dominate the global fleet while Generation III+ and IV
designs incorporate passive safety and materials innovations.
Proponents argue nuclear energy is a stable, reliable, low-carbon baseload
power source able to meet rising energy needs. Unlike intermittent
renewables, fission continuously operates 24/7 and maintains the grid
reliability required by modern societies and industries. The energy density
per unit fuel mass from fission vastly exceeds fossil or renewable
alternatives. However, nuclear faces challenges from high capital costs and
construction timescales, nuclear waste management and proliferation
concerns as well as safety risks if accidents occur. Nevertheless, many
experts see it as indispensable for climate goals given its clean attributes,
and over 50 new reactors are under construction worldwide. Ongoing
research aims to sustain a nuclear renaissance through new small modular,
advanced, and fast neutron reactors.
Nuclear fusion power
Nuclear fusion harnesses the energy from fusing atomic nuclei lighter than
iron, the opposite reaction to fission. The most promising approach is using
strong magnetic fields in doughnut-shaped tokamak reactors to heat and
compress hydrogen isotopes deuterium and tritium under extreme
conditions, where their nuclei fuse and release helium atoms along with
energetic neutrons. This fusion process occurs naturally in the cores of stars
and greatly outstrips any chemical energy source on an energy per unit mass
basis. Researchers envision inertial confinement fusion using lasers and
hypersonic z-pinches as alternatives to the magnetic confinement approach.
The International Thermonuclear Experimental Reactor (ITER) tokamak
project currently underway in France aims to demonstrate the scientific and
technical feasibility of fusion power by generating net energy from fusion for
periods of several minutes by 2035. Beyond ITER, commercial fusion reactors
would not emit greenhouse gases, deplete resources or create long-lived
nuclear waste. With hydrogen as fuel, worldwide reserves could last for
millions of years. However, achieving economically viable and self-sustaining
fusion remains an immense technical challenge still far in the future given
difficulty in maintaining plasma stability, tailoring magnetic fields or focusing
laser energy precisely enough for efficient fusion conditions. Yet many think
mastering fusion could revolutionize future energy production sustainably if
the scientific obstacles are overcome.
Nuclear batteries
Radioisotope thermoelectric generators (RTGs) that operate on the heat from
radioactive decay have powered interplanetary spacecraft explorations since
the 1960s. Efforts are underway by companies to design small modular
nuclear batteries optimized to decentralize electricity access for off-grid
communities, charging electric vehicles, powering remote infrastructure
stations and more on Earth. Proposed designs use uranium or plutonium-
based heat sources coupled to micro-CHP engines that convert heat to
electricity via thermoelectrics or Stirling engines. The multi-decade long
operating lifetimes from self-contained and sealed devices could enable
independent power for areas without transmission grids. However nuclear
batteries face commercialization barriers from public acceptance issues,
developing long-term waste storage and obtaining regulatory approvals for
small-scale reactors despite inherent safety advantages versus larger plants.
Their potential role in energy access remains an open question.
Nuclear waste management
Effectively managing nuclear waste produced from both power generation
and medical/research applications remains an outstanding technical
challenge requiring long-term geological isolation. Most waste solutions
center around deep geologic repositories that exploit low water flow and
geochemically stable formations to contain radionuclides for thousands of
years. Engineered thick concrete barriers and steel casks provide multiple
redundant levels of containment and isolation deep underground where the
heat from radioactive decay can dissipate harmlessly. Waste matrices like
glass or ceramics immobilize radionuclides, while advanced monitoring
systems track any subsurface fluid movement. Some countries like Finland
have made significant progress developing permanent nuclear waste
repositories with regulatory approval and community consent. However
political opposition and siting difficulties have stalled other repository
programs worldwide. Advanced reprocessing to reduce long-term
radionuclide inventories and transmute select actinides into shorter-lived
isotopes represent alternatives still under research. Considering the
enormous quantities of long-lived nuclear waste that must be properly
entombed, developing safe geological storage solutions on the timescales of
human civilization remains an unfinished story of high importance.
Conclusion
In conclusion, nuclear chemistry technologies applied across medicine,
industry and energy have greatly benefited humanity but also present
unique challenges that must be soundly addressed. Medical applications of
radioactive tracers and radiotherapeutics have revolutionized diagnosis and
treatment by non-invasively imaging physiological processes in vivo and
selectively targeting diseased tissue. Industrial processes make use of
radioisotopes for isotope production, materials analysis, non-destructive
testing and sterilization under strictly controlled conditions. Nuclear power
already supplies massive amounts of reliable low-carbon energy worldwide,
with the possibility of fusion and modular fission batteries decentralizing
access if technical obstacles are one day overcome.
However, issues from waste management, safety risks, weapons proliferation
linkage and cost overruns associated with nuclear technologies demand
prudent regulation and innovation. Long-term isolation of highly radioactive
byproducts in geological repositories poses scientific and institutional
challenges on tens of thousands of year timescales. Incidents like Chernobyl
and Fukushima also remind of nuclear’s unforgiving realities if accidents
breach multiple safety barriers. Advancing novel reactor concepts and fuel
cycles to proliferate-resistant, walk-away safe and more resource efficient
designs therefore retains importance alongside non-nuclear climate
solutions. Public trust and transparent risk communication likewise matter
greatly for continued development. Overall, a balanced, evidence-based
approach is needed to maximize nuclear’s benefits judiciously, while
prioritizing safety, oversight, waste confinement and nonproliferation into the
deep future. With comprehensive management, nuclear science's peaceful
applications will likely expand to a technology for humanity as keen
understanding of the atom's power increases.
Nuclear chemistry is the study of how nuclei react and change. It involves
changes in the composition and structure of atomic nuclei. Many important
practical applications of nuclear chemistry have emerged that have
massively impacted medicine, industry, and energy production. This paper
will explore the diverse applications of nuclear chemistry across these three
domains and discuss both their benefits as well as some criticisms and
concerns about their use.
Part 1: Applications in Medicine
Medical imaging
One of the most widespread medical applications of nuclear chemistry is in
medical imaging techniques such as positron emission tomography (PET)
scans, single photon emission computed tomography (SPECT) scans, and
nuclear magnetic resonance (NMR) imaging. These techniques utilize
radioactive tracers, which are molecules that have been labeled with
radioactive isotopes. When these tracers are introduced into the body, they
can be detected by specialized cameras and used to form detailed 3D
images of tissues and organs.
PET scans use radioactive tracers that emit positrons. Common PET
radiotracers include fluorine-18, carbon-11, nitrogen-13, and oxygen-15.
These radioactive atoms are attached to molecules that are involved in
normal body processes like glucose metabolism, blood flow, and protein
synthesis. As the radiotracer accumulates in tissues, the positions of emitting
positrons can be detected and used to construct tomographic images of
metabolic activity in the body. PET scans provide extremely sensitive and
quantitative measurements and have revolutionized the detection, diagnosis,
and monitoring of many cancers as well as brain disorders like Alzheimer's
disease.
SPECT scans similarly use gamma-ray emitting radioactive tracers but form
lower resolution images than PET. Common SPECT radiotracers include
technetium-99m, thallium-201, gallium-67, and iodine-123. Like PET tracers,
these label molecules involved in key physiological processes. By monitoring
the distribution and movement of radiotracers in the body, SPECT scans can
identify abnormalities and lesions. For example, SPECT scans with thallium-
201 or technetium-99m can detect blood flow issues in the heart muscle to
diagnose heart disease. Iodine-123 scans are also useful for diagnosing
thyroid disease and cancers.
NMR imaging, more commonly known as magnetic resonance imaging (MRI),
uses the magnetic properties of atomic nuclei instead of radioactivity. Many
MRI scans utilize the hydrogen nuclei naturally present in water molecules in
the body. Powerful magnets and radiofrequency pulses are used to excite the
magnetic dipoles of these nuclei, causing them to emit radio signals that can
be used to construct diagnostic images. MRI provides excellent soft tissue
contrast and has become an invaluable tool for examining the brain, spine,
joints, and many other internal structures without exposure to radiation.
Contrast agents containing gadolinium can also be intravenously
administered to enhance MRI images.
Radioisotope therapy
In addition to diagnostics, some radionuclides have therapeutic applications
for treating various medical conditions. One of the most well established is
the use of iodine-131 to treat hyperthyroidism and thyroid cancer. Iodine-131
has similar chemical properties to stable iodine and readily accumulates in
the thyroid gland where it destroys remaining thyroid tissue through beta
radiation exposure. This reduces overproduction of hormones in
hyperthyroidism while also destroying any cancerous thyroid cells. Treatment
is usually very effective with few side effects.
Strontium-89 and samarium-153 are also effective medical radioisotopes for
treating bone metastases from cancers like prostate and breast cancer.
These beta emitters selectively concentrate in areas of increased bone
turnover like cancerous bone lesions. Their radiation can help strengthen
bones weakened by metastases and relieve pain by ablating the cancer cells
within bone tissue. Radioimmunotherapy uses antibodies tagged with short-
range alpha or beta-emitting radioisotopes to bind to and destroy cancer
cells at a molecular level. Targeted isotopes include yttrium-90, iodine-131,
lutetium-177 and bismuth-213.
Other promising therapeutic radionuclides in development include actinium-
225 and lead-212. Actinium-225 generates four alpha particle emissions in
its decay chain and shows potential for treating acute myeloid leukemia and
other cancers if attached to monoclonal antibodies. Lead-212 can also
generate alpha decays and has a very short half-life of only 10.6 hours,
allowing it to deliver highly localized radiation doses without traveling far
from tumors. As radiotherapeutics continue to be researched and refined,
selective internal radiation exposures may become viable alternatives or
supplements to external beam radiation treatments for various cancers and
other conditions.
Radiopharmaceutical production
The production of radiotracers and radiopharmaceuticals for medical
applications is a major industry that generates billions in revenue annually.
Common medical radioisotopes like technetium-99m, iodine-123 and -131,
gallium-67, thallium-201, fluorine-18 and others are produced globally in
specialized nuclear reactors, particle accelerators, or generators. Radioactive
milling and processing facilities purify and formulate radionuclides into stable
chemical compounds suitable for intravenous injection or ingestion by
patients before scanning or therapy. Stringent regulations and quality
controls ensure the radioactive drugs are manufactured under high purity,
sterility, and maximum specific radioactivity standards. Continuous fission
reactors like those in Canada routinely supply over 80% of the U.S. demand
for the workhorse technetium-99m isotope needed for tens of thousands of
SPECT scans every day. The global medical radioisotope market, dominated
by the top three firms, is projected to grow annually by over 5% through
2027 due to expanding clinical applications and replacements for aging
reactor infrastructure. Overall, nuclear medicine has revolutionized diagnosis
and treatment, helping improve millions of lives.
Part 2: Applications in Industry
Isotope production
In addition to medical uses, nuclear processes are employed industrially to
produce important stable and radioactive isotopes. Light water reactors
generate sizeable quantities of plutonium-239 as a byproduct of uranium-238
absorbing neutrons. Plutonium-239 has a half-life of 24,100 years and its
decay produces mostly alpha particles, making it well suited for
thermoelectric applications in radioisotope thermoelectric generators (RTGs).
RTGs powered U.S. space missions for over 50 years including Voyager,
Galileo, and Curiosity by using the heat from plutonium-238's radioactive
decay.
Tritium, a radioactive isotope of hydrogen, is primarily used in self-luminous
sights for firearms, emergency exit signs, and other low light applications. It
is commercially produced by irradiating a lithium target with neutrons in a
nuclear reactor, followed by chemical separation. Large quantities of
naturally occurring krypton-81 are also collected from gaseous fission
products extracted from reactor off-gases. This stable noble gas isotope finds
use as an inert filler for energy efficient light bulbs and flat panel displays.
Neutron activation analysis
Another nuclear technique employed in industry is neutron activation
analysis (NAA), which involves irradiating samples with neutrons in a nuclear
reactor. This process causes certain elements in the sample to become
radioactive via neutron capture. By precisely measuring the gamma radiation
signatures emitted as these artificially produced radioisotopes decay, it is
possible to quantitatively determine the elemental composition of even
complex industrial materials down to trace quantities. NAA is useful for
quality control in sectors like mining, metallurgy, electronics manufacturing
and more. It can rapidly screen bulk samples for contaminants or verify
purity in a non-destructive manner.
Industrial radiography
Industrial radiography utilizes penetrating gamma and X-rays from
radioactive isotopes to examine the internal structures and defects in large
industrial components without having to dismantle or destroy them.
Common radiographic sources include cobalt-60, iridium-192, selenium-75
and caesium-137. The images reveal flaws invisible from the surface like
cracks, voids, corrosion or faulty welds in critical infrastructure parts like
pipelines, pressure vessels, bridges and machinery. This allows issues to be
addressed before catastrophic failures occur. While X-ray machines can also
perform industrial radiography, radioactive sources provide more penetrating
power for larger and higher density objects. However, their encapsulated
sources must be carefully shielded and handled to prevent exposure when
not in use.
Sterilization
Today, over half of all medical devices and many food products worldwide are
sterilized using gamma or electron beam radiation from radioactive isotopes.
Cobalt-60 is a popular gamma source that can penetrate packaging and
thoroughly sterilize items. The high-energy photons destroy microbes like
bacteria and viruses without leaving chemical residues. As no thermal or
pressure factors are involved, radiation sterilization maintains product
integrity and is suitable for heat- and moisture-sensitive items. In addition to
consumables, radiation has widespread uses decontaminating medical
equipment and sterilizing surgical gowns, drapes and implants before they
reach hospitals and patients. When combined with strict quality controls,
radiation-based sterilization provides a safe, effective and environmentally-
friendly alternative to steam, EtO gas or other chemical sterilants.
Part 3: Applications in Energy Production
Nuclear fission power
Nuclear fission reactors harness the energy released during nuclear fission
chain reactions to generate electricity on a commercial scale. Fissile
uranium-235 or plutonium-239 atoms are bombarded with neutrons and then
split apart, releasing additional neutrons, heat in the form of kinetic energy,
and gamma radiation. In a nuclear power plant, the heat generated is used
to produce steam that drives turbines connected to electricity generators.
Over 450 nuclear reactors worldwide currently supply about 10% of the
global electricity demand and one-third of low-carbon power. Generation II
light water reactors dominate the global fleet while Generation III+ and IV
designs incorporate passive safety and materials innovations.
Proponents argue nuclear energy is a stable, reliable, low-carbon baseload
power source able to meet rising energy needs. Unlike intermittent
renewables, fission continuously operates 24/7 and maintains the grid
reliability required by modern societies and industries. The energy density
per unit fuel mass from fission vastly exceeds fossil or renewable
alternatives. However, nuclear faces challenges from high capital costs and
construction timescales, nuclear waste management and proliferation
concerns as well as safety risks if accidents occur. Nevertheless, many
experts see it as indispensable for climate goals given its clean attributes,
and over 50 new reactors are under construction worldwide. Ongoing
research aims to sustain a nuclear renaissance through new small modular,
advanced, and fast neutron reactors.
Nuclear fusion power
Nuclear fusion harnesses the energy from fusing atomic nuclei lighter than
iron, the opposite reaction to fission. The most promising approach is using
strong magnetic fields in doughnut-shaped tokamak reactors to heat and
compress hydrogen isotopes deuterium and tritium under extreme
conditions, where their nuclei fuse and release helium atoms along with
energetic neutrons. This fusion process occurs naturally in the cores of stars
and greatly outstrips any chemical energy source on an energy per unit mass
basis. Researchers envision inertial confinement fusion using lasers and
hypersonic z-pinches as alternatives to the magnetic confinement approach.
The International Thermonuclear Experimental Reactor (ITER) tokamak
project currently underway in France aims to demonstrate the scientific and
technical feasibility of fusion power by generating net energy from fusion for
periods of several minutes by 2035. Beyond ITER, commercial fusion reactors
would not emit greenhouse gases, deplete resources or create long-lived
nuclear waste. With hydrogen as fuel, worldwide reserves could last for
millions of years. However, achieving economically viable and self-sustaining
fusion remains an immense technical challenge still far in the future given
difficulty in maintaining plasma stability, tailoring magnetic fields or focusing
laser energy precisely enough for efficient fusion conditions. Yet many think
mastering fusion could revolutionize future energy production sustainably if
the scientific obstacles are overcome.
Nuclear batteries
Radioisotope thermoelectric generators (RTGs) that operate on the heat from
radioactive decay have powered interplanetary spacecraft explorations since
the 1960s. Efforts are underway by companies to design small modular
nuclear batteries optimized to decentralize electricity access for off-grid
communities, charging electric vehicles, powering remote infrastructure
stations and more on Earth. Proposed designs use uranium or plutonium-
based heat sources coupled to micro-CHP engines that convert heat to
electricity via thermoelectrics or Stirling engines. The multi-decade long
operating lifetimes from self-contained and sealed devices could enable
independent power for areas without transmission grids. However nuclear
batteries face commercialization barriers from public acceptance issues,
developing long-term waste storage and obtaining regulatory approvals for
small-scale reactors despite inherent safety advantages versus larger plants.
Their potential role in energy access remains an open question.
Nuclear waste management
Effectively managing nuclear waste produced from both power generation
and medical/research applications remains an outstanding technical
challenge requiring long-term geological isolation. Most waste solutions
center around deep geologic repositories that exploit low water flow and
geochemically stable formations to contain radionuclides for thousands of
years. Engineered thick concrete barriers and steel casks provide multiple
redundant levels of containment and isolation deep underground where the
heat from radioactive decay can dissipate harmlessly. Waste matrices like
glass or ceramics immobilize radionuclides, while advanced monitoring
systems track any subsurface fluid movement. Some countries like Finland
have made significant progress developing permanent nuclear waste
repositories with regulatory approval and community consent. However
political opposition and siting difficulties have stalled other repository
programs worldwide. Advanced reprocessing to reduce long-term
radionuclide inventories and transmute select actinides into shorter-lived
isotopes represent alternatives still under research. Considering the
enormous quantities of long-lived nuclear waste that must be properly
entombed, developing safe geological storage solutions on the timescales of
human civilization remains an unfinished story of high importance.
Conclusion
In conclusion, nuclear chemistry technologies applied across medicine,
industry and energy have greatly benefited humanity but also present
unique challenges that must be soundly addressed. Medical applications of
radioactive tracers and radiotherapeutics have revolutionized diagnosis and
treatment by non-invasively imaging physiological processes in vivo and
selectively targeting diseased tissue. Industrial processes make use of
radioisotopes for isotope production, materials analysis, non-destructive
testing and sterilization under strictly controlled conditions. Nuclear power
already supplies massive amounts of reliable low-carbon energy worldwide,
with the possibility of fusion and modular fission batteries decentralizing
access if technical obstacles are one day overcome.
However, issues from waste management, safety risks, weapons proliferation
linkage and cost overruns associated with nuclear technologies demand
prudent regulation and innovation. Long-term isolation of highly radioactive
byproducts in geological repositories poses scientific and institutional
challenges on tens of thousands of year timescales. Incidents like Chernobyl
and Fukushima also remind of nuclear’s unforgiving realities if accidents
breach multiple safety barriers. Advancing novel reactor concepts and fuel
cycles to proliferate-resistant, walk-away safe and more resource efficient
designs therefore retains importance alongside non-nuclear climate
solutions. Public trust and transparent risk communication likewise matter
greatly for continued development. Overall, a balanced, evidence-based
approach is needed to maximize nuclear’s benefits judiciously, while
prioritizing safety, oversight, waste confinement and nonproliferation into the
deep future. With comprehensive management, nuclear science's peaceful
applications will likely expand to a technology for humanity as keen
understanding of the atom's power increases.
